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SUmiHART
Endotoxin Q ipopolysaccharide, LPS) is  a p a rt of the  envelope o f G ram -negative 
bacte ria . Among the  d iffe re n t m ethods fo r the  detection and m easurem ent of 
endotoxin, the  L im ulus amoebocgte Igsate (LAL) assay is  the  m ost w ide ly used. 
The reagent used in  th is  assay is  the  lysa te  of blood cells (amoebocytes) of one of 
the  species of horseshoe crab, usua lly Lim ulus polgphem us.
The m ost recent developm ent am ong the  objective and q u a n tita tive  LAL assay 
m ethods is  a chrom ogenic m ethod, w h ich  uses a syn th e tic  chrom ogenic peptide 
su b s tra te . This m ethod is  based on the  p rin c ip le  th a t endotoxin-activated lysate 
releases from  the  colourless substrate yellow  p -n itro a n ilin e  (pHA), w h ich  can be 
m easured spectropho tom etrica lly .
In  th is  study, the  o rig in a l tw o-stage assay, as recom mended by the  LAL 
m anu factu re r, was optim ized. This resulted in  a te n -fo ld  increase in  se n s itiv ity  
of the  assay and a tw o-fo ld  decrease in  the  volumes of expensive reagents.
The processing tim e  of la rge num bers of sam ples w a ^ s ig n ific a n tly  decreased by 
using m icrop la tes fo r spectrophotom etric readings in  a IIIICROELISA IR ln iR eader.
Subsequently, the  tw o-stage assay was fu rth e r m odified and a one-stage m ethod 
was developed. This resulted in  a fu rth e r five -fo ld  increase in  s e n s itiv ity  of the 
assay, to  0 .2  pg endotoxin/m l of pyrogen-ffee w a te r, w h ich  is  the  equivalent of
0.002 Endotoxin U n its (EU)/ml of pyrogen-free w a te r, w ith  the  lin e a rity  of the 
s tandard  curve in  the range of 0-2 pg /m l or 0-0.023 EU/m l. In  plasm a, the 
th resho ld  of s e n s itiv ity  was 1 p g /m l (0.012 EU/m l) and the  standard curve was 
lin e a r in  the  range 0-30 p g /m l (0-0. 345 EU/m l). Other advantages of the one- 
stage assay were: a fu rth e r decrease in  reagent volumes and reduction of the 
tim e  required fo r processing large num bers of sam ples.
x iii
In  th is  study, the  chrom ogenic LAL assay v a s  used fo r detection of endotoxin in  
c lin ic a l and n o n -c lin ic a l s tud ies. Endotoxin is  though t to be on im p o rta n t facto r 
in  the  pathogenesis of G ram -negative in fections, a lthough its  exact ro le  rem a ins 
u n kn o vn . However, d iffic u ltie s  arise  when the  LAL assay is  used fo r the  detection
bt^cuus^ {>/
o f endotoxin in  hum an blood. This is  ^  the  presence in  blood of in h ib ito rs  and 
non-specific a c tiva to rs  of the  assay.
The c lin ic a l studies involved th ree  tr ia ls : septic shock, cyclic  neutropenia and 
acute p a n c re a titis .
The septic shock W a l consisted of tw o groups of pa tien ts:
Group 1 -  ten  c r itic a lly  i l l ,  bu t no t necessarily septic shock pa tie n ts  w ith  d a ily  
LAL assays and sim ultaneous blood cu ltu res;
Group 2 -  e igh t acute septic shock pa tien ts , who had fo u r-h o u rly  LAL assays fo r 
the  f ir s t  48 hours, and the rea fte r d a ily . Blood fo r blood cu ltu res and 
fib ro n e c tin  was taken sim ultaneously w ith  blood fo r LAL assays. 
Cardiovascular and re sp ira to ry  ^  were also measured a t the  
same tim e .
The septic shock t r ia l dem onstrated the  need for frequent m on ito rin g  o f endotoxin 
levels in  acute cond itions. In  Group 2, an inverse corre la tion  between endotoxin 
levels and plasm a fib ro n e c tin  was shown. In  m ost cases, endotoxin levels 
corre lated w ith  card iovascular and resp ira to ry  Indices. However, there  seemed 
to be no co rre la tion  between the  severity  of septic shock and absolute levels of 
endotoxin. Several hypotheses are discussed fo r fu tu re  ve rifica tio n .
x iv
The cyclic  neutropenia t r ia l involved one p a tie n t. In  the  acute pa n cre a titis  t r ia l 
16 pa tien ts  were exam ined The resu lts  of bo th  studies were
unsa tis facto ry . This was m ost lik e ly  ^ inadequate sam p ling . Therefore no 
conclusions could be made about the  ro le  o f endotoxin in  these cond itions. A 
d iffe re n t approach is  suggested fo r fu tu re  stud ies.
In  the  n o n -c lin ic a l stud ies, the  LAL assay was used to  exam ine tw o p ra c tica l 
prob lem s. One was the  rem oval of endotoxin from  hum an blood and the  o ther 
was in ve s tig a tio n  of the  ro le  of endotoxin as an occupational ha za rd . Thus the  
perform ance of an extra -corporea l f ilte r  (DEP-1) fo r rem oval o f endotoxin from  
hum an blood was tested. The f ilte r  appeared to  be incapable of ex trac ting  
c lin ic a lly  s ig n ific a n t am ounts of endotoxin from  hum an p lasm a . Endotoxin levels 
were measured in  baffle  p la te  m a te ria l from  the  h u m id ifica tio n  system  of a 
sem i-conductor fac to ry  and in  a dust sam ple from  books in  an a rch ive  lib ra ry . 
Endotoxin, w h ich  was found in  bo th , could have been a t least p a rtia lly  responsible 
fo r the  c lin ic a l sym ptom s reported by the  facto ry  w orkers and lib ra ry  s ta ff.
I. miRODucnon 
1 i . Endotoxin 
H i.H is to r y
The h is to ry  of fever goes hack 2 500 years and is  as old as the  h is to ry  of m edicine 
its e lf (644). Since th e n , th roughout the  centuries, fever has been seen not on ly as 
a th re a t, sym ptom  or expression of disease, bu t also as an in d ica tio n  of activa ted 
defence, w h ich  should be prom oted by the  phys ic ian  (644, 383). The Greek 
phys ic ia n  H ippocrates in  the  4th cen tu ry B.C. described m any diseases 
accom panied by fever. In  c.%K) B.C., another Greek phys ic ian , Parm enides, was 
p ra is in g  the  benefic ia l effects o f fever as a cure fo r a ll illnesses. His fe llow  
coun trym an,G alen, in  the 2nd century AD .,reported fever as a cu re ,o r as having  
a t least a favourable in fluence on a va rie ty  of cond itions.
In  th t  m odem  era, fever therapy has been applied to  tre a tm e n t of psych ia tric  
cond itions (459, 579), para lys is  (625, 626), cancer (78, 79, 80, 111, 127), bacte ria l 
endocard itis  (538), herpes zoster (34), encepha litis , encephalom yelitis, 
rheum ato id  a r th r itis , chorea, various eye and sk in  diseases (579), neurosyphilis 
(126, 217, 365), abdom inal typhus (467), gonorrhoea and m any o ther conditions 
(14).
There were also several com m ercial bacte ria l preparations developed fo r fever 
in d u c tio n , w h ich  were used fo r trea tm en t of d iffe re n t c lin ic a l conditions (385). 
The f ir s t  o f these, "P yrife r", was a p repara tion  obtained by grow ing a 
non-pathogenic ‘colon* bacterium  in  m ilk . I t  was m arketed in  seven s treng ths, 
ra n g in g  from  50 to 500 bacteria  per m l. T yrom en" was an endotoxin preparation 
obtained a fte r iso la tion  and p a rtia l p u rifica tio n  of endotoxin from  Pseudomonas 
aerucpTiQsa. I t  was prepared and m arketed by Baxter Laboratories. "Pyrexal
(lip e za l") vas a prodvol developed by Yonder QmbH, Bern, Svitzerlond, vhioh  
contained a purified and highly potent endotoxin, obtained according to the 
method ofVestphal (000).
The term  "pyrogenio substance" vas firs t used in  1802 by T B illroth (38). In  1875, J. 
Burdon-Sanderson named the (ever-producing bacterial substances "pyrogen" 
(55). In  1802,Pfeifier observed th at chdera vibrics,in  addition to the toxin vhioh  
they excreted into the culture medium -  the exotoxin -  produced another, quite 
different toxin, vhioh vas tigh tly  anchored to the bacterial cell (420). Pfeiffer 
coined the term  "endotoxin" for it  (058).
The la tte r name referred both to pathophysiologioal properties of the bacterial 
substance, vhioh exerted a speoifio toxic action, and to its  structural property of 
being tig h tly  anchored to the bacterial cell.
In  1884 the Danish physician Hans C.J.Qram made an accidental discovery of a 
nev Staining technique (182), vhioh led to Classifying bacteria into tvo  m ajor 
groups: Gram-negative and Gram-positive.
Endotoxins vere firs t isolated in  1933 by Boivin and Hlesrobeanu (47,48), vho also 
firs t determined their biochemical nature. Their technique involved extraction 
v ith  cold trichloroacetic add and provided LPS preparations vhioh also 
contained significant quantities of jnrotein and lip id . Endotoxin-assooiated 
protein later found v ith  LPS prepared by this method is mltogenio for B 
lymphocytes (221,334,383,552,553), irrespective of any mitogenio effects of LPS, 
vhioh is refleoted in  high immunologio activity of Bdvin-type LPS preparations.
Boivin mode also a rem arkable discovery, viz, th at Ibe bacteria vhioh produced 
endotoxins vere a ll of the Gram-negative type.
The term  "lipopolysacohar ide" (LPS) is most frequently used to describe the 
endotoxins obtained by the extraction procedure of Vestphal and Lüderitz (383). 
They utilized hot aqueous phenol for extraction (043). This technique provides LPS 
practically free of protein and is probably novadays the most extensively used 
method for production of LPS preparations (300). Hovever, the term  
lipopolysacoharide" m erely describes endotoxins biochemically, and the term s 
lipopolysaccharide (LPS), glycolipid (for endotoxins from rough m utants), 
0-antigen (0-somatio or O-spedfio antigen), bacterial pyrogen and endotoxin 
have been used interchangeably (300).
11 2 . Biochemistry
The envelope of most Gram-negative bacteria is built up of the fblloving layers
outvards from  the cytoplasm of the cell (450):
1. The plasma or oytoplasmio membrane appearing as a unit membrane of 
three layers;
2. A th in  peptidoglycan layer (called also m urein or mucopeptide (53)).
3. A usually som evhat structureless lipoprotein zone (periplasmic space);
4 . An outer phospholipid-protein membrane appearing as a second unit 
membrane of three layers;
5. Lipopolysacoharide that can usually only be made visible by application of 
suitably labelled antibodies,such as those conjugated v ith  fe rritin .
0  chains
CAP Y,
S layer
:
PM
m m # niiima
Fig 1 Cell v a il o f G ram -negative Ix io te ria .
pm  -  p lasm a m em brane
PG -  r ig id  o r R lager (peptidc^lgoan)
om  -  outer m em brane
LPS -lipopo lgsaccharide
CAP -  polysaccharide capsules
pp -  p ro te ins
Ip -lip o p ro te in s
p i -  phospholip ids
eca -  en terobacteria l com mon antigen
F -  üagellum
P j -  fim b ria
P2 -  p ilus
From : Freer, J R . :  m ustra ted  guide to  the  anatom y of the  ba c te ria l ce ll envelope. 
In : DES. S tevart-TuU , m . Davies (eds J: Im m unoloau o f the  B acteria l Cell Envelope. 
John V ile g  & Sons, Chichester 1985, pp 355-383.
Differences in  distances of separation between the  layers, i f  no t in  the  n um ber of 
la ye rs , exist in  various G ram -negative species. Also, m any G ram -negative
bacte ria  have an outerm ost surrounding envelope, va rious ly  term ed capsules
col*
w ith  K lebsie lla spp. and meningococcus spp.. K antigen w il^ o o l i l and V i an tigen 
w ith  Salm onella to p h i. Some bacteria  also have tw o form s o f filifo rm  extensions -  
flage lla  and p ili o r fim b ria e . Capsules, V i antigen and m ost K antigens are 
polysaccharides bu t a few K antigens are prote ins (305).
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Polysaccharide
; Monosaccharide , •  Phosphate , Ethanolamine 
Long Chain( Hydroxy ) Fat ty  Acid
Lipopolçsoccharides are oharaolerisUcall^  fovnd in  the Qrazn~negalive baoteria 
and they are knovn lo represent the endotozlc principle of Oram-negative 
organisms (299). Hovever, an endotoxin-like m aterial, chemicallg verg sim ilar to 
Gram-negative endotoxins, has been isolated from  the Gram-positive organism  
lis te ria  monoootoaenes. In  contrast, the Gram-negative spirochaetes Barrelia 
reonrrentis. Porrelia hispanioa and Treponema pallidnm  lack LPS (57,154,199). 
Also, apart from the “stm ctnral endotoxin", vhioh builds va ils  of Gram-negative 
bacteria, there is also "free endotoxin" vhich is released from  cells during normal 
healthg grovth (91, 101, 384,473). From the point of viev of physico-chemical
properties, endotoxins are high molecular veight (^ 2  x 10  ^to ID  x 1 (f) (309,436),
heat stable (100* C) substances. Endotoxins from different groups of 
Gram-negative bacteria conform to a common structural principle: they consist 
of a polysaccharide and a covalently bound lipid component, termed lipid A (542). 
The polysaccharide component consists of tvo  subcomponents: the 0-specific 
chain and the core. As an exam ple,Fig.2 shovs schematically the architecture of 
a Salmonella lipopdlnsaccharide.
Fig 2 Schematic structure of a ^im onsiia lipopolysaccharide.
From: Rietschel, E. T., Sohade, U., Jensen, m., VoUenveber, H .-V ., Lüderiti, 0., 
Greisman, S.G.: Bacterial endotoxins: chemical structure, biological activity and 
role in  septicaemia. Scand.J.Infect.Pis. 1982,Suppl.31:8-21.
The heteropclysaccharide (0-specific chain and core) carries those structures 
vhich are recognized by lectins,specific antibodies and bacteriophages (300). It  is 
nigft involved in  bacterial virulence (293), the induction of certain host derived 
mediators (382,510) and the tumour necrotic activity of lipopolysaccharides (450).
On the other hand, lip id  A is re^)onsihle for the endotoxio properties of 
lipopolysaccharides (103).
The 0-speoiflo chains are polymers of oligosaccharide molecules, and they consist 
of a sequence of identical units, the so-called "repeating units" (301). In  rare  
oases, 0-specific chains m ay represent a homopolysacoharide, such as a mannan 
or a galactan. Each serotype of Gram -negative bacterium is characterized by a 
unique structure in  the 0-spedfic chain, thus creating a great variety of 
lipopolysaccharide structure and composition.
Studies on 0-spëcific chains have revealed m any nev sugar classes as v e il as 
unusual sugar derivatives. The average length of 0-specifio chains varies firom 
one species to another, but a high degree of heterogeneity is seen v ith in  species 
(174,400).
core polysaccharide consists of an outer core and an inner core (52). The outer 
core in  the fiiim onrtin species is a lipid A -distal branched digcsaccharide 
containing the common hezoses: 11-acetyl-D-glucosamine, P-glucose and 
D-galaotose. The inner core is a lipid A-proxim al branched digcsaccharide 
containing unique, core-specific sugars, L-glycero-P-mannoheptose (L, P-Hep, 
Hep) and 2-keto-3-deoxy-P-mannooctonate (EDO) (301). The 0 chain is linked to 
the subterm inal glTicose residue; the reducing EPO group forms the link to lipid A. 
Heptose and EPO residues are substituted by phosphate, phosphoryl -  and 
pyrophosphoryl -  ethanolamine groups (280). Together v ith  the carboxyl groups 
of EPO, these confer negative charge to the m decule, vhich is neutralized by a 
m ixture of cations, including m etal ions and pdyam ines. These cations are 
alvays present in  original lipopdysaccharide preparations (162).
The h ig h ly  charged in n e r core re ^ o n  m ay be p o te n tia lly  im p o rta n t fo r the  
physio log ica l functions of tran s loca tion  and in te g ra tio n  o f lipopolysaccharides 
in to  the  outer m em brane, and fo r con fe rring  s ta b ility  on the  outer m em brane. 
This s ta b ility  m ay occur th rough  ca tion-m edia ted ion ic  linkages betveen 
lipopolysaccharide m olecules them selves and betveen lip jpo lysaccharides and 
pro te ins (485).
A ll Salm onella species synthesize LPS v ith  a s im ila r ly  s tructu red  core. H ovever, 
in  o the r Enterobacleriaoeae. such as E co li.S h ioe lla  s d d . Arizona s p p  and in  o ther 
b a c te ria l fa m ilie s , s tru c tu ra lly  d is tin c t core types have been iden tified  (639,649).
The above com plete LFS s tru c tu re  is  synthesized by v ild  S (smooth) fo rm  of 
bacte ria , m any o f v h ic h  are pathogenic in  m an and in  experim enta l an im a ls . 
From  m any G ram -negative organ ism s, R (rough) m u tan ts  have also been 
iso la ted. As a re su lt o f genetic defects they synthesize incom plete LFS, from  
v h ic h  the  0-polysaccharide is  absent and the  core is  present in  d iffe ren t degrees 
o f com pletion. A lthough R fo rm  bacteria  are usua lly non-fx ithogenic, the  
incom plete LFS v h ic h  they possess exh ib its  a ll toxic and other b io logical 
a c tiv itie s  expressed by com plete Lre. Their non-pathogenic character is  m a in ly  
due to  th e ir  in a b ility  to  invade and p ro life ra te  in  the  m acroorganism  (150). In  
Salm onella species, five  m a in  classes (and a num ber of sub-classes) of R m utan ts
have been recognized, and designated R^j to  R^ in  the  order of increasing defect.
R m u ta n ts  made s tru c tu ra l, b iosyn the tic  and genetic investiga tions of the core 
region of lipcjw lysaccharides feasible. I t  v a s  also shovn  th a t incom plete LFS 
from  n il m u ta n ts  had endotoxio a c tiv ity  s im ila r to th a t of the complete LFS from
0-po lysacchar id e
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Ihe parent s tra in . This indicated that the polysaccharide part vas not essential 
for endotoxicitg. Farther vork demonstrated that free lipid A exhibited the 
characteristic biological activities of LFS and vas the endotoxic principle of 
lipopolgsaccharides (for the reviev of literatore see 301,309).
Fig 3 . Schematically shovn varions R classes in  genns Salmonella.
From: Galanos, C., Frendenberg, III. A., Liideritz, 0., Rietschel, EX., Vestphal, 0 : 
Chemical, physicochemical and biological properties of bacterial 
lipopolysaccharides. In :, E Cohen (ed J, Proa. Clin. Biol. Res, vol.29: Biomedical 
Applications of the Horseshoe Crab (Limnlidae). Alan R. Liss, Inc., Rev York 1979, 
pp 321-332.
Lipid A, vh ich is covalently bonnd to the core polysaccharide, consists of a
phosphorylated hexosam ine disaccharide k ick lM ne  (cen tra l phosphorylated p -  
1 Ê -linked D-glocosam ine disaccharide), to  v h ic h  long cha in  D -3-hydroxy fa tty  
acids ore ester o r am ide lin k e d . The com position o f the  fa tty  acids in  lip id  A can 
be inflnenoed even by m edium  com position (173, 255). H ovever, as on ly m in o r 
differences exist in  the  lip id  A po rtion  of IPS m oie ty from  taxonom ioally rem ote 
bacte ria , and i t  is  constant fo r la rg e r groups of bacte ria , lip id  A represents 
therefore the  m ost conservative and least va riab le  stm o lT ira l elem ent of IPS (451). 
H ovever, pho losyn the tio  bacteria  , such as Rhodopsendomonas v ir id is . Rh. 
palT tstris. Ph a rrlfo v irid is . Rh. sphaeroides. C hrom atittm  vinosttm . Thiooapsa 
roseopersioi n a and Rhodom iorobinm  v a n ie lli. as v e il as cyanobacteria, tv o  
R itrobaoter species and tv o  saprophytic representatives of genus Pseudomonas: 
Pfl dimiTiTdn and Ps. vesiou laris lack the usual baoJcbone s tructu re  of lip id  A (106, 
227,322,323,324,554,580,639,650). As a re su lt, both the  IPS and the free lip id  A of
X
H Ç -0  — 7
P -0 — Y
CHg
 A ______
I
ç=o
R
( 3 - 5  mol )
A
znosl of Uiese species ore nonlozio (324).
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Fig.4. Generalized slrvclTire of lipid A.
X Y Z n Bacterinm
H P COR 10 Excherichia coli
H PEtn COR 10 Vibrio choleras
4-AraH H COR 10 ProtensmiraW lis
4-AraH PEtn COR 10 Salmonella minnesola
4-Arah Glen H 8 Chromobacterinm violacenm
P = phosphate
4-AraH m 4 - amino 4 d e o x g -l- arabinose
Glen = 2 - amino -  2 - deoxg-D- glucose
FEtn = phosphorglethanolamine
PS = polgsaocharide
From: Rielsoliel, E. T., Schade, U., Jensen, DU., VoUenveber, H .-V ., Lttderilz, 0 ., 
Qreisman, S.Q: B aderial endotoxins: chemical slm clnre, biological acUvilg and 
rcle in  septicaemia. Scand.J.Infect,Dig. iro2,SuppI.31;8~21.
The gtrwAnre of Upld A makes i l  cm amphipolhio moleonle Iv llh
hgdrophobio and hgdrophilio regions) as v e il as an ampholerio moleonle iv llh  
bolh and basic residues). These unique oharacUrisUcs endov lipid A v ilh
dislinol properlies, vh ich make i l  a 'rtla l consUloenl of Ihe ceU vaU of 
Qrom-negaliee baoleria, vhere i l  has bolh slm clnral and fim clional roles.
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Because of th e ir compact and ordered arrangem ent, the lipid A fdttg acids form a 
comporativelg rigid structure. The dense packing cf the hgdrophobic moietg cf 
lip id  A, vh ich  is favoured hg the absence cf unsaturated fdttg acids, causes a high 
visoositg of the outer membrane. This inhibits hgdrophobic molecules from  
diffusing into the outer membrane and therefore is responsible for the marked 
im perm eobilitg of the membrane to bile acids, detergents and lipophilic 
antibiotics. In  this vag ,lip id  A plags an essential rd e  in  the function c f the outer 
membrane as a permeation barrier (133, 369). In  addition to its im portant 
structural role, lipid A is essential for the maintenance cf the integritg cf the 
outer membrane and cell shape.
113 . Biological activitg
ezert nuxnerous phgsiopathdogical effects upon living organisms and 
th e ir organs. Table 1 summarizes various bidlogioal aotivities demonstrated so 
fa r v ith  endotoxin.
nTable 1. Biological acliviUes cf endotoxin.
Stim ulation of the
Replacement of helper T Igmphoogtee 
in  induction of ontibodg response 
B-cell m itogenicitg 
Polyclonal antibody induction 
Adjuvanticity 
macrophage activation 
Immunogenicity 
Complement activation 
Stem cell mobilisation (CFÜ-S)
IgG synthesis in  nevbom  mice 
Induction of non-specific resist­
ance tc infection 
Induction of tolerance to endotoxin
Stim ulation of mediator production 
Interleukin -1  
Colony stim ulating factor 
In terferon
Glucocorticoid-antagonizing factor 
Tumour-necrotizing factor 
Thymidine 
Arginase
Endogenous pyrogen
Masminogen activating factor
Hageman (X II) factor
neutroph il im m obilizing foctor
Leucocyte endogenous mediator
Lymphocyte activating factor
Lysosomal hydrolases
Collagenase
Elastase
Prostaglandins
Kinin
ÔÜISŒ
Pyrogenioity
Hypothermia
Abortion
Foelopathy
Haemorrhagio tumour necrosis 
Lethal toxicity 
Endotoxic shock
Enhanced resistance to irradiation  
lethality  
Leucopenia 
Leucocytosis
Local Shvartzm an reaction 
Generalized Shvartzm an reaction 
Bone m arrov necrosis 
Embryonic bone resorption 
Hypotension 
Hypertension 
Platelet aggregation 
Troznbocytopenia 
Limulus lysate gelation 
Toxicity enhanced by BCG 
Toxicity enhanced by adrenalectomy 
Enhanced derm al reactivity to 
epinephrine 
Induction of early refiraotory state to 
temperature change (endotoxin pyro- 
genicity)
Type C RRA virus release firom mouse 
spleen cells 
Helper activity for Friend Spleen Focus 
Forming Virus in  mice 
Inhibition of phosphoendpyruvate 
oarboxykinase, glycogen synthase.
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Table 1. Biological activities of endotoxin -  continuation 
Stim ulation of m ediator produolion Others
(continuation)
Superoxide onion 
Histamine and serotonin
(continuation )
fructose -  1 ,6 -diphosphatase and 
glucose -  6 phosphatase 
Enhanced activity of pyruvate kinase 
Disseminated Intravascular Coagulation 
Hyperglycaemia 
Hypoglycaemia 
Hypoferraemia
Decrease in  iron absorption from the gut 
Decreased serum zinc 
Decreased serum transferrin  
Increased serum copper 
Decrease in  vater and fcwd intake 
A rthritis and synovial inflam m atory 
reactions 
Oliguria 
Polyuria
Spermatozoa agglutination in vitro
Hyperlipidaemia
Fibrinogen decrease
modified from: GoUahon,K.Am ichalek,S.m Vannem uehler,m . J .,mcGhee, J .R : 
Lipopolysaccharide regulation of the immune response. In: A. Dovotny (edJ: 
Beneficial Effects of Endotoxins. Plenum Press, Ilev  York and London 1983, pp. 
327-353.
Recently it  has been shovn that free lipid A also exhibits these activities.
Qcls OS a m itogen for B-lgm phocgtes and a polgclonal acU valor of these 
cells , thus rep lacing  helper I-lgm phoogtes in  indooUon of ontibodg responses
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(366). The apparent specificity of the B-lymphocyte proliferative response to 
endotoxin vould suggest that such responses m ight jnrove to be useful as a 
general means of defining B-cell populations. Hovever, results obtained by a 
number of investigations have indicated Significant species variab ility in  the 
capacity of B-lymphocytes to respond to endotoxin. For example, endotoxin vas 
unable to e lic it proliferative responses in  cultures of human lymphocytes (397, 
415), unless defined culture systems vere used (273, 328). mice are the most 
commonly used model for proliferation of B-lympohoc^e population in  response 
to endotoxin. Rat lymphocytes have characteristic responses to endotoxin very 
much like these cf a mouse (618). Results obtained for rabbit (49,508) cmd guinea 
pig (27, 113) B-cells are contradictory. B-cell proliferative responses are also 
observed in  chicken (637), axolotl and nevt (81), ham ster (207) and the rainbov 
trout (123).
Although both lipopolysaccharide and free lipid A activate complement, the 
mechanism of this process is different; lipopolysaccharide activates complement 
through the alternative pathvay (is . in  the absence of antibody), vh ile  free lipid  
A activates comfdement through the olassical pathvay in  the absence of 
antibody (335). In  the presence of specific antibody, LFS may also aotivate the 
classical pathvay (347).
Pyrogenicity is one of the most sensitive indicators of endotoxin activity, but this 
ossag is used prlmorUg in  rabbits, since IPS norm allg indooes a hgpolbermic 
response in  other common laboratorg anim als -  mioe and rats -  and no reaoUon 
in  guinea pigs »16). Hovever, it  is posslbie to obtain hgperthermlo response in  
mioe after preconditioning them at 36® C (429).
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Humans appear to be the species most sensitive to endotoxin. The threshold dose 
for pyrogenicity cf IPS is sim ilar to that in  rabbits, thus making results of the 
Rabbit Pyrogen Test for Endotoxin valid v ith  regard to humans; but the 
dose-response curve is steeper (185). In  contrast, sub-human primates (baboons, 
vervets) are relatively resistant to the pyrogenic effects of LPS. The susceptibility 
of humans and baboons to endotoxin pyrogenicity differs by a factor of more than 
1:100000(301).
The degree of susceptibility to endotoxin betveen different species varies 
depending on the parameter l>eing assessed, but van nUert and Frens (616) made 
the folloving lis t of dim inishing sensitivity: rabbit, horse, goat, dog, cov, sheep, 
cat, svine and chicken. As the mouse, ra t and guinea pig exhibit neither a fever 
reaction nor a leucocyte response to endotoxin, they could not be compared v ith  
the others. There are several experimental models, hovever, in  vhich the 
natural sensitivity cf animolg tovards LPS may be increased. Enhanced 
susceptibility to endotoxin lethality develops vhen the phagocytic atAivity of the 
RES (rediculoendothelial system) is stimulated v ith  zymosan (28), triolein  
(glyceryl trioleate) (555), glucan (84), BCG, (565) group A streptococcal pyrogenic 
exotoxin (SPE C) (487), Coranebacterium narvum (128). m uramyl dipeptide (HIDP) 
(447), graft-versus-host reactions (230), brucellosis (603), typhoid fever and 
tularem ia (187), as v e il as a number of other infections (564), and antigen- 
antibody complexes (159). The fact that reticuloendothelial stim ulation by this 
group of agents significantly enhances endotoxin sensitivity is a cause for 
concern. This concern is based upon the applicaUcn of many of these agents in  
experim ental clinical immunotherapy, as v e il as the potential vide-spread 
therapeutic employment of these agents (103).
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Agents vh ich  depress RES phagocytic function may also increase susceptibility to 
endotoxin. To this group belong the folloving: carbon tetrachloride (125, 141), 
thorotrast (colloidal thorium  dioxide) (24,23,474,030), lead aoetate (129,274,303), 
cadmium (83), and carrageenan (23). The protein synthesis inhibitors,
actinom ycin D (37, 421) and ct-amanitin (506) are other sensitizing m aterials. 
Other pharmacological conditioning, vhich greatly increases sensitivity to LPS, 
involves adrenalectomy (67,504) and treatm ent v ith  galactosamine (161).
The age of the individual is also a factor influencing reaction to pyrogens. In  
general, susceptibility to endotoxin increases v ith  age. Adult rabbits are 
approximately 50 tim es more sensitive than infants (532). Young mice are also 
less susceptible than more mature animals to the lethal and sublethal action of 
pyrogens (439). S im ilarly, the pyrogenic response to endotoxin increases v ith  age 
in  m an (3(R). The hypothesis vhich attempts to explain this suggests that the 
biological activities of endotoxin may depend on the degree of sensitization of the 
host to the endotoxin from the alim entary trac t. This spontaneous sensitization 
is a result of a cross-allergic reaction v ith  intestinal bacterial flora (276,425,531, 
552, 633). V ith  regard to chiclcens, on the other hand, chicle embryos are 
extrem ely sensitive and fully grovn chiclcens are almost completely resistant to 
the lethal effects of LPS (533). Sim ilarly, nev-bom  guinea pigs (604) and young 
dogs (441) are more sensitive than adult anim als. Also, individuals of the same 
age v lth in  the same sf^cies may vary considerably in  their susceptibility to LFS. 
This explains the poor precision of the Rabbit Pyrogen Test for Endotoxin (22,262).
LPS has a profound effect on polymorphonuclear leucocytes (PIÏIIIL) in  vivo; there 
is an in itia l marlced leucopenia, foUoved by a leucocytosis (15). This may in some
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instances be of diagnostic value (eg. in  the diagnosis of neonatal sepsis) (052). 
Endotoxin is also responsible for hypotension (158), vh ich  is one of the im portant 
diagnostic criteria  of septic ^loclc (279). Hypotension occurs as a res^ t of 
motivation of one of mediators -  the kin in  system. Hovever, Volff and colleagues 
noted an Increase in  pulse pressure, after adm inistration of relatively sm all 
doses of endotoxin to human volunteers (600). At these doses, they did not observe 
a fa ll in  systolic blood pressure.
LPS m ay also affect the carbohydrate metabolism. Shortly after injection of LPS, 
blood sugar levels increase and reach a maximum (several tim es norm al levels) 
in  approximately tvo  hours. This transient hyperglycaemia is folioved by 
hypoglycaemia, vh ich becomes profound (057). A further notevorthy fact is that 
endotoxin can account for either oliguria or polyuria (181,029). In  infusion studies, 
a pblyuric phase commonly precedes the development of oliguria (82,181,029).
li.4 . Clinical aspects
The role of endotoxin in  pathogenesis of bacterial infections is increasing. This is 
 ^ the rising proportion of Gram-negative sepsis in  the total number of septic 
cases (3,118,200,270,271,438) vh ich  a t present amounts to 00%-70% (279,303). An 
increase in  Gram-negative sepsis appears to coincide v ith  the "antibiotio era". 
]>espite antibiotics and recent technological advances in  medicine and surgery, 
m ortality due to Grom-negative septicaemia is increasing (7,142,270,313,303, 
550). In  some forms of Gram-negative septicaemia, m ortality may be even as 
high as 80%-90% (260,279, 303,303), although on average m ortality due to this 
cause is claimed to range betveen 30% and 50% (438).
17
The precise aetiology of shock in association v ith  sepsis is uncertain and clearly 
also involves factors other than bacteraemia (279). nevertheless, the presence of 
bacteria in  the bloodstream of shocked patients cannot be ignored. As many as 
h alf of the patients v ith  septicaemia due to aerobic Gram-negative bacilli, and 
one th ird  of those v ith  Bacteroides species as the infecting organism develop 
shock. In  contrast, shock occurs in  only one patient out of ten suffering from  
septicaemia due to Staphulococcus aureus (505). The m ajority of patients vho 
develop septic shock become infected vh ile  in  hospital. This frequently folio vs  
operations on the gastrointestinal or genito-urinary systems, particularly vhen 
surgery has been performed under emergency or semi-elective conditions (279). 
m ajor traum a and bums also carry an increased risk of Gram-negative sepsis 
and septic shock (212, 329). In  addition, the transplant patient vho is rendered 
immunocompromised has an increased risk of developing these complications. 
The non-surgical causes of septic shock include pneumonia, endooarditis, 
m eningitis and dermatologioal infeotions. Advonoed age, diabetes, m alnutrition, 
uraem ia, malignanoy and immunologioal defeots, and treatm ent v ith  
chemotherapeutic and corticosteroid drugs can also be predisposing factors (279).
Intensive care patients are a group especially at risk of developing septicaemia 
(672). The combination of their illness (traum a, bum , surgery, metabolic coma, 
etc J and iatrogenic factors (foreign Ixwiies, ventilation, drugs, etc J render them  
more susceptible to severe infections. One of the frustrations in modem intensive 
care medicine is th at,  ^ improvement in  techniques of resuscitation, the 
patient survives the period of shock itself, only to die as a consequence of the 
delayed effects v ith  m ultiple organ failure (611). This is vhere prediction, 
diagnosis, m onitoring and treatm ent of septic shock come as an acute problem. 
In  early phases of sepüc shock the features of infecUon predominate, eg . fever.
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tachycardia, hyperventilation and varm  extrexnities, together v ith  a degree of 
hypotension (the hyperdynamic phase). Cyanosis, vasoconstriction,oliguria and 
confusion, together v ith  more marked hypotension, are later features (the 
hypodynamie phase) (279). Clinical indices of shock are fever, urine flo v of less 
than 20 m l per hour and a blood pressure usually belov 90 mm Hg (512).
nevertheless, the precise role of endotoxin during Gram-negative bacterial sepsis 
rem ains unresolved (451). In  part, this may be due to the vast array of biological 
effects produced by LFS (see Table 1). many of these are nonspecific and can be 
induced by other agents. Consequently, it  is not surprising tlm t some 
m anifestations sim ilar to those produced by endotoxin v ill be found in  other 
conditions, unrelated to the presence of endotoxin. On the other hand, the 
presence of endotoxin in  the circulation does not necessarily result in  any clinical 
m anifestations. Transient endotoxaemia has been observed fcflloving urethral 
instrum entation (524), colonoscopy (263) and other enttoscopic and 
roentgenological manipulations but vas not accompanied by a rise in  
temperature or any other sign of m alaise. Ih  contrast, in  septic sho(^, vhere 
endotoxin is implicated as a m ajor pathogenic factor, levels of endotoxin 
sometimes may be relatively lov (308). This may be explained, a t least partia lly, 
by the that man becomes rem arkably hyperreactive to circulating
endotoxin during those Gram-negative bacterial infections in  vhich reactivity 
vas tested,ie.typhoid fever,tularem ia and brucellosis (451). A lso,it is lilcely that 
factors other than endotoxin are more critical in  determining the lethal outcome 
of sepsis (259). Although the exact pathogenesis of the septic response remains 
undetermined, the response appears to be host-determined (648). It  has been 
suggested that mediators may have a role in  this response (36).
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11 5 . Assays for endotoxin
A large number of different techniques has been introduced for the identification 
and quantitation of endotoxin. This fact reflects the lim itations of many of the 
procedures and shove that the existing assays are unsatisfactory. The usefulness 
of the individual method is largely dependent upon both the sensitivity (Table 2) 
and the specifioity of the technique itself. Other factors vhich determine the 
value of the assay are: ease or difficulty of performance, cost, tim e requirements, 
and the circumstances for vhich the procedure is utilised.
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Table 2 Sensitivily of assays for detection of endotoxin
Assay method Smallest detectable level
(approximate) in  |ig of endotoxin
Lethality in  adult rats (LD^)*
Lethality in  adult rabbits (LD^)
Lethality in  adult mice (LDgg)
Inhibition of haemagglutination 
Induction of local Shvxirtzman reaction 
Damage to mouse sarcoma 37 
Fever in  man 
Hypothermia in  mice
Lethality in  lead acetate treated rats (LDgg) 
Abortion in  mice
Lethality in  thorotrost-treated rabbits (LD q^q)
Epinephrine-induoed rabbit skin necrosis, at 23^  
Complement activation 
Dermal inflam m ation (SLDgg)*
Stim ulation of haem agglutinating antibody (rabbit) 
Lethality in  histam ine-sensitized mioe (LDgg)
Lethality in  adrenaleotomized mioe (L I^ ) 
Leucocytosis in  mice
Epinephrine-induoed skin necrosis, a t 37®C 
Chick embryo lethality (LDgg)
Fever in  rabbits
Actinomycin D-enhanced mouse lethality (LD^)
B-cell m itogenicity
Limulus gelation assay
Hypoferraemia in  rats
Fever in  rabbits (intrathecal injection)
750
500
150
10
10
10
35-007
2
12
10
10-01
10-01
02
015
01
005-0007
003
0025
002
001
0004-00005
0002
OOOl
0001-00000001
00001
<000001
*LDgQ : Lethal dose gg *SLDgQ : Skin lesion dose gg
J c . rotundicauda:O •
L. polyphemus: #, trldentatus: A
Fig. b A
F i g .  5b
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Illodllied from  IHcCabe, V  j Endotoxin: miorobiologiool, chem ical, pathophysiologic 
and clin ical correlations. In: L. Veinstein, B II Fields (eds J: Seminars in  Infections 
Disease, vol m ,Thiem e-Stratton In cn ew  York 1980, pp38-88. 
and
Braude, A. J: Absorption, distribution and elim ination of endotoxins and their 
derivatives. In: IH . Landg, V.Braim (eds J: Bacterial Endotoxins. Rutgers Universitg 
Press, nev Brnnsvick, n J . 1904, pp 98-109.
12. Limtdits amoebocgte Igsate assag 
121. natttral history
Limnlns amoebocgte Igsate is obtained bg Igsis of circulating blood cells 
(amoebocgtes) of the horseshoe crab. Ilovadags, there are four extant species of 
horseshoe crabs, in  three genera: Limulus (= Xinhosura. the svord ta il) 
Ddophemus (Fig 5). Tachonleus tridentatus. Tachonleus aiaas and Carcinoscomius 
rotundicauda. (406,519) Serologicallg, three of these species, ie . L. polgphemus.T 
oiaas and C rotundicauda appear to be con-generic (517). Figure 0 shovs the 
distribution of each species.
Fig 5 . Limttlttg polpphemus: a) dorsal viev; b) ventral v ie v .
Fig JO. Distribution of extant species of horseshoe crabs
From: Sekiguchi, K .,nakam ura, K- Ecologg of the extant horseshoe crabs. In: E. 
Cohen (ed J: Proa.nm  Biol. Res. .vol29: Biomedical AppUrotjons of the Horseshoe 
rrnT  ^mTnTTiirtflgl. Alan R Liss,Inc.,Rev York 1979,p.p.37-45.
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I».__polgphemu8 oconrs on Ihe AUontio coast of north America, and is videlg  
distributed firom IRaine to Yucatan (518). The other three species occur in  the 
Pacific Ocean. T. tridentatus occurs in  vestem  and southern Japan, Taivan, the 
Philippines, north Borneo and Sumatra (502). T. aiaas and C. rotundicauda live in  
alm ost the same area (502). Theg have been found along the shores of the Bag of 
Bengal, Thailand, m alagsia, the Philippines and Borneo. T. oiaas has also been 
recorded in  the Torres Straits. L.polophemus and T. tridentatus are distributed 
firom north to south, vh ile  T .gigas and C rotundicauda are distributed firom east 
to vest.
A ll four species are tgpioal benthic anim als, digging in  the mud and sand of 
estuaries and shallov m arine voters near the shore (553). C.rotundicauda is also 
able,hovever, to m igrate up rivers into firesh voter (11).
In  the taxonomio sense, though, the horseshoe crab is a misnomer, vhich  
vronglg classifies the fdm ilg Limulidae as being in  the class Crustacea, vh ile  in  
fdot theg belong to the class merostoznata (520)and are thus much more closelg 
related to scorpions, spiders, m ites, tioks and other representaUves of the class 
Araohnida,than to crabs,lobsters or shrimps.
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Tables. Taxonomg of horseshoe crabs.
Phglum : Arlhropoda
Subphglum : Chelicerala
: merostoznata 
Snbdass iXiphosuro
: Ziphosurida 
Suborder :
SuperfiomUg :Limnlaoea
Fam ilg : Limulidae
Qenera : Limulus. Taohopleug. Caroinoscomius
modified firom: Sterm er, L: Phglogeng and taxonomg of fossil horseshoe crabs. J.
Paleontol.lQ52: 26(41,630-630.
and
Shuster, C . I I .  J r: Ziphosurida. Enouolopedia of Soienoe ,
m oQ rav-H ill Book Comp, ^ e v  York 1082,pp.766-770.
Limulidae are oalled liv in g  fiDssils'',as their earliest ancestors (order Aglaspida) 
firom the Cambrian period, dating back 500 m illion gears, vere olearlg 
recognizable as horseshoe crabs (370), vhich are thus also called "Paleozoic relics" 
(466). Forms nearlg identical to Limulus date firom the Triassio some 230 m illion  
gears ago, and bg the late Jurassic (135 m illion gears ago) Hlesolimulus, the 
nearest ancestor of todag's horseshoe crab to be found in  the fossil record, had 
appeared (553). Fossils of this creature exhibit morphologg virtuallg identical 
v ith  th at of the extant Limulus.
The horseshoe crab oves its name to its  oharaoteristio shape. Its  other common 
names include: horsefoot c r a b ,  horsefeet, pan crab, piggyback crab and king crab 
(520). The name "king crab" (11,218,401,530) is due to the crab's blue blood. The
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blood dronlates in  the open oardiovascnlar sgslem (442), pouring into baeznocoel, 
cmd consists of ozie tgpe of circulating bkwd cell, the aznoebcwgte (haezziocgte), azid 
haezziolgmph. The blue colour of haemolgmph is due to the respiratory pigzzzent -  
haezziocgazün, its  predomiziant protein, in  vhich a zzzOlecule of oxygen is carried 
betveen tvo  copper atozzis. Aziother im portant haemolgmph protein -  
haeznagglutizzin -  comprises ozilg a szzzall percentage (apprczizziatelg 2%) (310) of 
the total protein in  serum. This invertebzxite lectin firom haemolgmph of Urcrtius 
polqphemus vas firs t described bg noguchi in  1903 (373). It  is capable of 
agglutinatizig bacterial cells (422). It  vas also found to have afidziitg for sialic acid 
(*-acetyl zieuram inic acid, lA lA ) residues (74). Sialic acid-contaiziing 
glycocozijugates are present in  every mammabnn cell mezzzbrcme thus for 
e%azzzizied(136). These sialic add residues occupy a terzziinal position in  
cdigosaocharide chaizzs cmd thus tezid to have cm external position in  the 
zziezzibrane (598). Therefore the UmnlTtg haezzzagglutiziin should be vez^ useful in  
the study cmd purification of mezzibrcme glycoproteizis, although as yet it  has not 
been videly expldted for this purpose (138). The Limglng haemagglutiziin vos 
firs t isolated and characterized in  1968 by Hlarohalozzis cmd Edelman (315).
Hov there is evidezzce for tvo  separate agglutizzizis in  Limulus serum. One, 
directed tovards Gram-negative bacteria, has probable speoifidty for the 
2-keto-3-deoxy-octozzate (EDO) zndety of the LPS mdecule (as reported by 
Rostam-Abadi and Pistole) (462). Prelizziiziary evidence suggests that this 
agglutiziin is identical to the serum haezziagglutizzin v ith  reported speoifidty for 
WAWA (462), vh ich vas termed "lim ulin" bg Roche and IRonsigng (455). The other 
agglutinin, isolated by Gilbride and Pistole, is reactive v ith  Gram-positive 
microorgaziiszns azid appears to have a m decular speoifidty for galactose-like
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residues C75, 172,613, 619). These agglutinins mag serve as "opeonins" for the 
phagocytic removal of foreign cells firom the haemdymph of the horseshoe crab 
(172,422,424). They represent also an enormous potential as tools for selective 
isolation of different types of cells, in  particular lymphocyte subpopulations, and 
also as "cell probe" reagents for investigating the participation of specific cell 
surface glycoproteins in  the in itiation of blastogenesis and differentiation (76, 
316). The amoebooyte is the only type of circulating cell in  the Wood of Limulus 
polqphemus (110,297). It  is a nucleated cell, the cytoplasm of vh ich  is packed 
v ith  granules (286). Hovever, Jorgensen and Smith have shovn that 
haemolgmph contains tvo  difiierent cell types, one v ith  large granules and 
another v ith  no granules,but many mitochondria (250).
The Limulus amoebocgte contains the entire coagulation system of this m arine 
invertebrate (290,671). Cell-firee plasma does not dot and is not required for 
coagulation, since extracts of vashed amoebocytes (amoebooyte lysate) gel 
folloving incubation v ith  bacterial endotoxins (289,290).
Exposure of T.imnltM blood to bacterial endotoxin results in  aggregation of the 
amoebocytes. Aggregation is asodated v ith  marked changes in  cell shape, 
flattening v ith  an apparent increase in  cell diam eter, development of long 
processes th at extend firom cell to cell, striking degranulation and disruption of 
amoebocytes, «"*1 subsequent extracellular clot form ation (110, 282,288). This 
endotoxin-induced clotting phenomenon has been characterized as a possible 
defence mechanism, serving to immobilize invading Gram-negative bacteria (21, 
284) and it  has been postulated that the Limnimi amoebooyte m ay play an 
im portant role in  host defence against bacterial invasion and dissemination (21, 
282,290,513). Additional evidence for the rde of the Limulus amoebooyte in  host
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defence vas reported by nacbum and colleagues, vho shoved that the 
amoebocgte contains an endotoxin inactivating capability (353). The bactericidal 
activity remains vhen the amwlxwyte lysate is treated v ith  m ild heat (60®C for 
10 m inutes) (351) in  order to inactivate the clotting system (561). This indicates a 
system at least partly distinct from the LPS activation of the clotting system 
(423).
Endotoxin cannot enter the intact cell. Consequently, in  vivo, endotoxin must 
mediate the degranulation and lysis of amoebocytes before the activation of the 
dotting system. Liu and colleagues proposed the existence of endotoxin receptor 
site(s) on the outer membrane of Limulus amoebooyte. They isolated and purified 
a protein v ith  a molecular veight of about 80 000 from amoebooyte membranes 
(296). This protein binds v ilh  endotoxin and enhances the Limulus lysate 
coagulation process as effectively as about a l(X)-fold excess of endotoxin. It  is 
possible that the "endotoxin-receptor protein" plays a role in  the Limulus 
coagulating system.
Secretion in  Limulus amoebocytes is by exocytosis (398). Amoebooyte secretory 
granules move tovards the plasmalemma v ith  outer granules fusing v ith  the 
plasm alem ma,folloved by sequential exocytosis of more internal granules.
Amoebocytes appear unable to phagocytize E. coli (13). In  the presence of the 
bacteria, the cells degranulated, flattened, became im m obile, and massive 
amounts of extracellular gel vere formed. Hovever, amoebocytes vere able to 
phagocytize carbonyl iron particles, especially vhen these had previcusly been 
rendered endotoxin-free by heating (13). It vas suggested that Limulus 
amoebocytes could handle foreign particles in  tvo  vays. The extracellular
27
d o llin g  sgslem deals v ilh  Grom-negative organisms and phagocytosis deals 
v ith  other types of foreign particles.
The m ajor biomedical applications of lim ulidae are: the detection of bacterial 
endotoxin, using a lysate firom the amoebocytes, and the inrobing of cellular 
membrane constituents, using agglutinins from  the haemolgmph (520). The 
credit for the Limulus amoebocgte lysate (LAL) test for detection of endotoxin goes 
to Dr.Frederik Bang. In  1956 he observed th at vhen horseshoe crabs vere injected 
v ith  live or dead Gram-negative bacteria, their blood clotted, resulting in  fatal 
intravascular coagulation (21). Subsequently,in 1964, Levin and Bang discovered 
th at the agent responsible for the clotting reaction in  the horseshoe crab vas  
localized in  the amoebocytes and that the lipopolysaccharide fraction of the cell 
v a il of the Gram-negative organisms triggered the clotting reaction (288,289). In  
1968, Levin firs t reported the use of Limulus losate bioassay to detect the presence 
of endotoxin (283).
Amoebooyte lysate is prepared firom v a ^ e d  amoebocytes (286), vhich in  the 
original method have been disrupted by osmotic lysis by suspension in  distilled 
v a te r, or by fireezing and thaving (290). Further modifications of cell rupture 
methods involved the use of;
-  Shaking during lysis v ith  distilled vater
-  vortex m ixing
-  tissue grinding (blender or homogenixer)
-sonification
-  use of Tris (tris [hydroxymethyl] aminomethone) -  buffered 3% saline pH 70 
as a medium to suspend cells for lysis (223,600,667).
The method of producing LAL v ith  the maximum sensitivity to LPS involved:
e n d o t o x i n
anti-LPS factor
factor C factor C
factor B factor B factor G factor G
proclotting enzyme clotting enzyme
peptide C 
coagulogen coagulin
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avDidanoe of the anticoagulant n-ethglm aleim ide rngmi in  the procedure of 
bleeding crabs, efieotive mechanical homogenization of cells and optim al 
pgrogen-free conditions (000). Also, Tris-bufiered saline seems to have an 
advantage over distilled v a ter (223).
12 2 . Biochemistrg
Reaction betveen Limulus amoebocgte losate and endotoxin
Endotoxin activates the clotting cascade of Limulus amoebocgte Igsate (Fig .7). 
En<tot(nin reacts v ith  LAL in  conjunction v ith  an appropriate concentration of 
divalent cations,usuallg Ca** andAur mg^ (208,372,559,594).
Fig.7, Clotting cascade of endotoxin -  activated Limulus amoebocgte Igsate.
C,B,G -  proenzgmes 
C,B,G -  activated enzgmes
modified from the presentation of T. Ulorita during the "International Conference 
on Endotoxin Assags", mag 25-26,1984, Academic medical Centre, Amsterdam, the 
netherlands, in  the paper: Biochemical characterization of Limulus clotting 
factors and inhibitors vhich interact v ith  bacterial endotoxins.
Components ^  atyioebocate Insate taking part in  the reaoUcn v ith
endotoxin
Factor C vas discovered bg Hakamura and Levin, vho called it  Proteose H (355). 
Tsuji in  his model proposes that Proteose H consists of tvo  separate proenzgme- 
enzgme sgstems (594). Factor B, discovered bg Ohki and colleagues (389), is also
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called proacllvalor (355). It  is a precursor of the proclotting enzyme activating 
factor, designated activator. Both the activator and the clotting enzyme are 
trypsin-type serine proteases. Thus, lim ited proteolysis by the activator of an 
Arg-X or Lys-X bondCs) in  the proclotting enzyme molecule probably causes 
activation of the proenzyme (356). This is sim ilar to blood coagulation 
mechanisms of higher anim als, in  vhich a cascade-lilce activation by lim ited  
proteolysis of several protease precursors is involved (% ).
The in tact molecule of the activator an.V . 50 OCTO) presumably is composed of tvo  
identical subunit chains on.V. 22 (KX)) associated by noncovalent bond(s). 
Probably each of the subunits consists of m ultiple polypeptide chains, including a 
heavy chain (m .V. 17 000), linlced by disulphide bond(s) (355). Active factor B 
converts prœ lotting enzyme to the clotting enzyme (203).
The clotting enzyme, also termed coagulase (486, 594), vas isolated by Sullivan 
and Vatson (561) and the proclotting enzyme vas purified by Tai and Liu (568). 
The proclotting enzyme, also Icnovn as the procoagulant enzyme (286, 430), or 
prœoagulase (486), appears to be a protein consisting of a single peptide chain 
On.V. 150 OOT). It  contains ^-carboxyglutamic acid (569). The clotting enzyme in  
the study of Sullivan and Vatson had a molecular veight of 84 000 and consisted of 
tvo  identical subunits (m .V .43 000). These findings vere later confirmed by Seid 
find Lin (499). They demonstrated that, in  the Limulus amoebocyte lysate, tvo  
active forms of the clotting enzyme existed, v ith  the molecular veight of 79 000 
and 40 000. The amino acid compositions of the tvo proteins vere very sim ilar, 
indicating a "monomer" -  "dimer" relationship, but atempts to interconvert the 
79 OOO protein into the 40 000. protein have not been successful.
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Clotting enzyme displays substrate spedfioity sim ilar to th at d  mnmmnUnn 
blood coagulation factor, footer Xa (357). The dotting enzyme from Taohapleus 
tridentatus. vhich has been purified and characterized (357), shovs very sim ilar 
properties.
Limulus amoebocytes contain a t least tvo  independent coagulation pathvays,
endotozin-mediated and (1 -> 3) -  p - D -  gluoan -  mediated (Fig.7), both of vhich  
result in  the transform ation of ooagulogen to ooagulin. (1 -> 3)  ^p -  D -  glucan 
sensitive footer is named footer Q and acts on the proclotting enzyme (332).
Ooagulogen, also called the dottable protein (286, 430, 539), constitutes 
approximately 50% of amoebocyte lysate (354,539,540). Reported estimates of the 
gjgg of th^ Limirlgg poloDhemus amoebocote lysate ooagulogen indicate that its  
m decular veight lies betveen 19 000 and 27 000 (154,341,569,671) and that each 
molecule consists of a single chain (540,569). Hovever, ZRosesson and colleagues 
(341) oonduded that ooagulogen consists of tvo  chains of equal mass, connected 
by a disulphide bridge. The firs t ooagulogen to have the amino acid sequence 
determined vas that of Tachnpleus tridentatus (360,571). Its  chain consisted of 
175 residues (571); the molecular veight vas betveen 16 000 and 23 000 (354,514). 
Furthermore, under the same conditions the molecular veight of coagulogens 
from  a ll four species of horseshoe crab vas found to be identical (515) and equal to 
20 000. Hovever,immunological studies have shovn th at although coagulogens of 
a ll three Asian species vere dosely related to one another, they vere very 
different from  the American species (515). Physiooohemical properties, the 
gelation mechanism and nminn acid sequences of a ll four coagulogens obtained 
from the extant species of horseshoe crabs have been elucidated in  the vork of
31
nakam ura and colleagues (339).
The d o llin g  enzgme causes Umiled proleolgsis of Ihe Limulus ooagulogen (Fig .7) 
hg release of C-peplide conlaining 43 amino acids. The rem aining fragm enl, 
designaled coagulin or Ihe n-peplide and consisling of Â and B chains, 
polymerizes via disulphide cross-links lo form a clol (309,569). C-peplide, vhich  
is released during coagulalion from Ihe ooagulogen of Tachnpleus conlains 28 
amino acids and appears homologous lo prim ale fibrinopeplide B.
Specificiln of Ihe reaclion belveen Limulus amoebocnle Insale and endoloxin.
The LÂL assay has been considered very s^^cific for endoloxin, despile reporls by a 
number of invesligalors aboul Ihe aclivalion of LAL by olher subslances (411). 
many of Ihese are high-m olecular-velghl carbohydrates, like peplidoglycan 
(647),synthetic dexlrans (566),carrageenan (408), (l->3)-  p - D - glucan (254,332), 
mannans and dexlrans (327), and lipoleichoic acid (645).
These reports atwul non-si% cificily of the LAL lest have been dismissed on the 
grounds that polysaccharide concentrations required for a positive reaclion vere 
far in  excess of the endoloxin concentrations required lo produce a positive 
ypgulustest. For example. Levin calculated that as little  as 01% -  0000 25% 
contamination v ith  endotoxin could have been responsible for the positive results 
of peptidogl^ xm in  the LAL assay reported by Vildfeuer and colleagues, although 
they did attem pt to exclude contamination (287). Sim ilar claims of reactivity in  
the LAL assay have been refuted, also on the basis of endotoxin contamination 
(497, 521, 666), for dithiols (426), throm bin, thromboplastin, polyribonucleotides 
and ribonuclease (117).
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Recent studies, hovever, have shovn that a cellulose-derived m aterial can 
mediate a LAL-coagulation pathvag, vhich is independent from that mediated by 
endotoxin (215, 408). This LAL-reactive m aterial (LAL-Rin) vas shovn to be 
nonpyrogenic, as, at tested doses betveen 380 and 2 CHK) ng per leg, it failed to elicit 
a pyrogenic respox^e in  rabbits. It  vas also unreactive in  a number of in  vitro  
biological assays -  human leucocytic pyrogen (IP ), lym phocyte-activating factor 
(LAP), peritoneal macrophage tumouricidal activity and arginase release (412). 
Also, the reactivity of LAL-Rm v ith  LAL varies depending upon the lysate used. 
Although a ll four LAL preparations used vere standardized to the US national 
reference endotoxin prepared from E. coli. the mallinclcrodt LAL Consistently 
yielded negative results, regardless of concentration. Furthermore, cellulose 
reduced the activity of LAL-RHl but had no effect on endotoxin. Gas 
chromatographic and mass spectrophotometric analyses also indicate that a 
cellulose-derived m aterial is the source of LAL-Rm. This is indicated by the LAL 
activity of the 24 000 -  molecular veight peak, and by the fact that both this 
fraction and 95% of the Limulus activity are reduced by treatm ent v ith  cellulose. 
Also, although LAL-Rm can be virtually elim inated by constant rinsing, the level 
of LAL-Rm returns overnight, typically to 25% of the starting value (408). It  vas 
shovn additionally that endotoxin exposed to conditions occurring in the process 
of industrial manufacturing of this cellulose-derived m aterial vas degraded and 
vashed out, vh ile  LAL-Rm, after exposure to the conditions of the production 
process, retains its endotoxin-like activity (215). As LAL-Rm gives positive results 
in  the chromogenic LAL assay, it suggests that the activation of LAL occurs at or 
before the proclotting enzyme stage (see Figs.7 and 8) (408).
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123. lim ulus amoebocyte lysate assays for endotoxin 
Introductom remarks
The LAL test may be applied in  various areas of research into endotoxin, but its  
single most Im portant use is as an alternative test to the official Rabbit Pyrogen 
Test for Endotoxin
The LAL test has numerous and great advantages compared v ith  the rabbit test. 
Of these, the most im portant are speed, sim plicity, quantification and reduced 
sample volume. The LAL assay is much more sensitive than the Rabbit Pyrogen 
Test. It  is also much more specific,since not a ll pyrogens are endotoxins. The LAL 
assay does not suffer firom the disadvantages of a bioassay, such as great 
variab ility of results. Age, veight, sex, route of adm inistration, previous history 
of the test anim al, its health and genetic make up a ll influence an anim al's 
response. Even if a ll of these factors could be controlled, there vould s till be 
certain biological variations in  the response of identical members of the same 
species to drugs and toxins. One individual v ill not respond identically to the 
same dose of a substance vhen it  is administered on tvo separate occasions 
either. Also, some substances have the capacity not only to elicit many biological 
effects directly, but also to activate various body systems to produce other 
physiological and pathological changes in  the organism indirectly.
many species have systems to potentiate or inhib it the action of drugs or toxins. 
Furthermore, these modifying systems may not be equally manifested in a ll 
individuals of the same species. The signs and symptoms shovn by test anim als 
after drug or toxin adm inistration are, then, the sum of the effects of the 
substance itself plus the effects of the activated potentiating or inhibiting system 
vhich existed in  the anim al prior to drug adm inistration. All of these factors
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may be active vhen endotoxin is administered to test anim ais (589). There are 
also cyclic and chronobiological factors, both circadian (26, 2(%) and circannual 
(26, 525) vhich may affect the Rabbit Pyrogen Test. In  addition, the Rabbit 
Pyrogen Test is unsuitable for testing of some drugs because of their 
pharmacological effect upon rabbits. For excunple, epinephrine, methylene blue, 
and am photericin B are inherently pyrogenic (64). Pyrogen-free phosphate ion 
m ay induce a febrile response vhen injected in  sufficient quantities (418). 
Conversely, calcium gluconate, some sedatives and anaesthetics, corticosteroids, 
phenothiazine derivatives and antipyretic drugs may lover rabbit temperatures 
and mask the pyrogenic potential of test solutions (29,32,418).
Certain drug classes are inappropriately pyrogen tested because of various 
properties. Examples include cancer chemotherapeutic agents, such as 
L-asparaginase (% ),and antibiotics like lincomycin (3%). Short-lived radiwictive 
drugs also are not appropriately tested by the Rabbit Pyrc^en Test because of 
tim e, sample size, problems of personnel exposure to radiation and control of 
radioactive vaste (85, 87). The rabbit bioassay is unsuitable for screening 
intrathecal products on acount of its insensitivity (% ). The intrathecal route of 
adm inistration is exquisitely sensitive to the presence of pyrogen (30). The 
sensitivity of the Limulus test is especially advantageous for screening drugs 
designed for intrathecal adm inistration, such as: contrast media, cancer 
chemotherapeutic agents, antibiotics, radiopharmaceuticals, and chemical dyes 
(85).
Finally, the susceptibility of rabbits to nonspecific febrile responses, the 
development of endotoxic tolerance and the restrictions for testing biological 
agents vluch contain antigenic m aterials are additional problems that may be
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encountered v ith  the rabbit assay (183,188,418,578).
The Limulus amoebocyte lysate assay correlates v e il v ith  the accepted, but less 
specific and less sensitive assays for endotoxin (Table 2) and it  has been approved 
by the United States Pharmacopeia as the official Bacterial Endotoxins Test (606). 
This, after meeting certain requirements, allovs the use of LAL for end-product 
testing. Hovever, the European Pharmacopoeia has not yet recognized the LAL 
assay. Hovever, although the existing national legislation excludes its  
application for end-product testing, the LAL test has become useful to European 
manufacturers of drugs and medical devices as an in-process control of ra v  
m aterials, components and of various stages during the manufacture of drugs 
and devices (350,620,621 ). The high sensitivity of the LAL test in  comparison v ith  
the rabbit test ensures a vide safety m argin.
The rapid nature, sim plicity and lev  cost of the LAL test a llov the extensive 
testing necessary to evaluate variations in manufacturing procedures that v ill 
ultim ately improve the purity of the final product (224).
Limulus amoebocate lusate assans
The original LAL assay vas a simple gelation test (gel-clot test) (283). Subsequent 
modifications have involved a micro-slide method (145, 180), a micro-method 
v ith  dye and phase contrast (390), a micro-slide method in  veils v ith  capillaries 
(139), a m icro-slide method in  veils v ith  dye (325), a m icro-slide dry-up method 
(178), a m icro-capillary method v ith  dye (168), a m icro-capillary method based 
on hydrostatic pressure (364), a m icro-plate method v ith  capillaries (269), a 
micro—plate m icrodilution method v ith  dye (431 ) and a LAL-bead assay (203). The 
gel-clot test is cheap and very simple but has a m ajor disadvantage, namely that
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i l  is not quantitative. Also, its  sensitivity, atO D 2- 10 EU per m l (375) is le v . In  
the turbidixnetric (nephelometric) test, the optical density of a turbid m ixture of 
LAL and endoloxin is measured in  the spectrophotometer or in  a nephelometer. 
The most commonly used vavelength is 360 nm (optimum) (375,577). This is a 
quantitative test, as turbidity is proportional to the amount of active clotting 
enzyme,and hence to the amount of endotoxin present in  the test solution. It  can 
be performed in  tvo  v a ^ : as an end-point method or as a kinetic assay. The 
la tte r vas firs t described by Hollander and Harding in  1976 (226). Kinetic assays 
offer sensitivity as high as 00005 EUAnl (104,249,375,381), but are expensive and 
require highly specialised equipment. End-point methods are usually cheaper to 
perfbrm ,but are much less sensitive. Their threshold of sensitivity in  most cases 
is only 001 EUAnl (5,107,577). H ovever,fink and colleagues (131),and Valois (614) 
reported obtaining much higher sensitivities vhich vere comparable v ith  those 
of the kinetic assays.
The colorim etric test is also quantitative, but unlike the turbidim etrio method, 
the reading of the endpoint is indirect. The precipitated clot is assayed by the 
Lovry procedure for protein measurement, vhich requires a spectrophotometer 
v ith  visible lig h t vavelength capability (usually %)0 or 700 nm ) (375). Since the 
protein in  the precipitate is directly proportional to the amount of ooagulogen 
cleaved by active clotting enzyme, a standard curve can be constructed for 
determ ination of endotoxin concentration in  the tested samples. This method 
vas firs t reported by D iva and colleagues in  1974 (371). Later it  vas improved by 
Handan and Brovn (362),alloving detection of 005 EHAnl.
The radioisotopic method, vhich is based either on measurement of ^ ^-lobeHed 
ooagulogen (348) or ^^I-lobelled anUbodies to 0-polysaooharides of
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(281), is quantitative and has a sensitivity of up to 005 EUAnl (375), but it  is 
labour-intensive,and requires special facilities and expensive equipment.
The rocket Immunoelectrophoresis assay, vhich involves crossed 
immunoelectrophoresis of LAL against rabbit antiserum (20) is sem iquantitative, 
v ith  a sensitivity very sim ilar to that of the radioisotope method (375). It  is also 
expensive and requires specialized equipment.
The fluorogenic assay, vh ich  uses amoeboc^e lysate labelled v ith  a fluorescent 
probe, fluorescamine, is based on measurement of changes of fluorescent 
polarization. These changes are proportional to the amount of endotoxin present 
in  the test solution (668,669).
Finally, there are enzym atic methods, vhich measure cleavage of a synthetic 
chromogenic peptide substrate by the clotting enzyme (196,233,357, 389). The 
chromogenio LAL assay v ill be discussed in  more detail belov.
Chromogenic LAI assau
The chromogenic LAL assay vas firs t described in  1977 by Dakamura and 
colleagues (358). In  this method the ooagulogen is completely or partially  
replaced by a chromogenic substrate. The chromogenic substrate is a sm all 
synthetic peptide covalently bound to a chromophore. The synthetic peptide 
contains the same, or a sim ilar, sequence of amino acids as ooagulogen. Thus the 
clotting enzyme acts on the chromogenic substrate in  the same vay as on 
ooagulogen. The chromogenic substrates currently available for LAL a ll contain 
pora-nitrooniline (pHA) as the chromophore (2^ ). Vhen linked to the synthetic
endotoxin
ooagulogen
proclotting enzyme I
coagulin (gelation)
clotting enzyme
S -  2423 chromogenic 
substrate
p -  nitroaniline 
(colour)
Fl a  . %
#
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peptide, pora-nilroanillne is coloxnrless and vnen nree, it  is gellov. It  is released 
in  proportion to the amount of endoloxin present in  a sample (FigS). Optical 
measurement of the colour makes this method quantitative.
Fig. 8 The principle of the Limulus amoebocyte lysate assay v ith  the 
chromogenic substrate S-2423.
The Limulus clotting enzyme exhibits amidase activ ity . This Factor Xa-like serine 
proteinase appeared to have a substrate specificity sim ilar to blood clotting 
factors and their related enzymes. Thus it acted upon a number of chromogenic 
substrates, vhich vere originally developed for determination of components of 
the coagulation and fibrinolytic systems (2,233,655; see also monograph? 
1,43,147,495,534).
The clotting enzyme disp lay a high specificity tovards para-nitroanilide 
(peptide-pHA), v ith  the COOH-terminal Qly-Arg sequence (196). Furthermore, the
c lo ttin g  enzyme has preference fo r hydrophobic residues (Leu o r Val) in  the  Pg
position. Increasing the length of the peptide chain has little  effect on the 
reactivity of the substrate. Therefore, Harada-Suzuld and colleagues 
recommended the tripeptides, Boo-Leu-Qly-Arg-pIlA and Bz-Val-Gly-Arg-pfiA  
(vhere Boo = tert-butoxycarbonyl and Bz = benzyl) as substrates for the clotting 
enzyme (197). And,indeed, commercial peptide substrates, vhich have been used 
in  the chromogenic LAL assay, ie . S-2222, S-2422, S-2433, S-2423 are a ll 
tetrapeptides (2).
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The chromogenic LAL assay is usually performed in  tvo  stages, since optim al 
conditions for the activation of the proclotting enzyme by endotoxin are: pH 
00 -75 and relatively high ionic strength, vh ile  optimum pH for most available 
substrates is usually greater than 80 v ith  lo v  ionic strength (375).
Furthermore, ooagulogen present in  the lysate competitively inhibits the 
omidose activity of the clotting enzyme on a chromogenic substrate. This 
renders many LAL preparations incompatible v ith  cforomogenic substrates, 
vhich is seen as a loss of sensitivity of the method.
Generally, hovever, the method appears to be much more sensitive than the 
Limning gelation test. Harada-Suzuld and colleagues in  their vork reported th a t, 
uncer certain conditions, the chromogenic substrate assay method vas 50 tim es 
more sensitive than the gelation test (197).
Applications of the LAL ossan
There are nov many applications of the LAL test. The general areas of application 
are given in  Table 4. Further details are given belov.
Table 4 . Applications of the LAL assay.
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Hon-olinical Clinical
m ains va ter bleed
industrial vo ter cerebrospinal fluid
vastevater urine
food products synovial fluid
airborne dusts gingival specimens
biologioal reagents fluid
pharm aceutical products urethral and cervical exudates
medical devices ocular aspirates and scrapings
ear specimens
Don-olinioal applications
Endotoxin is nbiquitons and varied levels are found throughout the environm ent. 
m taier-Calgan (350), in  a study in  the Vest German tovn of Darm stadt, found 0.2 
ng of endotoxin per m l in  central pump v a te r, 0.4 ng per m l in  central tovn  
vater,O S  ng per m l in  domestic drinking vo ter, and lb  ng per m l in  drinking  
va te r in  an office supply. Voter in  a natural svim m ing pool in  Darmstadt 
contained 25 b |lg of endoxin per m l.
mtOler-Calgan also reported that the endotoxin level in  grape sugar from  
emergenoy rations vas 256 ng/g. Furthermore, Jjmulug amoebocyte lysate assay 
has been used for testing other food products to determine their quality. Among
these products ve re  ground beef 1236,237,238) and o ther Idnds of m eat (500), lean 
fis h  (557) and mllJc (195,208,331).
The assay has l» e n  shovn  to be o f value in  de te rm ina tion  of bacterio logical 
q u a lity  o f v a te r  (124,248) and in  assessment of the  effectiveness of v a s te v a te r 
renova tion  (247). I t  has also confirm ed the  la rge endotoxin load of the  m arine  
env ironm ent %34), v h ic h  is  the  h a b ita t o f horseshoe crabs.
The L im ulus amoebocyte lysa te  assay has been used to screen various 
occupational environm ents fo r the  presence o f a irborne endotoxin. Large 
q u a n titie s  of viab le  bacteria  and re la ted endotoxins can be found in  dusts in  
a n im a l confinem ent u n its  (72, 581), compost p lan ts  (71, 302), cereal g ra in  
e levators, m ills  and o ther processing p lan ts  (99, 393, 393), p ou ltry  processing 
p la n ts  (394,582), p lan ts  processing vegetable fib res such as cotton 133,70,134,391, 
392,484), flax  and grass (478,484) and also in  a ir  h u m id ifica tio n  systems (1 ^ , 135, 
475,477). A irborne endotoxin in  occupational environm ents is  though t to be the 
cause of various h yp e rse n s itiv ity  reactions v h ic h  are m a in ly  resp ira to ry  (63,65, 
229,476,479,535,615). These reports m ay he of value in  the  app lica tion  of the LAL 
assay in  rou tine  environm enta l screen tests. This is  because endotoxin levels can 
be used p o te n tia lly  as measures of “to x ic ity " or "cleanliness" of a irborne dusts 
(391,393).
amoebocyte lysate assay has also been used fo r tes ting  biological 
reagents fo r endotoxin con tam in a tion . Since endotoxin is  very potent In  a v id e  
range of b io log ica l a c tiv itie s  (See section 13), i t  can a lte r m any biological assays 
and processes. The LAL assay has been employed fo r detection of endoloxin in  
some m itogens, such as concanavalin A (Con A) (150, 448), phytohaem agglu lin in
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(FHA) and pokeveed m itogen (FVHl) (132); in  some batches of horse serum , used in  
tissue cu ltu re  m edia (152); in  some therapeu tic agents, used in  experim enta l 
research, such as antilgm phocgte serum  (ALS) and tra n s fe r facto r (TF) (152), 
in te rfe ro n  OFIl) and Igmpholcine (LK) preparations (41), e ry th ropo ie tin  (152, 437, 
343); and in  type C RUA v iru s  reagents, used to study ce ll m ediated im m une (Cmi) 
responses (ICR).
The LAL assay has been employed ro u tin e ly  in  the  pharm aceutica l in d u s try  fo r 
both  in-process and fin a l pyrogen tes ting  of in jec tab le  pharm aceutica l products, 
and fo r tes ting  of m edical devices before release.
Endotoxic reactions are usua lly system ic, and are m anifested by fever, c h ills , 
rig o rs , tachycard ia , headaches, hypotension, d ia rrhoea, m ya lg ia , nausea, 
v o m itin g  and other adverse host responses (330). In  the  m ost severe cases the 
p a tie n t m ay develop endotoxic shock, v h ic h  m ay be fa ta l. For th is  reason, 
m anufacture rs are lega lly  obliged to test in jectab les and ce rta in  m edical devices 
fo r endotoxin con tam ina tion . Vhere the  le g is la tion  of the  given country pe rm its , 
the LAL assay fo r endotoxin is  the only test employed; o th e rv ise , i t  is  used as an 
a u x ilia ry  test (320,635). Local reactions to endotoxin are also kn o vn . The LAL ssay 
established th a t contact d e rm a titis  in  a v o rk e r using irra d ia te d  latex gloves va s  
caused by endotoxin (516). This case h ig h lig h ts  problem s associated v ith  
endotoxin contam ination  of “p las tic  so ftva re " fo r the pharm aceutica l in d u s try  
and d ifficu ltie s  connected v ith  re-use of m edical devices. Indeed, the LAL assay 
has been developed in to  a m ethod fo r de te rm in ing  pyrogen burden (pyroburden) 
(378) on packaging components used in  s te rile  m anufactu ring  (214).
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The LAL assay has been used by the Centers for Disease Control (CDC), USA, in  
investigating outbreaks of pyrogenic reactions associated v ith  parenteral fluids 
and medical devices, as part of their Hospital Infections Program (219,220). The 
LAL assay has been used for detection of endotoxin in  reusable cardiac catheters 
(272, 446), hepatic catheters (%1) and Foley catheters (170) after outbreaks of 
pyrogenic reactions in  patients. Inadequate sterilization, vh ich did not render 
the catheters pyrogen-free, vas blamed in  these cases, vh ich occurred in  the 
USA. Interestingly, plasticvare is pyrogen-free im m ediately folloving
moulding (318, 378) but rapidly becomes contaminated if  the manufacturing 
environm ent is not controlled. Also, the risk of endotoxin contamination 
increases if  the final product is a result of a complex process, as is the case v ith  
catheters (170). Also, in  the USA, there is a legal requirem ent for catheters to be 
sterile and to pass lead content, acute toxicity and anim al im plantation tests 
according to the Federal Hazardous Substances Act, but they are not required to be 
endotoxin or pyrogen-free, or to be routinely tested for pyrogenicity. This legal 
loophole may be a reason for pyrogenicity of seme brand nev medical devices 
(170).
The amoebocyte lysate assay has also been applied to routine pyrogen
testing of parenteral products . The US Pharmacopeia
designates the LAL test as the "official" pyrogen test for va ter for injecUon and 29 
different radiopharmaceutioals (376). The LAL assay, among others, has been 
employed for LVPs (Large Volume Parenterals) (151,318, 319, 410,590,601), SYPs 
(Small Volume Parenterals) (601), vaccines (bacterial as v e il as live and 
inacUvated v ira l) (88,222, 269,275,386,440), allergenic extracts (54,222), viscous, 
opaque solutions of iron dextran (155), a variety of anUtumour agents (151,152, 
523), intravenous fdt emulsions (193, 403), antibiotics (206, 311, 367, 572, 595),
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rad iog raph ic  con trast m edia (ECIH) and ccxzgnlalion fac to r p repara tions (132,222), 
p lasm a fra c tio n s  (a lbum in , im m unog lobu lin , crgopoor plasm a) (167,222,251,317, 
319, 407, 549), peritonea l d ia lys is  solutions G19) and radiopharm aceutioa ls (151, 
222,349,443,601).
C lin ica l app lica tions
The L im ulus amoebocyte lysa te  assay has been used fo r detection o f endotoxin in  
g in g iv a l in fla m m a tio n  (507), synovia l flu id  (114, 115, 596), ascites flu id  (73, 576), 
u rin e  (242, 243, 244, 245, 307), cerebrospinal flu id  (112, 246, 352, 460, 522, 586), 
u re th ra l (253, 431,432, 434,541) and cervica l exudates (433,542), ocular aspira tes 
and scrapings (304,661 ) and ear specimens (35).
The LAL test fo r detection of endotoxin in  blood has also been described (104,131, 
202,291,584) bu t i t  is  com plicated by the presence in  blood of n a tu ra l in h ib ito rs  of 
the  tes t (292), and the  usefulness of the LAL assay in  p lasm a/serum  has been 
disputed (114,116,285,438,463,556).
Theore tica lly, th ree  types of factors m ay affect the  chrom ogenic LAL assay: 
those v h ic h  in te rfe re  v ith  LAL; 
those v h ic h  in te rfe re  v ith  endotoxin; and 
those v h ic h  in te rfe re  v ith  the  chrom ogenic substra te .
A pparen tly , a ll th ree  are present in  blood and in  the LAL its e lf.
As m entioned above in  subsection lJ12.,the c lo ttin g  enzyme of the  LAL cascade 
displays substrate specific ity  s im ila r to th a t of facto r Xa, v h ic h  is  a blood 
coagulation fac to r. In  th is  v a y ,fa c to r Xa can replace the  c lo ttin g  enzyme in  the
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LAL coagula lion p a lh v a g , cleaving coagulogen, v h ic h  resu lts  in  the  fo rm ation  of 
coagulin and subsequent non-specific gel fo rm a tio n . Factor Xa can also compete 
v ith  the  c lo ttin g  enzgme fo r the  chrom ogenic substrate v h ic h  in  fact va s  
in it ia lly  syn the tized fo r facto r Xa. A part from  facto r Xa, blood also contains 
several o the r enzymes v ith  am idase a c tiv ity , e g . p lasm in , th ro m b in  and 
urokinase, v h ic h  cleave some substrates having  the  -G ly-A rg-pH A te rm in a l 
sequence (149,638). F u rthe r, coagulogen, i f  present in  s ig n ific a n t quan tities  in  LAL 
designated fo r use in  the  chrom ogenic assay, v i l l  in h ib it the  chrom ogenic 
reaction , as the  c lo ttin g  enzyme v i l l  p re fe re n tia lly  cleave i t  to  the  exclusion of 
the  chrom ogenic substra te  (com petitive in h ib itio n ).
In  order to  ob ta in  L im ulus am oelxKyte lysa te , v h ic h  v c u ld  be h ig h ly  specific to 
e n d o to x in ,it is  also necessary to remove facto r G. Factor G is  p-D-glucan sensitive 
and acts ufw n the  p roc lo ttin g  enzyme (see F ig?). On the  o ther hand, 
a n tith ro m b in  HI and ct2*T>lasmin in h ib ito r (o2tm tip la s m in ), v h ic h  are
proteinase in h ib ito rs  n a tu ra lly  occuring in  blood plasm a, ve ry s tron g ly  in h ib it 
the  am idase a c tiv ity  o f the  c lo ttin g  enzyme (357, 457). P urified a n tith ro m b in  n  
v a s  also found to have a strong in h ib ito ry  effect on the LAL assay (638). Since the 
active  consituents of the  LAL are pro te ins, common p ro te in  dénatu rants, such as 
sodium  dodecyl sulphate (SDS) and urea also prevent ge lation of the  lysate by LPS 
(558). m oreover, anticoagulants can have a profound, dose re la ted , in h ib ito ry  
effect on LAL. For exam ple, i t  has been shovn  th a t the  LAL reagent can be 
in h ib ite d  by che la ting  agents v h ic h  remove the d iva le n t cations essential fo r the 
com plete a c tiva tio n  o f the  LAL p roc lo tting  enzyme (289,380,558). C itra te  and EDTÀ 
(ethylenediam ine te traace tic  acid) are such agents.
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EDTA has also been shovn  lo  cause s tru c tu ra l changes in  endotoxin due to  the  
rem ova l o f d iva le n t caUons. Such m odified LPS vo u ld  no t c lo t the  LAL (558). 
A n ticoagu lan ts v h ic h  depress plasm a calcium  levels should also be avoided since 
depression o f plasm a calcium  levels resu lts in  the  a c tiva tio n  of g lobu lins v ith  
esterase a c tiv ity , v h ic h  disaggregate and detoxify endotoxin (458).
V ith  h ep a rin , ea rly  repranrts stated th a t doses of up to 100 u n its  per m l of plasm a 
(292), o r even of 1 OW u n its /m l (% 8,289) had no effect on the  ge la tion of LAL, and 
values up to  200 u n itsA n l ve re  recommended fo r anticoagula tion (449). Hovever, 
S u llivan  and Vatson reported th a t as lit t le  as one u n it of heparin  per m l v a s  
in h ib ito ry  to  the  LAL gelation tes t, a lthough th is  in h ib itio n  v a s  overcome by the 
add itio n  of ca lcium  chloride and sodium  chloride to  LAL (560). HlcConnell and 
Cohen also found th a t, v ith  concentrations of heparin  of approxim ate ly 30 
u n its A n l, the re  v a s  a 90% reduction in  endotoxin detectable by the  chrom ogenic 
LAL assay (310). Hovever, the  in h ib ito ry  effect of up to  IK ) u n its /m l could be 
neu tra lized  by the  add ition  of protam ine sulphate. In  con tras t, Eonneberger 
found in h ib itio n  o f gel fo rm a tion  on ly v ith  concentrations of heparin  exceeding 
50 u n its /m l (457). This difference in  concentrations o f heparin  affecting the  LAL 
assay m ay be due to  a difference in  se n s itiv ity  betveen the  chrom ogenic and gel 
te s ts .
Endotoxin in h ib ito rs  present in  hum an blood can also in te rfe re  v ith  the  LAL 
assay. Vebster shoved th a t a t 3 7 ^ ,endotoxin in  serum  v a s  inactiva ted  ra p id ly  
a t a ra te  of up to 600 n g /n il/h o u r. A t 5®C in a c tiva tio n  v a s  s lo ve r, but s t ill 
accounted fo r the  disappearance of a substan tia l frac tio n  of the  added endotoxin 
a fte r 24 hours (62®).
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Levin and colleagues suggested th a t the  in h ib ito ry  na ture  of blood va s  p r im a rily  
the  re su lt o f reversib le  b ind ing  betveen endotoxin and serum  prote in (s), ra th e r 
th a n  destruction  of endotoxin (292). Das and colleagues found th a t endotoxin in  
p lasm a v a s  bound to  the  surface of p la te le ts (97). This v a s  thought to  be an 
in te rm ed ia te  step in  detoxifica tion by the  re ticu loendothe lia l system .
Skarnes and Chedid dem onstrated th a t a b iological in a c tiva tio n  of endotoxin v a s  
a tv o -s te p  reaction  (528); the  f ir s t step being degradation o f endotoxin by the 
o rg lobu lin  fra c tio n  of serum , foUoved by a second step of detoxifica tion. Later 
Skames postulated th a t a -g lobu lin , v h ic h  caused disaggregation of LPS, v a s  a
hea t-stab le  lipop ro te in  esterase. Detoxification va s  effected by the second
cc^-globulin esterase, v h ic h  v a s  organophosphate-resistant and hea t-lab ile  and
v h ic h  reacted enzym atica lly  v ith  the  disaggregated LPS (526,527,529). S im ila r 
tv o -s te p , a lb e it non- enzym a tic  detoxification of LPS va s  postulated by U levitch 
and Johnston (60S). Johnson and colleagues also dem onstrated th a t o rg lobu lin  
v a s  an endotoxin in a c tiv a to r (240). But th e ir studies sugested th a t i t  va s  a single 
p ro te in  v h ic h  inactiva ted  endotoxin by disaggregation, and th a t i t  va s  n e ith e r a 
lipop ro te in  no r a serine esterase. In  con trast, ea rlie r studies by Schultz and 
Becker, and la te r studies by the  Qalanos group, suggested in a c tiva tio n  of 
endotoxin by lipop ro te in  (146, 489). I t  has also been suggested th a t the  
com plem ent system  m ay pa rtic ip a te  in  the detoxification of LPS in  plasm a (239, 
321). F in a lly , antibodies ve re  also ind icated as factors revers ib ly  in a c tiva tin g  
endotoxin (292,465,670).
Despite a ll of the  d ifficu ltie s  in he ren t in  testing  blood fo r endotoxin in  the LAL 
assay, and despite the  value of th is  app lica tion of the assay being often
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quesUoned, i l  is s till potentially an invaluable tool in  cases of onrtn|«yxfieim1n, 
bacteraem ia,septicaem ia and septic shock.
A ll shock, including septic shook, is essentially an inadequate capillaxy perfusion 
(198), a state of systemic imbalance betveen supply and demand for oxygenated 
blood (512). Gram-negative organisms are responsible for tvo -th irds of the caseB 
of septic shock, and Gram-positive organisms for the rem ainder, and they are in  
decline (512). H ovever,it is s till unclear vhether endotoxin is a prim ary cause of 
Gram-negative septic shock. Several other questions also rem ain to be ansvered, 
nam ely the role of endotoxin in  the pathogenesis of shock, vhether there is 
dose-related correlation betveen endotoxin levels and the severity of the septic 
shock, and vhether endotoxin assay may be of value in  prediction, diagnosis and 
prognosis of the shock (306,438,451).
The pathogenesis of acute pancreatitis, although s till unclear, seems to be quite 
different. The favoured theory is that of pancreatic autodigestion, vh ich vas 
introduced by debs in  1876 (266). This theory proposes that pancreatic zymogens 
(proenzymes) are in  some vay activated v ith in  the pancreas itself. The active 
enzymes (particularly trypsin) then activate other proenzymes (chymotrypsin, 
elastase and phospholipose A), vhich leads to digestion of pancreatic and 
peripancreatic tissues (548,587,641). Hovever, endotoxaemia has been reported to 
accompany acute pancreatitis (61, 142). In  this clinical condition, endotoxin 
seems to be of intestinal origin, escaping from portal blood into the systemic 
circulation, due to im paired hepatic reticuloendothelial system function a t the 
onset of pancreaUtis (130,143,264). The Liehr and Foulis groups found that the 
presence of endotoxaemia seemed to correlate v ith  the outcome and the severity 
of the disease (144,295). Hovever, it s till remains unclear vhether there is any
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correlation betveen the presence of endotoxin and the course and outcome of the 
illness. It  has not yet been demonstrated vhether endotoxin may be an 
indication of poor prognosis in  patients v ith  fulm inant (haemorrhagic ) 
pancreatitis (204).
In  neutropenic patients, systemic endotoxaemia vithout bacleraemia has been 
reported as a cause of fever (204). Endotoxin in  this clinical condition vas thought 
to permeate from the intestinal tract into the circulation as a consequence of 
intestinal mucosal damage by cytotoxic agents, or because of numerical and 
ftm ctional defects of neutrophils, or because of im paired hepatic 
reticuloendothelial cell clearance of endotoxin (204). Gram-negative bacteraemia 
originating from the digestive tract in  neutropenic patients has also been 
described (373).
13. Fibronectin 
131. Biochemistry
Fibronectin vas isolated and partially purified from human plasma by Ulorrison 
and colleagues in 1948 (337). It  vas termed "cold insoluble globulin" or CIg. In  
1970, it  vas purified to homogeneity and investigated by mosesson and Umfleet 
(340). Other synonyms used in the literature are: large, external transform ation- 
sensitive (LETS) protein (663),cell surface protein (CSF) (231,665),fibroblast surface
antigen (FSA) (471,472), a n ti-g e la tin  factor (659), opsonic ccg-surfaoe binding (SB)
glycoprotein (45,46), galactoprotein a (62,157), cell attachm ent or cell adhesion 
factor or protein (189,265,404), zeta protein (454), cell spreading factor (189), and 
humoral recognition factor (258,480).
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F ibronectin  exists in  tv o  form s: as soluble plasm a fib rone ctin  and insoluble ce ll 
surface (ce llu la r) fib rone c tin  (340). Soluble fib ro n e c tin , apa rt from  in  plasm a, 
exists in  cerebrospinal flu id , am n io tic  flu id , jo in t flu id , sem ina l plasm a, lym ph , 
tissue flu id  and o ther body flu ids  (4,468,536), v h ile  ce llu la r fib ronectin  has been 
found in  m ost, i f  no t a ll, body tissues (4). F ibronectin  is  produced by fib rob lasts 
(471, 662), p la te le ts (673), neu troph ils  (225), vascular endothelia l cells (235), 
e p ith e lia l cells (69, 140), a s tro g lia l cells (612), sm coth m uscle cells (56), m acro­
phages (6),hepatocytes (8,622),chondrocytes (100),and o ther selected ce ll types.
Plasm a fib rcn e c tin  is  a n tig e n ica lly  re la ted  to  ce ll surface fib ronectin  (471, 663), 
bu t ap a rt from  the  difference in  s o lu b ility  of the  tv o  form s, there m ay be s lig h t 
differences in  th e ir am ino acid sequences, since m onoclonal antibodies can be 
generated, v h ic h  recognize on ly one fo rm  of the  molecule (16,261). There is  also a 
p o ss ib ility  th a t a s tran d  of the  p lasm a fo rm  is  s im p ly  sho rte r, as i t  va s  found 
th a t the  m olecular v e ig h t of plasm a fib rone c tin  v a s  10 000 daltons less than  the 
ce ll surface fo rm  of the  m olecule (662). Plasm a fib rone ctin  is  a strand-lilce  
m olecule v ith  a d iam eter of 2 nm  and a le ng th  of 120-160 nm  (119,120).
F ibronectin  from  both plasm a and tissue appears to  have a m olecular v e ig h t of 
440 000 -  450 000 daltons, and consists of tv o  very s im ila r disulphide-bonded 
subunits of 220 000 -  230 000 daltons (340,342,405).
F ibronectin  is  a la rge  g lycoprote in , v ith  carbohydrate content in  both plasm a 
and ce ll surface fib ronectins of 4 .4 -5 8  % (62,339,623,664), v h ile  the carbohydrate 
content of am nioUc flu id  fib rone c tin  is  95-96% (469). The m a in  carbohydrate 
com ponents of fib rone ctin  are: m annose, galactose, n-acetylglucose and s ia lic  
acids (588). S tructu ra l studies of fib rone c tin  ind ica te  th a t there are a t least ten
s. aureus
Heoarin
Fibrin
X I I I Gelatin
Cells
Heparin
Fibrin
SH
SH
SH
SH
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repeating vnlts of homologous "finger" sequences, each stabilized bg an invariant 
p air of intrachain disulphide bonds. In  addition, there are repeating units of tvo  
other tgpes of homologous sequences (419).
Fibronectin binds to collagen, gelatin, fib rin , hyiluronic acid, heparin cr heparan 
sulphate, Staphglocoocus aureus and other bacteria, actin, sulphated 
proteoglgcans, sphingolipids (gangUcsides), PDA, transglutaminase (factor xm  a) 
and the Clq complement component (39,153,211,232,267,326,345,417,501).
Fig9 Diagram of human fibronectin dim er.
The nS^ term in i are to the left; the COOB-termini to the rig h t. Disulphide bonds
are shovn as th in  lines connecting tvo  portions of the polypeptide strand. Loops 
containing sim ilar sets of disulphide bonds are homologous, numbered arrovs 
indicate the order of sequential protedgtic cleavage bg plasmin cr trgpsin. The 
dotted arro v  depicts a trgptic cleavage site vhich is evidently missing in  
one-half of the subunits. The approximate sites of transam idation bg factor xm a; 
of hinMing to StapholccQccus aureus. heparin, fib rin , gelatin and cells; and cf the 
cryptic free sulphgdrgl (SH) groups are indicated.
From: mosher, D. F., mosesson, m. V : Plasma fibronectin: rdes in  hemostasis, 
macrophage function and related processes In: EJ. Bovie, AA. Sharp (edsJ: 
Hemostasis and Thrombosis. Buttervorths International medical Revievs: 
Hematology, vol 2 . Buttervorths, Vcbum , IHA. 1%5, pp 173-196.
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13 2 . Clinical significance
Lov fibroneclin levels have been reported in  the clinical conditions of sepsis (277, 
388,428,464,492,547), disseminated intravasctdar coagulation (DIO (122,346,388, 
547), adnlt respiratorg distress sgndrome (ARDS) (90,388), hepatic fdilnre v ith  or 
vitho nt gastrointestinal bleeding (177,388), bum  in jnrg  (121,192,278), acoidental 
and surgical tram na (122,256, 257, 452, 483, 493) and after transfusion of stored
hicAit^ ijf ___
blood ( microaggregate debris) (537).
The functions and patbopbgsiological role of plasma fibronectin are uncertain, 
and a ll the evidence is indirect. Hovever, it  is thought that fibronectin mag be of 
clinical importance as a non-invosive measurement of RES function (257,278), 
since it  is postulated that fibronectin mag be a non-specific opsonin responsible 
for uptake and oleoronoe of predominantlg non-baoteriol particulates, such as 
collagenous tissue debris, cellular debris, immune complexes, denaturated 
proteins and products of intravoscular coagulation (343,480,483).
To date, there have been several clinical studies on fibronectin replacement 
therapg using crgoprecipitate in  criticallg  ill septic patients v ith  multisgstem  
failure. Crgoprecipitate is prepared firom plasma (427) and is enriched in  plasma 
fibronectin and several other plasma proteins (9, 68, 338, 340). The results of 
crgoprecipitate adm inistration to septic traum a, bum or complicated surgical 
patients v ith  m ultiple organ failure and lo v  fibronectin levels, shov general 
improvement in  the patients' condition, a reversal of the febrile and septic state, 
increased alertness, and improvement in  cardiovascular, pulmonarg and renal 
functions (12,453,481,483,491,492).
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Unfortnnatelg, the studies in  vh ich  these interesting results vere obtained vere  
uncontrolled, non-randomized and non-double blind. Furthermore, the 
crgoprecipitate used as the source of fibronectin is also enriched in  fibrinogen, 
factor V m  coagulant activitg and von Villebrand factor (344). This mag be 
im portant in  réévaluation of the significance of fibronectin in  crgoprecipitate for 
criticallg  ill patients, as it  has been found th at the fibronectin molecules 
recovered firom plasma cr^precipitates lack the polgpeptide domain required for 
binding to Stanhalococcus aureus (547). Other data suggest that opsonic activitg  
of crgoprecipitate declines v ith  storage in  excess of approximatelg four months 
(480). This vould indicate th at the alleged improvement in  patients' condition 
obtained in  some studies after adm inistration of crgoprecipitate vas due to 
factors other than fibronectin. In  fact, the decrease in  the fibronectin level of 
mang criticallg  ill patients mag be merelg a reflection of their acute or chronic 
nutritional deficiencies; indeed, fibronectin has been postulated as a nev 
nutritional param eter (314), in  v iev of the fact that plasma fibronectin has a 
h alf-life  of approximatelg 15-24 hours (183,482) and its levels have been shovn to 
drop rapidlg in  response to starvation in  healthg volunteers, and return to 
norm al soon after refeeding (102,4%).
Further, none of an im a l models to date supports the hgpothesized relationship 
betveen sepsis or endotoxaemia and fibronectin depletion. Rats 0ven  
intravenous endotoxin shoved either no change or increase in  bioassagable 
fibronectin levels (298). Fibronectin concentrations in  rats remained unchanged, 
or increased as a result of septic shock or Escherichia coli bacteraemia (18, 258). 
Generalized Shvartzm an reaction in  rabbits, and intraabdom inal abscesses in  
rats , generated a significant increase in  fibronectin levels, at a tim e vhen RES 
function vas depressed (ITO).
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In  v iev  of the above, clinical tria ls  v ith  intravenous adm inistration of plasma 
fibronectin should be conducted v ith  extreme caution, as theg mag actuallg cause 
organ failure. It  has been postulated th at fibronectin infusion in  the presence of 
alreodg elevated plasma fibronectin mag increase the deposition of exogenous 
and/or endogenous particles in  pulmonarg and other capillarg beds (18,480).
Anns OF THE STUDY
The a im s of th is  studg ve re  tvo fo ld :
1. to  develop a sensitive , q u a n tita tive , sim ple and inexpensive L im ulus 
amoebocgte Igsate (LAI) assag fo r the detection of endotoxin;
2. to  app ly th is  assay in  c lin ic a l studies (septic shock, cyclic neutropenia and 
acute pan cre a titis  tr ia ls ) and in  n o n -c lin ica l studies (perform ance of 
extra -corporea l f ilte r  fo r rem oval of endotoxin firom hum an blood, 
m easurem ent o f endotoxin content in  baffie p late m a te ria l from  the  
h u m id ifie r system  and in  a dust sam ple from  archive books).
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n  mATERiALS, mrraoDs a iid  p a tie iits
2 J . Equipm ent
2 1 1 . Disposable p la s tic va re
For d ilu tio n s  o f endotoxin and storage of plasm a sam ples, s te rile , polystyrene 
test-tubes v ith  caps by Talcon** (12x75 m m , ca t.n o . 2003, D ivision o f Becton, 
D ickinson and Co., Cockeysville, HID 21030, USA) ve re  em ployed.
LAL tests v e re  perform ed in  Ta lcon" s te rile  polypropylene test-tubes v ith  caps 
(12x75 m m , c a t. n o . 2003).
P lastic tip s  fo r volum es 0 - ^  |il ve re  from  L . I . P . Equipm ent and Services (Shipley, 
V est Y o rksh ire , BD17 7AS) o r from  Gilson Co. (for han d ling  blood only) (Gilson 
France SA, %4CK) V illie rs  le Bel, France).
"Volac" tip s  fo r volum es 0-1000 JU ve re  m anufactured by John Poulten Ltd. 
(Barldng, Essex, IG ll 8QD).
A ll p la s tic  v a re  v a s  shovn  not to  b ind  endotoxin.
P lastic tip s  ve re  rendered pyrogen-free by autoclaving in  standard conditions, 
i e . a t  121*C a t 15 IbAnch^ fo r 20 m inu tes .
m icrop la tes fo r spectrophotom etric readings ve re  non-cobalt trea ted EIA 
m io ro titrO tio n  plates (Dynatech Laboratories L td ., B illin g sh u rs t, Sussex).
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2 i 2.Gla88vare
Pyrex disposable screv cap culture tubes made from borosilicate glass (13x100 
m m , cat .no 3944913, Coming Glass Vorks, Coming, HT 14830, USA) vere employed. 
In  order to obtain pyrogen-free heparinized test-tubes, caps and tubes vere  
soaked in  1% Deoon 90 overnight, then rinsed, vashed six tim es in  tap v a ter and 
subsequently six tim es in  distilled v a ter, dried and after closing tubes v ith  
sim ilarly pretreated caps, they vere heated at 180*C for a t least 12 hours. Then 
01 m l of heparin vas added to a ll tubes, vhich subsequently vere dried in  a 
drying oven to obtain a shell of heparin.
2 1 3 . Spectrophotometer
Absorbance of samples vas determined at 410 nm in  a miCROEUSA miniReader 
niR 590 (Dynateoh Laboratories Ltd.,Sussex).
22 . Reagents
2 2 1 .Heparin
For heparinizing test-tubes, pyrogen-free heparin vithout preservatives, a t a 
ooncentration of 1000 units per m l, vas used.
2 2 2 .Boiling buffer
This buffer, used for extraction of endotoxin from plasma, vas prepared as foUovs: 
ODOgTRIS 
2 D 3 g m g C l2  
OBOgDaCl
distilled va ter to 1 litre .
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The pH VOS adjusted to 7.4 v ith  IlaOH or HCl, accordingly. To render the bufler 
pyrogen-free, 23g of asbestos vas added to every 21 volume of the buffer. Then 
the suspension vas mixed thoroughly and left overnight. The supernatant vas 
subsequently filtered through a 022 |im m illipore filte r. The filtra te  vas divided 
into approxim ately 10 m l aliquots, vhich vere autoclaved a t 121®C at 15 Ib A n clf 
for 20 m inutes.
2 2 3 .Limulus amoebocyte l^ a te  and chromogenic sulKtrate 
In  the early part of this vork, a commercially available Limulus Amebocyte 
Lysate Chromogenic Reagent Set QUA. Bioproducts, Valkersville, HID 21793, USA) 
vas used. This vas complemented by S-2423 chromogenic substrate OCabi 
Diagnostica, Stockholm, Sveden).
Later, the Quantitative Chromogenic LAL (QCL-1000) Idts OH A . Bioproducts) vhich  
included the chromogenic substrate, vere used.
Coatest Endotoxin kits (Eabi Diagnostica) and the Limulus Amebocyte Lysate Color 
Chemistry kits aHallinclcrodt,St.Louis,mO 63134,USA) vere also tested.
23 . Blood collection and plasma preparation
Human venous blood vas dravn v ith  stringent precautions. The venepuncture 
site vas treated v ith  2% (v /v ) iodine in  alcohol and alloved to dry. Blood vas 
dravn into a sterile disposable plastic syringe. After removing the needle, blood 
vas transferred into the screv-capped pyrogen-free heparinized glass test-tube. 
Blood in  a tig h tly  capped tube vas then mixed by slov, gentle 180® inversion of the 
tube several tim es. Tubes vere immediately placed on ice.
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Subsequenüy, blood vos cenlrlftiged a l +4®C a l 100 x g for 10 minutes to obtain 
platelet ricb  plasma (PRP), and if  not used im m ediately, tbe plasma vas stored at 
-20®C.
Just before tbe assay, plasma vas put on ice to th a v  and kept on iœ  throughout 
the extraction procedure.
The extraction procedure consisted of tvo  steps:
1) 50 |U of PRP plus 1S0|U of boiling buffer, plus 50 |U of pyrc^en-free vo ter (PFV) 
or appropriate dilution of endotoxin in  pyrogen-free vo ter. PRP for the 
standard odrve vas pooled from 5~- ÿ healthy volunteers, vhose plasma 
had been shovn to be endotoxin-free. To the 0 pgAnl sample for the 
standard curve and to the patient’s plasma, FFV vas added instead of 
endotoxin dilution.
2) heating of diluted plasma at 100®C for 1 minute in  a boiling vo ter bath.
The precipitate formed vas sedimented by centrifugation at 1500 x g a t room 
tem perature for 10 minutes and the supernatant containing the plasma extract 
VOS removed. A ll samples vere prejKired in  duplicate.
2.4. Preparation of baffle plate m aterial and dust for endotoxin assay 
Baffle plate m aterial (from the semiconductor factory) vas soaked in  PFV 
(proportion 1:4 v /v ) for 1 hour at room temperature (27®C). The container vas 
agitated a fov tim es during the procedure and some soaking solution vas 
removed. Subsequently, serial ten-fold dUuUons of the soaking soluUon vere 
tested in  the one-stage LAL assay.
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A dust sample vas taken from the surfaces of a collection of old, vater-dam aged 
books, vh ich  are held in  the Ayrshire branch of Strathclyde Regional Council 
Archives.
O lg of dust vas diluted v ith  1ml of PFV and soaked for 15 minutes at 37®C. Then 
the container vas agitated and centrifuged for 5 minutes a t 1500 x g at room 
tem perature. The supernatant vas used as a starting point for serial, ten-fold 
dilutions, vh ich vere subsequently tested in the one-stage LAL assay.
25. LAL assay
2 5 1 . T vo-stage assay
In  this assay, 50 |U of tested sample vere incubated at 37®C in  a vater bath v ith  
50 |U of LAL. Then 100 |U of S-2423 vere added and the m ixture vas further 
incubated a t 37®C. The reaction vas term inated by the addition of 50% (v/v) acetic 
acid. Each sample m ixture vas then centrifuged at 1500 x g for 10 m inutes. Tvo 
hundred and fifty  m icrolitres of supernatant from each sample vere then 
transferred to an individual v e il of a m icro-titre plate and absorbance of each 
sample vas measured in a 1HICR0ELISA miniReader.
V ith  each set of patients' samples, the foUoving controls vere set up:
1. Reagent control
For th is, 50 |ll of PFV replaced 50 (11 of plasma extract, and vas incubated 
v ith  LAL and chromogenic substrate in the same vay as plasma extract;
2. Standard curve background control
Plasma extract vas prepared, as for the 0 pg/m l value of the standard curve.
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and incubated v itb  LAL as usual, bu t 100 (U of acetic acid v a s  added p rio r to 
iro  (U o f chrom ogenic substrate in  order to  prevent any chrom ogenic 
reaction ;
3. P a tien t p lasm a background con tro l
This v a s  set up as the  standard curve background con tro l, bu t using pa tie n t 
p lasm a.
252 .  One-stage assay
In  th is  m od ifica tion , 100 (II o f test sam ple ve re  incubated v ith  100 (II of a m ix tu re  
o f LAL and chrom ogenic substra te . The reaction v a s  te rm ina ted  v ith  100(11 o f 50% 
(v /v ) acetic acid. The absorbance of 250 (II of each sam ple va s  subsequently 
m easured in  the  miCROELISA m iniR eader, in  the  same m anner as in  the 
tvo -s ta g e  m ethod. The same contro ls ve re  also set up .
2 6 . Comparison of th ree  com m ercia l Icits fo r the chrom ogenic LAL assay 
In  th is  com parison, the  assay used to test the Coatest Endotoxin k its  (Eabi 
D iagnostica) and the  Q uantita tive  Chromogenic LAL (QCL-1000) Id ts  v a s  a 
one-stage m od ifica tion , as described in  p a rt 322 .
The m a llin ck ro d t Id ts  ve re  tested in  accordance v ith  the  m anufacturer's 
in s tru c tio n s , ie .  a 1:4 m ix tu re  of LAL and the  chrom ogenic substrate v a s  
incubated according to the  label incubation tim e  c la im , v h ic h  is  d iffe ren t fo r 
every ba tch .
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2.7. ColoTiIalions
2.71. Calculation of endotoxin concentration in  test samples 
Endotoxin potencies in  assayed samples vere either determined graphically firom 
the plotted standard curve or (particularly in  cases of m ulti-sam ple experiments) 
vere determined v ith  the aid of the Hevlett-Paclcard (model 10) calculator, using 
the linear regression programme.
2.72 The intra-assay coefficient of variation(C.V J vas calculated according to the 
fbrmxda;
C.V. - ^ x lO O
X
1) vhere SD .- Standard Deviation of group of values
2j X = mean value;
SI>. . n / ^
If n -i
3) vhere d (deviation)  ^Ixq -  x|
Xjj = value of sam ple
= 2 *
5) X (mean value) D
6) n = number of values
2 S . Study on th e  extra-oorporeal f ille r  to rem ove endotoxin fro m  h u m an  blood. 
For stu d y, th e  I  vo -s tag e  LAL assay v a s  em ployed, bu t th e  incubation  tim e
v it h  S-2423 v a s  3 m in u tes , and a ll volum es doubled in  com parison v it h  th e  
m ethod described above.
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Experiments assessing the ability of this sm all particle-size sorbent filte r (1-DEP) 
to remove endotoxin firom human plasma vere carried out a t room tem perature, 
using human plasma obtained by plasmapheresis and firom patients requiring 
venesection for haemochromatosis and polycythaemia.
The endotoxin used in  this study vas firom E. coli Endotoxin Sets (5 x 2 3  mg per 
v ia l, code F 185, m allinckrodt Inc., St. Louis, mo. 63134, USA). Each vial vas 
reconstituted v ith  10 m l of pyrogen-firee v o te r.
Concentrations of endotoxin used in  different experiments vere 25 ngAnl of 
plasma and 250 pgAnl of plasma. The samples vere dravn before and after the 
filte r a t different tim e intervals.
23 . Patients
2 3 1 .Septic shock tria l patients
These patients vere evaluated in  tvo  groups;
Group 1 -  ten critically ill, but not necessarily septic shock, patients, v ith  
daily LAL assays and simultaneous blood cultures;
Group 2 eight acute septic shock patients, vho had four-hourly LAL 
assays for the firs t 48 hours, and thereafter daily. Blood for 
blood cultures and fibronectin vas taken simultaneously v ith  
blood for LAL assays. Cardiovascular and respiratory 
parameters vere also measured at the same tim e.
All blood samples from the above groups vere dravn under the supervision of, 
and subsequently processed by, the author.
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Blood cullures in  this tria l vere processed routinely at the Department of 
Bacteriology and Immunology of the Vestem  In firm ary, Glasgov. Dr Steven Edlin, 
of the Intensive Therapy Unit (ITU) a t the Vestem  In firm ary, measured nnd 
calculated patients’ cardiovascular and respiratory parameters (Table 5).
Table 5. Cardiovascular and Respiratory measurements
C ard iac Index (Cl) = -------------- ^ ------------------- lA n in A n ^
Body Surface A rea
S ystem ic V ascu lar “ x79S dynesecA un5
R esistance (S V R ), CO
P u lm o n ary  V ascu lar m miRAfLz.RAQR) % 793  dyne seoAun^
R esistance (PVR) CO
A lveo lar a r te r ia l oxygen 
difiierence (A -a)IX >2
= IFIO2 X (Pb-47) -  PaC02l -  Pa02 m m  Hg
P u lm o n ary  sh u n t ^  
Qt
C 6>2-C a02
m —-------------m---- %
C c02“ Cm v02
Abbreviations
CO Cardiac Output
IHAP mean A rterial Pressure
RAP Right A trial Pressure
mPAP mean Pulmonary Artery Pressure
PAOP Pulmonary Artery Occlusion Pressure
MO2 Fractional Inspired Oxygen
Pb Atmospheric Pressure
64
PaCOg A rte ria l Pressure of Carbon Dioxide
PqOj A rte ria l Pressure of Oxygen
C&>2 End C ap illa ry  Content of Oxygen
CaO j A rte ria l Content of Oxygen
Cmv<>2 m ixed Venous C ontent of Oxygen
m r Paul nevmcm of the Department of Surgery at the Vestem  Infirm ary assayed 
plasma fibronectin in  the patients' samples. The method of plasma preparation 
and the description of the assay are given belov.
Tvo-m l blood samples lor plasma fibronectin assay vere dravn , either together 
v ith  the blood for the LAL assay (ie . from the venepuncture site) or separately, 
through the indvelling arteria l line via a three-vay tap, folloving the removal of 
a large flush sample. The blood vas placed either in  a Sterilin EE/5 vial v ith  
fwtassium EDI A for routine laboratory tests (Sterilin Ltd, Feltham, IHiddlesex, 
England) or in  an Eppendorf 15 m l micro test-tube (Eppendorf Gerdtebau, Hetheler 
& Hinz GmbH, Hamburg 65, Vest Germany) containing 2mg of EDTA. The sample 
vas im m ediately placed on ice. Subsequently, blood vas centrifuged at 13 000 x g 
for 2 minutes in  a microcentrifuge and, if not tested im m ediately, the plasma vas 
stored at -20®C. If  samples vere stored over a period of tim e, aprolinin (Trasylol, 
Bayer AG, Leverkusen, Vest Germany) at a concentration of 40 lU /m l plasma vas 
added. The assay method vas a modification of a procedure recommended by 
Boehringer Hlannheim Biochemica (Fibronectin Opsonic Protein, in  vitro  
turbidim etric immunoassay for the quantitative determination of human 
opsonic protein). The Biochemica Test-Combination kits (Boehringer Hlannheim)
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vere used for the assay. In  this assay, 5 (U of patient's plasma vas added to a 
reaction volume of 500 |U containing a 1 in  21 dilution of the fibronectin antiserum  
and the antiserum  buffer. The sample vas then mixed throughout and the optical 
density vas read a t 365 nm , using a Pye Unicam SP 450 spectrophotometer (Pye 
Unicam Ltd., Cambridge, England) at 1 minute and at 11 m inutes. Tvo control 
samples vere assayed v ith  every series of measurements. They vere prepared in  
the same vay as the patients' samples, ie . 5 (11 of standard fibronectin from the 
k it (0 (ig/m l or one of the folloving concentrations: 125 (Ig/m l, 250 (Ig /m l, 500 
(Ig /m l, 750 (ig /m l, 1000 (igAnl) vas added to 500 (11 of the reaction volume 
containing a 1 in  21 dilution of the fibronectin antiserum and the antiserum  
buffer. Plasma fibronectin concentrations in patients' samples vere calculated 
from the standard curve plotted from the respective control samples.
292.  Acute pancreatitis patients -  prelim inary tria l
Blood from these patients vas taken and plasma samples vere prepared by Dr. 
Colin Vilson of the Department of Surgery at the Royal In firm ary, Glasgov. This 
heterogenous group consisted of 16 patients. In itia l samples for the endotoxin 
assay vere taken v ith  delays of up to four days (tvo patients) from the onset of 
clinical illness. Seven patients in  this group had m ild pancreatitis diagnosed 
la te r, vh ile  five others, although prim arily suspected of having some form of 
pancreatitis, had some other illness diagnosed la te r. Six patients had blood taken 
for endotoxin assay on one or tvo  occasions only. On average, the patients vere 
sampled once or tvice daily. The clinical assessment of these patients vas made 
by Dr.C. Vilson.
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2 3 3 .Cyclic neutropenia patient
Blood from  thie patient vas taken and plasma samples vere prepared by 
D r. m oira Robertson of the Department of Haematology a t the Vestem  In firm ary, 
Glasgov. The clinical assessment of this patient vas also made by Dr.Robertson.
This patient had cyclic neutropenia v ith  neutrophils cycling on a 21 day basis,
and reciprocal Tg lymphocytosis. During periods of neutropenia (defined as < 05 x
10® neutrophils A), the patient usually had one or tvo  mouth ulcers (occasionally 
Herpes simplex vas grovn),general malaise and occasional perianal problems. 
For this study, a tvo-stage LAL assay vas employed, but the inculxition tim e v ith  
S-2423 vas 3 m inutes, and a ll volumes vere doubled in  comparison v ith  the 
method described above.
23.4 .Cases of syndromes, due to the environmental endotoxin.
Semi-conduotor footom vorkers.
A group of 19 norm ally healthy subjeots (14 females: age range 28-52 years, mean 
41 years; 5 males: age range 30-44 years, mean 39 years) vorking in  this factory 
reported vork-related respiratory and systemic symptoms, vhich in  some vere 
suggestive of hum idifier fever (HF). All of them vere found to have normal 
serology against a variety of infectious agents, including Legionella spp .. but 
serum precipitating antibody against antigens in  the factory hum idifier vater 
VOS present in  12 subjects, and vas most pronounced in  those v ith  the 
symptoms most in  keeping v ith  HF. Extensive serological identity betveen these 
antigens and sera, and others firom confined outbreaks of vas found. Pdlovmg 
m odification of the hum idifier system in the factory,the symptoms resolved in  14
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of the 19 subjects, and the serum IgG levels, vh ich previously had been 
significantly raised, Iwcame significantly reduced. The clinical and lalw ralory 
assessment of these vorkers vas conducted by Dr. Charles IQcSharry and his 
group. The individual symptom profiles vhich each individual attributed to their 
vorking environment are summarized in  Table 0.
Table 0. The extent and nature of symptoms in  19 factory vorkers.
Group 1 Group 2
1 2 3 4 5 6 7 8 9  10 1 2 3 4 5 6 7 8 9
luquovemest June 84 7 7 7 7 7 7 7 7 7 7  n a n n a a y y y
Vork specific 7 7 7 7 7 7 7 7 7  7 7 7 ^ 7 7 7 » ^ »
Time of S7mptoms v v v l v v l l l  1 i l i v v v i v v
General tiredaess * ♦ ♦ * * * * * ♦ ♦  *  *
nu-like illness ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦  *  *  * *  *
Shortness of breath ♦ ♦ ♦ ♦ *  ♦ ♦ ♦ ♦ ♦  ♦ * *
Cough *  *  *
Chest tightness *  *  *  *  *
Headache ♦ * *
♦ ♦ ♦ * * * * ♦  ♦
Shivering and chills * * * ♦ ♦ ♦ *  *
Vheexe * *  ♦ ♦ ♦ * *
Anorexia *  *  ♦ *  *
Veight loss *
hiscellaneous a a h a a f e h a a
g c d
A bbreviations
T h e  e x t e n t  of sym ptom s in  19 facto ry  vo rkers : y  - yes; n  -  no; v  - a U v e e k ; 1 
= firs t day back a t v o rk ; i  *  in te rm itte n t.
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The nature of the symptoms: a = dry sore throat; b = nausea; c = conjunctivitis; 
d -  rh in itis ; e = lightheadedness; f = rash; g = muscle pain.
Group 1 Considered to have hum idifier fever (vork-related symptoms)
Group 2 Hum idifier fever unlikely (symptoms probably due to an
abnorm al, non-physiological vork and sleep pattern, as a ll 
vorkers in  this group vere vorking night-shift).
June 1984 Time of clinical reappraisal (after modification of the
hum idification system).
Table from  Dr. Charles DlcSharry, Department of Bacteriology and Immunology, 
Vestem  In firm ary, Glasgov.
A member of staff in  the Anrshire branch of the Strathclnde Regional Council 
Archives
This vom an complained of a "flu-like" illness, folloving several attempts to clean 
a collection of old, vater-dam aged books. Subsequent microbial analysis of the 
dust taken from the surfaces of the books demonstrated the presence of fungi and 
Gram-negative bacteria in  quantity.
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m  RESULTS 
3T. LFS binding
Before storting this studg, plastic tips and plastic test tubes vere tested for 
binding endotoxin. Concentrations of 0, 5, 10 and 20 pg of endotoxin per m l of 
plasma vere used in  tbe test. For this studg, tbe tvo-stage l a l  assay vas u%d, 
but the incubation tim e v ith  S-2423 vas 3 minutes and a ll reagent volumes vere 
doubled.
Results of the test for glass pipettes and glass test tubes (ie . disposable 
serological glass pipettes, volume 1ml, code D 80 4* PS, by John Poulten Ltd., 
Barking, Essex IG ll 8QD, and disposable glass culture tubes, 13 x 100mm, cat.no. 
99449 13 by Coming Ltd. -  see m ateria ls , methods and patients") vere compared 
v ith  results for glass pipettes and plastic test tubes, and v ith  results for glass 
test tubes and plastic tip s.
There vas no decrease in  endotoxin levels vhen sets v ith  plastic test tubes and 
sets v ith  plastic lips vere compared v ith  sets composed of glass vare alone. This 
indicated that there vas no endotoxin binding by plastic vare.
3 2. Development of the LAL assay
321. Tvo-stage assay
Endotoxin activity throughout is expressed in both picograms per m illiU tre 
(pg/m l) and Endotoxin Units per m illilitre  (EU/m l).
Early experiments v ith  the chromogenic LAL assay method (as recommended by 
the m anufacturer of the kits) vere not satisfactory and prompted evaluation of 
the optim al conditions for the assay.
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H vas found th at the optim al tim e of incubation of plasma extracts v ith  LAL vas  
30 minutes (Fig 10).
Fig 10. The relationship betveen inctfoation tim e v ith  LAL and extinction in  
plasma extracts v ith  20 pgAnl, 50 pg/m l and 200 pgAnl of endotoxin. The 
subsequent incubation tim e v ith  S-2423 for a ll samples vas 3 m inutes.
The highest absorbance readings vere obtained using a lal v ial reconstituted 
v ith  1.4ml PFV,as instructed bg the m anufacturer 01LA,Bioproductg) (F ig ll).
Fig 11 The relationship betveen LAL concentration, and the extinction after
incubation for 30 m inutes. The subsequent incubation tim e v ith  S-2423 vas 3 
m inutes.
Concentration of LAL:
1. 1 part PFV + lp a rt PFV
2 1 part P F V + lp art LAL 132
3. 1 part PFV + 1 part LAL 1:16
4. 1 part PFV + 1 part LAL 13
5. lp artP FV +1  part LAL 1:4
6. 1 part P F V + lp art LAL 12
7. 1 part PFV + 1 part LAL neat -  as per reagent control
8. 1 part LAL neat + 1 port LAL neat.
The optimum tim e of incubation of samples v ith  the chromogenic substrate 
S-2423 vas chosen to be 8 minutes (F ig l2). Although vhen the incubation vas  
extended beyond this tim e, the extinction vas s till slightly higher, the
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improvement of results thus obtained did not compensate for the increased assay 
procedure tim e.
Fig 12. The relationship betveen different incubation tim es v ith  S-2423 substrate 
and extinction. A ll plasma extracts vere preincubated v ith  LAL for 30 minutes.
^ 4 1 0  " ^410 P9 endotoxin /m l p lasm a -  0 pg endotoxin /m l p lasm a.
The manufacturers of chromogenic substrates, including S-2423, recommend 
measuring absorbance at 405 nm . Hovever, this vavelength appeared to be 
arb itrary  (according to a personal communication v ith  Kabi Diagnostica) and not 
optim al for the substrate, as shovn in  Fig 13. Thus the vavelength of 410 nm vas 
chosen a rb itra rily  because of the convenience offered by using the nuCROELlSA 
m iniReader. This alloved significantly faster processing of large numbers of 
samples.
Fig 13 The absorbance spectrum of p-nitroaniline released from S-2423, betveen 
350 nm and 550 nm .
Volumes of reagents used vere reduced to half of those recommended by the 
m anufacturer (m .A . Bioproducts). V ith  the assay conditions described above, ie . 
incubating plasma extracts v ith  LAL for 30 m inutes, and subsequently v ith  
S-2423 for 8 m inutes, the standard curve vas linear v ith in  the range 0-50 pg/m l 
of endotoxin (0-058 EU/m l) (Fig 14). The threshold of sensitivity of the assay vas 
belov 5 pg/m l (006 EU/m l). The intra-assay coefficient of variation vas belov 5%.
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The standard curve in  pgrogen-free v a le r is also shovn in  Fig 14. It  vas linear 
v ith in  the range 0-10 pg endotoxin Anl (0-0115 EUAnl),and v ith  a sensiUvitg of 1 
pg endotoxinAnl W012 EUAnl). The absorlxmoe values for the standard curve of 
endotoxin in  PFV vere consistently lover than those of endotoxin in  plasm a.
Fig 14 Comparison of standard curves of endotoxin in  plasma and in  PFV.
322 . One-stage assay
The modified Ivo-stage assay described above, despite the advantage of 
sensitivity, vas time-consuming. Furthermore, the tvo  stages involved vere 
associated v ith  a high risk of contam ination. Thus an attem pt vas made to 
modify the LAL assay even further, to a one-stage method, by adding the LAL and 
ohromogenio substrate as a m ixture.
It  VOS found that the optim al propcnrtion in  the m ixture of LAL and ohromogenio 
substrate S-2423 vas 30 |ll LAL to 70 |il S-2423 (Fig 15). The optim al tim e for 
incubation of samples v ith  the m ixture of LAL and S-2423 vas 45 minutes (Fig 16).
Fig 15 Optimal proportions of LAL and ohromogenio substrate S-2423 for the 
endotoxin assay. “ ^10 endotoxinAnl PFV (0115£U/m l PFV) -  Opg
endotoxinAnl PFV (0000 EU/ml PFV).
Fig 16 Optimal incubation tim e of the m ixture of LAL and ohromogenio substrate 
S-2423 v ith  endotoxin. E^ O^ '  ^10 M  endotoxinAnl PFV (0115 EUAnl PFV) -  ^ jg  
Opg endotoxinAnl PFV (0 000 EUAnl PFV).
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The standard carve of endotoxin In  plasma onder these conditions vas linear in  
the range 0-30 pgAnl (0-0345 EUAnl) v ith  a threshold of sensiUvitg a t 1 pgAnl 
(OOlZEUAnl).
These resolts vere greatlg improved in  comparison v ith  those obtained in  the 
earlier, tvo-stage method (Fig 17).
Fig 17 Comparison of standard corves in  plasma obtained in  the tvo-stage and 
one-stage methods.
The standard oorve in  pgrogen-free v a ter in  the one-stage method vas linear in  
the range 0-2 pg endotoxinAnl PFV (0-0023 EOAnl), against linearitg  of 0-10 pg 
endotoxin Anl (0-0115 EUAnl) in  the tvo-stage method, and v ith  the sensitivitg of 
0J2 pgAnl (0002 EUAnl), against sensitivitg of 1 pg endotoxinAnl (0012 EUAnl) in  
the tvo-stage method (Fig 18). The intra-assag owfdoient of variation vas less 
than 5%.
Fig 18 Comparison of standard ottrves in  pgrogen-Oree vo te r, obtained in  the 
tvo-stage and one-stage methods.
Tvo-stage and one-stage modifications of the LAL assag in  pgrogen-free vo ter 
are compared v ith  the original method recommended bg OGLA. BioprodaoW, the 
m anufacturer of the Quantitative Chromogenio LAL (QCL-IOOT) Icits, in  Table 7.
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Table 7 Comparison of the original LAL assag in  pgrogen-free v a te r, as 
recommended bg nLA.Bioproduots, v itb  tvo-stage and one-stage
Sensitivitg, 
pgAnl (EU/ml)
Linearitg,
pgAnl
(EUAnl)
Total incubation 
tim e, minutes
Volume of 
reagents, |U 
LAL S-2423
QCL-1000
kits
10(0115) 0-100 
(0-1150)
13 100 200
Tvo stage 
modification
1 (0012) 0-10
(0-0115)
38 50 100
One-stage
m odification
02(0002) 0-2
(0-0023)
45 30 70
Table 8 demonstrates the oomfxirison of the tvo-stage and one-stage 
m odifications of the LAL assag in  plasma. niA.Bioproduots does not recommend 
its  QCL-1000 kits for determ ination of endotoxaemia in  m an. This results in  a lack 
of comparative data for plasma samples.
Table 8 Comparison of tvo-stage and one-stage modifications of the LAL assag in  
plasma
Sensitivitg, 
pgAnl (EUAol)
Linearitg, 
pgAnl (EUAnl)
Tvo-stage
modification
One-^age
modification
5(0860)
1 (0012)
0-50(0-0580)
0-30(0-0345)
Hovever, sensitive assag procedure vas not suitable for those samples vhere 
high concentrations of endotoxin vere expected. The assag procedure for such 
samples vas modified bg reducing the incubation period v ith  the m ixture of LAL 
and substrate. This elim inates the need for sample dilution.
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This m odification of osgag procedure vas particularly im portant for plasma 
samples. Significant differences had been observed betveen plasma samples 
diluted before and after the boiling stage. As a result of these observations, in  
order to use reliably the standard curve for determ ination of endotoxin levels in  
unknovn samples, the same dilution procedure vould have to be adopted for both 
the unknovn samples and the standard curve.
Reduction of the incubation tim e from 45 minutes to 20 minutes resulted in  the 
extension of the lin earity  of the standard curves in  plasma to 250 pg endotoxin Anl 
(2S75EUAnl)andin v a te r to 50 pg endotoxin Anl tO575 EUAnl) (Fig 19).
Fig 19 Standard curves for high concentrations of endotoxin in  plasma and 
pyrogen-free v a te r.
3 3 . Effect of beat on endotoxin in  plasma and in  pyrogen-firee va ter 
For this study, the one-stage method (see sub-section 322J vas employed. 
Plasma used in  this study vas pre-diluted in  the usual m anner (ie. 50 |U of FRF + 
150 |U of boiling buffer + 50 |U of PFV or appropriate dilution of endotoxin in  PFV). 
Ro significant differences vere found betveen beating of pl(Kma at 100®C for 1 
m inute and for 10 m inutes. Also, the temperature of 100®C appeared to be superior 
to the tem perature of 75*C. Surprisingly, the standard curve, after beating 
plasma for 10 m inutes at vas completely fla t (Fig. 20).
Fig.20 Comparison of four m o d e s  of beating of plasma.
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I l  vas also fomid th at the standard curve of endotoxin heated in  PFV vas  
consistently lover than the standard curve of nnheated endotoxin in  PFV CFig21).
Fig .21 Inflnence of heating on endotoxin in  pgrogen-hree v a te r.
3.4. Compariwn of three commercial kits for the ohromogenio LAL assay.
During the period of this stndy, tvo  other chromogenio LAL assay kits (Kahi 
Diagnostica and Hlallinckrodt) vere m arketed. The three commercial kits vere  
compared (Fig. 22). The poor performance of the m allinckrodt k it vas confirmed 
by using another batch of LAL and the substrate from  the same m anufacturer.
rig . 22 Comparison of performance of ohromogenio LAL assay kits from three 
different m anufacturers.
Three different lots of LAL from m . A. Bioproducts' kits vere also tested (Fig .23).
Fig.23. Comparison of performance of three ohromogenio LAL kits from  m . A. 
Bioproducts.
3 5 . C linical applications of the LAL assay 
35.1 Cyclic neutropenia
The patient (m B l vas a 35 year old vom an v ith  cyclic neutropenia (duration of 
cycle-21 days).
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Endotoxin ossags vere carried ont over three cycles of neutropenia in  patient
to determ ine vhether:
1. endotoxin vas present in  the patient's bloodstream during periods of 
neutropenia and m alaise;
2. there vas a correlation betveen the results of quantitative LAL assays and a 
rise in  the body tem perature of this patient.
Fig. 24 Endotoxin levels, body tem perature and neutrophil count during three 
cycles of neutropenia inH lB .,35 year old female patient.
In  th is patient, no tem poral relationship betveen fever, endotoxin levels and 
neutrophil counts vas foxmd during three studied periods of neutropenia.
352 . Septic shook tria l
In  an earlier study a t the Vestem  In firm ary, the sem i-quantitative gel-olot LAL 
assay vas one of a series of laboratory and clinical investigations on a group of 
patients v ith  septic shook (308). This prospective study vas undertaken to 
establish vhether endotoxaemia vas a constant feature of Gram-negative septic 
shook and to correlate the presence (or absence) of endotoxin in  peripheral blood 
v ith  the clin ical course and prognosis. From this study, it  vas shovn that 
endotoxin in  the bloodstream vas a feature of septic shook and that the continued 
presence of endotoxin in  the peripheral blood vas associated v ith  a pxwr 
prognosis.
V ith  the development of a quantitative ohromogenio LAL assay (described in  this 
thesis^ it  vas decided to determine vhether there vas any correlation betveen
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the quantitative levels of endotoxin in  blood and the severity of sepsis. Ten 
critically  ill but not necessarily septic shock patients vere examined in  the firs t 
group (Group 1). In  this group (7 males and 3 females: age range 35-74 years, 
mean 56 years),there vere five survivors and five non-survivors (Table 9). Septic 
status is a subjective clinical score.
Table 9. C linical and laboratory findings in  ten critically  ill patients.
Survivors
Patient Age Pathology LAL (noJ Blood cultures (no J Septio status
1 JÜ. 63 Smsll bovrel iaforct Negative (4) Negative (4) ±
2 EÜ. 65 Perforated duodeaal 
ulcer
Negative (4> Negative (5) ++
3 M û. 74 Perforated large 
bowel
Be^tive(Z) 
Negative (2)
Negative (z)
Positive (2 :1 Gram +, 
1 Gram)
++
4 A il.  50 M ultiple
5 R.O. 35 M ultiple ifljo ries
Hegetiw (14> Hegetiee (9>
Positive (5) Megetive (4)
Begetiee (26) Megetive(3?)
Positive (2) Positive {Zikm. -)
Megotive (2) Positive (2 1^3rom+,
IfSrom -)
Positive (2) negative (5)
BLOOD CULTURES _ _ _ _ _ _
FEVER + + +  + + + +
(> 3 7 .5 )
PIPBENZYL P
GENT
0-863
ENDOTOXIN
(pg/ml)
+ — — + + + - + +
AMPUTATION BRONCHOSCOPY 
LEFT LEG
AMP
TOBRA
0-575
(EU/ml)
0-288
TIME (days)
WOUND INFECTION
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Patient Age Pathologg
1 63
2 JJB.
non-STcrvivorg 
LAL (no J Blood otdtTcree Cause of death 
(noJ
Large bo*el 
obstraotioft
Ne^tive (1) Negative (1) Sadden caidiovaacalar 
collapse
52 (knito-arinary
sargery
Negative (7) Positive (2f>ram +) Coa^lioation of sepsis 
Negative (11)
3 R5. 55 Hetabolic 
(neoToleptio- 
maligpant syndrome)
4 VP. 43
5 AH. 61
Small bowel 
infarction
(polyarteritis nodosa)
Negative (3) Negative (7)
Negative (3) Negative (3)
Progressive coma
Benal failure
(treatment
discontinued)
Perforated gastric Ne^tive (7) Negative (9) Sepsis 
deer Positive (4:Gram -) (treatment
(histology later malignant) discontinued)
In  this group of patients there vas no olose correlation betveen the results of 
blood cultures and the doilg quantitative LAL assays. Hovever, in one patient 
(EO J, there vas an apparent association betveen significant levels of endotoxin, 
positive blood cultures and acute septic episodes (Fig. 25).
Fig 25 R jO., ^  gear old male jxitient v ith  septic shock, vho vas admitted to the 
Intensive Therapy Unit v ith  multiple injuries folioving a traffîc accident; blood 
cultures, endotoxin assays and fever correlated v ith  antibiotic therapy, clinical 
events and surgical care.
ŒHT = gentamioin; BEHZYLP = benzylpenioiUin; PIP = piperacillin; AIUP = 
am picillin; TOBRA = tobramycin.
Blood cultures: day 17 -  Enterobaoter cloacae, days 20 and 21 -  Aoinetobacter 
calcoacetic^»*. variant anitratus; vound infection — Pseudomonas aerugmosa and
8 0
Acinelobacler colcoaoelicus. variant anitratus.
Early in  this patient's course, transient endotoxaemia occurred alter amputation 
and bronchoscopy in  the absence of positive blood cultures. The vound infection 
on day 18 vas associated v ith  a high level of endotoxin in  the bloodstream. Blood 
cultures subsequently became positive.
Vhen the results from this group vere revieved, it  vas decided that for critical 
evaluation of the LAL assay in  septic shwk, frequent monitoring during acute 
septic episodes vas essential. Thus septic shock patients in  the Mcond group 
(Group 2) vere monitored at 4-hourly intervals for the first 48 hours at ITU and 
thereafter daily for one veek.
This closely monitored group (Group 2) consisted of 8 patients (6 males and 2 
females; age range 22-77 years, mean 57 years). Table 10 summarizes the 
prim ary pathology of these patients. Septic status is a subjective clinical score. 
Of the 8 patients studied,4 did not survive.
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Table 10 Clinical Information on 8 septio shook patients.
Patient Age Prim ary pathology Septic status Outcome
BL. 49 Post-operative genitourinary 
surgery
+++ Survived
jm . 65 Thoracic spinal abscess ++ Survived
PH. 22 Streotooooous viridans 
septicaemia (drug addiction)
++ Survived
J.V . 77 Post-operative perforated 
gastric ulcer
++ Survived
AHloD. 72 Post-operative genitourinary 
sxargery
+++ Died
AC. 60 Peritonitis ++++ Died
EB. 67 Infected varicose ulcers +++ Died
RmcD. 47 multiple traum a ++++ Died
The tim e oonrse of changes In  endotoxin levels of a ll eight patients Is shovn In  
Fig.20.
Fig 26. The tim e conrse of the LAL assags
The case histories of the eight Individual patients are given In  detail belov.
Patient B l.
This patient vas a 49 gear old voman vho developed septio shook 24 hours after 
OpqI condnlt siirgerg. Ske had had no antibiotics. On admission to ITU she had a 
temperature of 39.2*C, a sgstollo blood pressure of 60 mm Hg and a pulse of 153 
beats Aninute. Treatment vos commenced v ith  plasma, mechanical ventilation
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and an inotropic infusion of dopamine. A pulmonary arleng flotation catheter 
vas inserted and fluid infusion continued until the blood pressure vas above 100 
m m  Hg systolic and the pulmonary artery wclusion pressure vas greater than 8 
m m  Hg. Six litres of fluid vere required. She vas commenced cn am picillin, 
gentamicin and metronidazole. Fig.27 shovs endotoxin levels, alveolar arterial 
ox%en difference and pulmcnory shunt. Plasma endotoxin on admission vas 0 
pgAnl (0072 EUAnl) and v ith in  four hours rose to 19 i^A nl (0228 EU Anl). 
Thereafter it  fell gradually over the foUoving %  hours.
Fig 27. Endotoxin levels, alveolar-arterial oxygen differenoe and pulmonary shunt 
in  B I ., 49 year old female patient, admitted to ITU v ith  septic shoclc 24 hours after 
ileal conduit surgery.
There vas a dose temporal relationship betveen endotoxin and pulmonary shunt 
(r = 0 0211 ) and endotoxin and alveolar-arterial oxygen differences (r = 0 B852).
In  this patient there vas also an inverse relationship betveen changes in plasma 
flbronectin and endotcxin levels, v ith  r  = -Ob%9 and p < 005 (Fig28). Plasma 
fibronectin recovered to v ith in  the normal range (275-3X1 JlgAnl) as the 
endotoxin vas eliminated from the bloodstream.
Fig 28. Inverse correlation laetveen flbronectin and endotoxin levels in patient 
BL.
In  patient BL.there vas also good correlation betveen endotoxin and septic score, 
and fibronectin and septic score (Fig 29).
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Fig 29. Relationship betveen endotoxin, fibronectin and septic score  ^in patient 
BL.
In  this patient, Stanbalococcns anrens vas isolated firom six of 10 blood cnltnres 
taken v itb in  the first 48 boors. Blood ooltores taken on dags 5 and 0 yielded 
niorganellQ m o rg a n ll.
Patient AC.
This patient vas a 60 gear old man admitted to hospital v itb  an 11 boor history of 
vomiting, rigors and persistent lover aM om inal pain. He vas pgrexial v itb  a 
temperature of 39*C, a poise of 120 beats per minote and a systolic blood pressore 
of 70 m m  Hg. Shortly after admission, be vas taken for investigative laparotomy 
to the operating theatre, vhere an enlarged cirrhotic liver vas noted and 200 m l 
of yellov torbid peritoneal fioid vas drained. Escherichia coli vas coltored from 
this fioid. There vas no evidence of perforation of any viscos. Hovever, despite 
intensive therapy post-operatively, the patient died nine boors after admission. 
He had the highest endotoxin levels recorded in cor septic shock patients (180 
pgAnl = 216 EH Anl and 220 pgAnl = 264 EUAnl), despite only moderately elevated 
polmonary shont and alveolar-arterial oxygen difference (Fig30), and negative 
blood coltores.
Fig 30. Endotoxin levels, alveolar-arterial oxygen difference and polmonary shont 
in  AC ,60 year old male patient v ith  peritonitis.
The plasma fibronectin levels of this patient vere almost ondetectable at aroond
^  fer. J .  m i ]
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Palienl Â.mcD.
This palienl vas a 72 year old man adm illed lo a peripheral hospilal six hoars 
aller having a Iransreclal proslale biopsy performed as an oulpalienl. He vas in  
seplic shock v ilh  a syslolic blood pressore of 80 m m  Hg, a poise of 120 heals per 
m inole and a lemperalore of 40®C. Escherichia coli vas grovn from blood 
collores laken on admission. Despile appropriale anlibiolics, he conlinoed lo 
deleriorale and 48 hoors la ler he vas Iransferred lo ITU a l Ihe Veslern 
In firm ary. On admission, he vas in severe seplic shock v ilh  hypolension, 
lachycardia and pyrexia.
Palienl A . IHcD. illoslrales Ihe opposile siloalion lo palienl A.C., as his endoloxin 
levels vere negligible despile clinical evidence of overvhelming sepsis, grossly 
elevaled polmonary shonl and alveolar-arlerial oxygen difference consislenl 
v ilh  early Adoll Respiralory Dislress Syndrome (ARDS) (Fig 31).
Fig 31. Endoloxin levels, alveolar arleria l oxygen difference and polmonary shonl 
in A . mcD., 72 year old male palienl, admilled lo ITU v ilh  severe seplic shock aller 
a Iransreclal proslale biopsy.
The corresponding plasma hbroneclin levels of Ihis palienl are shovn in Fig 32.
Fig 32. Fibroneclin levels versos endoloxin levels in palienl A. HlcD.
The in ilia l level of plasma fibroneclin in palienl A. HlcD. vas 80 (ig/ml and 
remained very le v  doring Ihis palienl‘s coorse prior lo his dealh in ITU.
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Palien lPH .
This patient vas a 22 gear old man vho presented clinicallg v ith  septic shook, 
bat his endotoxin levels vere negligible. Polmonarg shont and alveolar-arterial 
oxggen diËerenœs vere also lov (Fig33). The patient vas a drag addict. 
Streptococcas viridans vas isolated from blood caltares prior to the development 
of septic shock.
Fig 33. Endotoxin levels, alveolar-arterial oxggen difference and palmonarg shant 
in  PH., 22 gear old male fntient,drag addict, v ith  Slreptococcng viridana iso la te  
from blood caltares.
Corresponding plasma fibronectin levels of this patient vere not dramaticallg 
depressed (Fig 34).
Fig 34. Fibronectin levels versas endotoxin levels in  patient P H .
Patients J V . and J m .
Patient J .V . vas a 77 gear old man v ith  a perforated gastric alcer. Patient J m . 
vas a 65 gear old man v ith  a thoracic spine abscess.
These patients, vho presented clinicallg v ith  septic shock, elevated palmonarg 
shant and alveolar-arterial oxggen differences, nevertheless had negligible 
endotoxin levels (Figs. 35 and 36) and all their blood caltares vere negative.
Fig 35. Endotoxin levels, alveolar-arterial oxggen difference and palmonarg shant 
in J .V ., 77 gear old male patient v ith  perforated gastric alcer.
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Fig 36. Endotoxin levels, alveolar-arterial oxggen difference and pxtlmonarg shunt 
in  J . i n 65 gear old male patient v ith  thoracic spine abscess.
The corresponding plasma fibronectin levels of these tvo  patients vere not 
dram aticallg depressed (Figs. 37 and 38). It  is interesting to note that both 
patients survived.
Fig 37. Fibronectin levels versus endotoxin levels in  patient J .V .
Fig. 38. Fibronectin levels versus endotoxin levels in patient J m .
Patient R.mcD.
This patient vas a 47 gear old m an, vho sustained multiple trauma in a road 
traffic accident. He remained stable for five dags but then developed septic shock. 
After 20 hours of monitoring, he vas taken to the operating theatre in an attempt 
to locate a focus of sepsis. A four-fold rise in endotoxin levels vas observed in  
association v ith  the surgerg (Fig 39).
Endotoxin levels in this patient vere measured in optical densitg (ODJ units, and 
not in pg/ml (EU/ml) At the tim e of assaging these samples, the standard 
endotoxin from the LAL kits did not react v ith  the LAL reagent, and consequentlg 
no standard curve could be constructed. The endotoxin levels presented in Figs.26 
and 39, vhich are expressed in pg/m l,are onlg an estimation, vhich vas made to 
allov comparison of the time course of endotoxin assags of this patient v ith  other 
patients in  this group.
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In  Uiis patient, there vas a direct relationship betveen alveolar-arterial oxggen 
difference and endotoxin (r = 0523) (Fig 39).
Fig 39. Endotoxin levels, alveolar-arterial oxggen difference and pxtlmonarg shxmt 
in  R . IRoD., 47 gear old male patient v ith  mxiltiple traxima.
The corresponding plasma fibronectin levels of this patient are shovn in Fig .40.
Fig.40. Fibronectin levels versxis endotoxin levels in  patient R.HloD.
After the in itia l period of 12 hoxirs vhen plasma fibronectin remained stable at a 
relativelg lov level of 70 |igAnl,the fibronectin level then fell to 25 Hg Anl. Despite 
a transient increase after administration of orgopreoipitate, the fibronectin level 
fell again. The patient died.
Patient E.B.
This patient vas a 59 gear old vom an, v ith  a historg of rhexmiatoid arthritis, 
vho developed septic shook from infected varicose xiloers. All blood oultxcres vere 
negative, bxxt Frotexrs s d d .. Enterobaoter cloacae and Strentococcxts faeoalis vere 
oxiltxired from the varicose xiloers. Thirtg six hoxirs after admission, she developed 
ARDS (Adxilt Respiratorg Distress Sgndrome) and died 24 hoxirs later. Her 
endotoxin levels vere slightlg elevated.
Dxiring this patient's coxirse in ITU, orgopreoipitate vas administered on several 
occasions. Since the fibronectin contained in the preparation mag have 
inflxienced the clinical coxirse, endotoxin levels and cardiovascxilar-respiratorg 
measxiremienls,this patient's results coxild not be analgsed in detail.
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353.  Acute pancreatitis -  prelim inary tria l
In  an earlier study at the Vestem Infirm ary, the semi-quantitative gel-clot LAL 
assay vas one of a series of laboratory and clinical investigations on a group of 
patients v ith  acute pancreatitis 1144). This prospective study vas designed to 
assess the incidence of endotoxaemia and complement activation in  pancreatitis, 
in  order to see vhether they vere related, and to correlate the presence of each 
v ith  the development of complications. In this study, it  vas shovn that half of 
the patients studied had endotoxaemia. moreover, endotoxaemia vas present in  
six out of seven patients v ith  systemic complications of the disease. It vas 
suggested that endotoxaemia could 1» at least partly responsible for the 
development of shock and other complications of acute pancreatitis.
V ith  the development of a quantitative chromogenic LAL assay (described in this 
thesis), it  vas decided to determine vhether there vas any correlation betveen 
the quantitative levels of endotoxin in blood and the severity of pancreatitis. In  
this tria l, a total of 15 patients vas examined.
After clinical and laboratory assessment (including endotoxin assays), the group 
of 16 patients vas divided into the folioving categories:
-  severe pancreatitis v ith  related endotoxaemia (one patient)
-  severe pancreatitis v ith  no significant endotoxaemia (one patient)
-  endotoxaemia unrelated to pancreatitis (tvo patients)
-  m ild pancreatitis v ith  no significant endotoxaemia (six patients)
-  m ild pancreatitis v ith  unrelated endotoxaemia (one patient)
-  a group of five patients v ith  various conditions, rejected on the grounds 
of inadequate sampling (tew fev samples to allov draving of any 
conclusions).
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Endoloxin levels in  all patients in this gronp, except for those of C.B., vere  
measnred in  optical densitg (0 JD J nnits, dne to the failure of standard endotoxin 
from LAL kits at the tim e of performing the assags.
Patient J.D ., vho had severe {Kincreatitis v ith  related endotoxaemia, presented 
v ith  abdominal pain and vomiting, hext dag, he became pgrexial (to 40^), 
developed rigors, hgpotension and jaundice, and clinical diagnosis of cholangitis 
vas made. Escherichia coli vas grovn from blocMl cultures. Severe acute 
pancreatitis vas diagnosed M  hours after the onset of pain, v ith  serum amgla%  
of 44(X) lUA (normal range 70-300 lüA) and from this point endotoxin levels vere  
monitored (Fig .41).
Fig .41. Time course of endotoxin levels in  J.D., 70 gear old male patient v ith  severe 
acute pancreatitis.
In  another patient v ith  diagnosed severe acute pancreatitis, no significant levels 
of endotoxin vere found. This mag have been attributed to the delag of 90 hours 
after onset prior to the collection of samples for endotoxin assag.
Tvo other patients had endotoxaemia probablg unrelated to pancreatitis (Figs. 42 
and 43). Peaks in their endotoxin levels could be attributed to surgical 
manipulations (intubation and extubation).
Fig.42. Time course of endotoxin levels in  CB., 47 gear old female patient. Severe 
aoute pancreatitis (serum amglase 1350 lUA) v ith  rapid development of renal and 
respiratorg failure. First endotoxin assag -  36 hours from the onset.
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Fig.43. Time conrse of endoloxin levels in  HC., 55 gear old male patient; post 
mortem examination shoved a perforated dnodenal nicer and broncho­
pneumonia, v ith  no evidence of acnte pancreatitis, monitoring of endotoxin 
commenced more than 96 hours after the onset.
Patient mm. represents results obtained in  a group of six patients v ith  
pancreatitis and no significant endotoxaemia (Fig .44).
Fig .44. Time course of endotoxin levels in mm, 48 gear old male patient v ith  miiA 
acute pancreatitis (serum amglase 1790 lUA) of alcohol aetiologg. Endotoxin 
monitoring started 22 hours brom the onset.
3 6. Hen-clinical applications of the LAL assag 
3 J6 i .  Extra corporeal filter to remove endotoxin firom human blood 
The maximum rate of endotoxin extraction firom human plasma, using the I-DEP 
filter, vas 16% of a phgsiological endotoxin load (i e . 250 pgAnl) over a period of 10 
minutes. Thereafter, no significant endotoxin extraction vas observed 
throughout the period of the runs (30 to 45 minutes). Both heparin and ACD (Acid 
Citrate Dextrose) vere tested as anticoagulants in the sgstem, and no difference 
in  filter function vas observed.
Bfovever, a significant spontaneous decrease v ith  time in the amount of 
measurable endotoxin in human plasma at r<x)m temperature vas noted. This 
phenomenon vas observed in consecutive samples proximal to the filte r. The fall 
in  endotoxin levels vas 36% after 15 minutes and 78% after 30 minutes 
respectivelg, and thus the mean rate of endotoxin decag vas calculated to be 1.3 
ngAnlAninute.
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3J62.Bafae plate m aterial
It  vas fbtmd that the concentration of extractable endotoxin in  bafQe plate 
m aterial vas 145 ng per m l of soaking solution (16675 EUAnl) (bafQe plate 
m aterial: PFV ratio = 1:4, v / v )  or 580 ng/g of bafQe plate m aterial (6670 EU/g).
3 6 3 .Dust sample
The sample contained extractable endotoxin activity in  the LAL assag equivalent 
to 370 ng per gram of dust (4255 EU/g).
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lY Discussion
41 Comments on m aterials, methods and patients"
Studies bg Harris and Feinstein demonstrated that certain hgdrophobic, aliphatic 
polgmers have a specific affinitg for binding endotoxin (200,201,202). <3eneraUg,it 
is thought that polgpropglene (as ve il as nev glass) exhibits a high degree of 
adsorption of endotoxin, vhile polgstgrene (and used glass) does not (377). 
Although it  vas shovn that plastic test-tubes and plastic tips used in this studg 
vere pgrogen-free and did not bind endotoxin, for crucial stages in quantification 
of endotoxin (such as dilutions of standard endotoxin and storage of plasma 
samples), polgstgrene test-tubes vere used, despite their much higher cost in 
comparison v ith  polgpropglene ones (see materials,methods and patients").
Reagents for the LAL assag prepared in the laboratorg (ie . buffers), vere 
depgrogenated v ith  asbestos, folloving the experience of the Thomas group (585). 
An alternative,used bg Tsuji and colleagues, vas activated carbon (595).
Because of the dangers of handling asbestos in the laboratorg, it mag be useful to 
compare the endotoxin adsorbing properties of the tvo substances.
Autoclaving of plasticvare used for the LAL assag, in conditions described in 
Chapter H (m aterials, methods and paUenls"), appeared to be a saUsfaclorg 
means of rendering it pgrogen-free, despite the findings of Tsuji and Harrison 
(593). Hovever, Tsuji and Harrison tested lipopolgsacchoride inacUvaUon onlg 
v ith  elhglene oxide,^Co irradiation and drg-heal treatments. The present studg 
shoved that standard curves of endotoxin heated in pgrogen-free voter vere 
much lover than standard curves of unheated endotoxin in PFV (Fig 21). This 
decrease yas time-dependent. This phenomenon mag be responsible for the
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satisfactory efficiency of vet-heat in depgrogenation of endotoxin-contaminated 
plasticvare used for LAL assags, as found empiricallg in our laboratorg.
Blood for the LAL assags vas alvags obtained bg venepuncture, despite the 
inconvenience and technical difficulties associated v ith  repeated venepuncture 
in criticallg ill patients, vho often present v ith  vasoconstriction. Vdisdnen and 
colleagues reported that arterial catheters vere not reliable for blood cultures 
and could not replace the venepuncture method (617), since Iheg vere often found 
to be colonized v ith  bacteria. This makes catheters an unacceptable means of 
obtaining blood for LAL assags too.
Heparin, vhich vas the anticoagulant of choice in this studg, often posed a 
problem vhen it vas used for blood of septic patients. It is generallg postulated 
that the concentration of hejgxirin of 20 units per ml of blocwl should not be 
exceeded, esj^iallg  in light of evidence that heparin at concentrations as lov as 
1 unit per ml could be inhibitorg to the LAL test (560). The results of UlcConnell 
and Cohen emphasize the importance of not exceeding this value if significant 
inhibition is to 1% avoided (310). Hovever, in septic shock patients, mang of vhom  
present themselves v ith  disseminated intr a vascular coagulation (DIO, this 
concentration of heparin frequently appeared not to be sufficient, and in order to 
prevent blood from clotting, concentrations of heparin betveen 30 and 40 units 
per ml vere used. These values greatly exceed clinicallg relevant heparin 
concentrations. Clinical anticoagulation is usually achieved at concentrations 
not exceeding 2 5 heparin units per ml of blood (383).
In this study, platelet rich plasma vas used in the LAL assay for endotoxin in 
blood. Although some authors did not find significant difference betveen platelet
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poor plasma (PPP) and platelet rich plasma (PEP), in results of LAL tests (77,104, 
148, %)5), it is necessary to note that these comparisons vere carried out using 
relativelg high concentrations of endotoxin. On the other hand. Das and 
colleagues reported that PEP improves recoverg of endotoxin (97). This mag t>e 
explained bg the ability of endotoxin to bind selectively to platelets (97, 210,216, 
546,631,632). In viev of this, the use of PPP (or serum) in the endotoxin assay mag 
result in fdlse-negative results, especially in cases vhere lov endotoxin levels are 
present.
Endotoxin inhibitors present in plasma mag be another reason for false-negative 
results of the LAL test in plasma. Strict adherence Ic proper blood ooUeclion and 
plasma preparation vithoul ong undue delay mag be an important factor in 
obtaining reliable results in clinical studies. Delays in handling plasma samples 
mag lead to rapid inactivation of endotoxin in plasma vhich has been shovn to 
be as high as 600 ng per m l of plasma per hour at 37^ (600 ngAnl greatly exceeds 
the highest concentrations of endotoxin ever found in humans) (638).
The method of inactivation of endotoxin inhibitors in plasma used in this studg 
vas a combination of dilution and heating of the plasma. This procedure proved 
to be more effective than dilution alone, and pH shift v ith  acetic acid reversed 
v ith  dibasic potassium phosphate buffer. It vas comparable onlg v ith  
chloroform extraction and gel filtration (108). Both of them, hovever, being verg 
tedious and prone to accidental contamination v ith  exogenous endotoxin, are 
unsuitable in the clinical situation. Also, Ta)cagi and colleagues found amidase 
activity of soywy» samples against the chromogenic substrate remaining after 
chloroform treatment of human blood (570). Hovever, aUtali treatment v ith  
HaOH-m , as developed v ith  this group, could remove the amidase acUvitg
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almost completely (570).
Later, the same group reported that a perchloric acid (PCA) treatment eliminated 
both nonspecific amidase activities and inhibitors from serum and plasma, v ith  
good recovery of added endotoxin (387,574).
Hakogi and Shimada proved that PCA pre-treatment of blood plasma from a 
range of domestic animals (covs, horses, pigs and chickens) accomplished 
complete removal of non-specific amidolytic activity and inhibitors, and ensured 
nearly 100% endotoxin recovery, irrespective of the species of animal. Thus they 
demonstrated the usefulness of this plasma pre-treatment method for the LAL 
test in the field of veterinary medicine (194).
Among the various methods for removal of plasma inhibitors and non-specific 
activators of the LAL test, extraction v ith  chloroform, first developed by Levin and 
colleagues (292), is historically the oldest, along v ith  the dilution method (292). 
Subsequently, other methods vere devised: ether extraction by niva (370), alkali 
treatment by Takagi and colleagues (570), acid extraction by Reinhold and Fine 
(444), gel filtration by Hollander and Harding (226), and ammonium sulphate 
precipitation by Goto and Hakamura (178). Hovever, dilution and heating, first 
reported by Cooperslock and colleagues (89), is considered by many groups as the 
method of choice (108, 131, 175, 585), particularly as it has been reported that 
heating not only inactivates inhibitors of the test, but also inactivates possible 
protein mimickers (175).
In study, for the standard curve in plasma, blood vas taken fiom normal, 
healthy volunteers. Samples of plasma vere checked against stored reference
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plasm a" v h ic h  had been recognized as endotoxin-negaUve, and i f  the same level 
of absorbance va s  obtained, such blotxl vas  regarded as endotoxin-free nnd i t  
VOS used as a reference. There is  a lack of agreement among vorke rs in  fie ld  
as to  vh e th e r norm al hum ans are endotoxaemic or not and vh e the r lov-grade 
endotoxaemia is  a phgsiological or ix itho logica l feature.
In  ea rly  studies there va s  a consensus of opinion about the absence of a positive 
LAL reaction in  the blood of hea lthy adults (203,285,291). Hovever, the methods 
used a t th a t tim e  a lioved the detection of h igh  concentrations of endotoxin o n ly . 
In  1 9 ^ , DuBose and colleagues (108), upon comparison of Limulus amoebocyte 
lysate test resu lts  from  hea lthy hum an plasma samples extracted by d ilu tion  
and hea ting , o r chloroform , concluded th a t lysate type and not extraction 
procedure va s  associated v ith  previously reported questionable positive tests 
(109). Hovever, more recent find ings, v h ic h  vere  obtained v ith  much more 
sensitive m ethods, have been very confusing. Fink and colleagues reported th a t 
the LAL assay in  plasma of hea lthy adults vas negative (131), vhereas the 
Pearson group found th a t a mean endotoxin level in  blood of norm al, hea lthy 
blood donors va s  betveen 0 02 and 157 pg Anl (409). A p re lim ina ry  tr ia l organized 
by D r. P .Friberger from  Kabi AB,Sveden, shoved the level of endotoxin in  norm al 
hum ans to be 6 pg /m l ± 8 (3%, 494).
Endotoxin (v ith o u t bacteraem ia) m ay be present in  the c ircu la tion  as a resu lt of 
in te s tin a l leakage of endotoxin or hepatic fa ilu re  (608, 653). Lov-grade 
endotoxaemia has been detected in  porta l venous blood of norm al ind ividuals, 
suggesting th a t penetration of endotoxins across the in te s tin a l mucosa m ay be a 
physiological event (234,435,592). The norm al, hea lthy liv e r presumably removes 
and detoxifies such molecules before they reach the system ic circu la tion (374).
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C hronic system ic endotoxaemia has 
been documented in  patients v ith  cirrhosis and portosystem ic venous shunts 
(294, 435, 576, 651). Fine and colleagues produced experim ental evidence for the 
hypothesis th a t endotoxin may also be released from  abnorm ally permeable 
bove l and absorbed in to  the circu lation v ia  the peritoneal cav ity  (92,93,573). The 
lym p h a tic  route of en try vas also indicated in  pathological conditions (19,96,166, 
396).
nevertheless, endotoxin vould norm ally be absent from  the system ic c ircu la tion  
and i t  vou ld  appear there only as a pathological phenomenon. H ovever,it is  also 
suggested th a t lo v  levels of endotoxin in  the system ic c ircu la tion  m ay be 
physio logica l, and th a t they take p ir t  in  the norm al function ing of the organism , 
l% ing responsible for bone m arrov  stim u la tion  and granulopoiesis (66, 333,627). 
Â m a jo r shortcom ing of th is  hypothesis is the fact th a t cx fundam ental
property of endotoxin is its  a b ility  to induce endotoxin tolerance in  a host 
organism  (Table 1). This biological a c tiv ity  of endotoxin is demonstrated as a 
resu lt o f repeated adm in istra tion  of non-le thal doses of LPS. Periodical release of 
endotoxin in to  the systemic circu lation, v h ic h  vou ld  be required i f  endotoxin 
ve re  to p lay a role in  norm al granulopoiesis, vou ld  render a live  organism  
to le ran t and therefore unresponsive to a ll aspects of biological activ ities of 
endotoxin, includ ing granulopoiesis. The tolerance thus induced vould of course 
be tem porary, but i f  endotoxin vere to play such an im po rtan t physiological role 
in  norm a l organism s, i t  vould have to penetrate in to  the peripheral blood 
throughout the ontogeny. In  nev-born babies, v h ic h  have im m ature 
im m unological systems, permanent tolerance could be induced in  th is  va y . 
Furtherm ore, the influence of m aternal endotoxin cannot be discounted. I t  could 
penetrate-through the placenta and thus be present in  the foetal blood, thus
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affecting  th e ir im m unological systems a t a s t ill earlie r stage. Hovever, in  fact, 
the  vho le  range of diverse host responses of adult humans and ind iv idua l hum an 
system s to endotoxin is unaffected. Indeed, they seem to be more pronounced 
v ith  age; fo r example, the pyrogenic response to endotoxin increases v ith  age in  
m an (305). These are only ra tiona l prem ises. Experimental data is s t ill laclcing.
In  order to obtain a defin ite ansver to th is  question, an independent assay, as 
specific and sensitive as the LAL test, is required. Only such an assay vould 
provide independent em pirical data and vould a llo v  defin ite determ ination of 
v h e th e r lo v  levels of endotoxin are continuously present in  norm al, hea lthy 
in d iv id u a ls . Results obtained to date, supporting the hypothesis of continuous 
presence of endotoxin in  norm al humans, m ay be sim ply a result of technical 
shortcom ings of the methods applied. This v ie v  seems to be supported by the 
find ings of Cohen and HlcConnell (77). They shoved th a t there vas a substantia l 
va ria tio n  (by more than 100%) in  recovery of endotoxin added to plasma samples 
fi'om  six norm al ind iv idua ls .
In  order to overcome variations in  ind iv idua l plasma samples ( "sam ple-related 
in terferences"), the Urbaschelc group developed a method of sample in te rn a l 
s tandard ization (104,608), vh ich  is compatible v ith  th e ir automated, Idnetic LAL 
m ic ro titre  test.
In  the  present study, differences betveen samples from  the same ind iv idua l, 
talcen a t d iffe ren t tim es, and differences betveen samples from  different 
in d iv idua ls , ve re  talcen in to  account by:
1 ) se tting  up plasma baclcground controls;
2) testing  samples from  the same ind ividua l se ria lly , in  the same experiment.
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and
3) using un ifo rm  plasma for standard curves throughout blocks of 
experim ents.
methods of so lubiliza tion of endotoxin firom bafQe plate m a te ria l and dust ve re  
devised according to Helme (214)^  and Ross and Bruch (461). These authors suggest 
th a t soaldng tested m ate ria l in  pgrogen-free v o te r for one hour a t room 
tem perature above 18®C can be used interchangeably v ith  scxdcing i t  fo r 15 
m inutes a t 37®C (461). Hovever, the recommended 1:1 (v /v ) proportion of tested 
m a te ria l and PFV could not be applied, as the volumes of PFV indicated by th is  
proportion vou ld  not cover completely the tested m a te ria l. A ltered volumes of 
PFV ve re  taken in to  consideration v h ile  m aldng calculations for concentrations 
of endotoxin present in  tested m ate ria ls .
Blood fo r LAL assays m ust be handled very carefully because of the h igh  ris k  of 
contam ination . Furtherm ore, i t  has to be processed prom ptly, because of the 
presence of fast-acting  endotoxin in h ib ito rs  in  plasma. Consequently, in  c lin ica l 
pro jects using the LAL assay, i t  is  esential to have close pa rtic ipa tion  of the 
research vo rke r doing the LAL assays, and also to have good cooperation of a ll 
persons involved. The need for such involvem ent is clearly illu s tra te d  vhen  the 
tv o  m a jo r projects (the septic shock tr ia l and the pancreatitis tr ia l)
described in  th is  thesis are compared.
In  the septic shock tr ia l,  patients vere chosen in  a selective m anner and, once 
included in  the tr ia l,  they vere monitored for purposes of th is  tr ia l every four 
hours. In  the acute pancreaUtis tr ia l, on the other hand,there vere  delays of up 
to four days from  the onset of the illness before inclusion of a paUent in  the tr ia l.
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and blood samples vere  taken tv lce  da ily a t tbe m ost. This frequency very often 
^  in su ffic ie n t and m ay result in  m issing periods of endotoxaemia or, a t tbe 
ve ry best, m issing  endotoxin peaks. This m ay be illu s tra te d  by the example of 
p a tie n t BL. from  the sepUc shock tr ia l (Fig27). This patient's endotoxin levels 
changed d ram a tica lly  v i t h in  eight hours and became unrem arkable v ith in  the 
f ir s t 32 hou rs. Yet another result of delay is th a t patients vh o  are included in  the 
t r ia l are receiving trea tm ent v h ic h  may affect endotoxin levels, thus m aldng 
in te rp re ta tio n  of results very d ifficu lt or even im |X)ssible.
Three assay controls (see: "H laterials, methods and patients", section 25. LAL 
assay) ve re  a lva ys  set up v ith  each assay, for the fo llo v in g  tv o  reasons. F irs tly , 
i t  v a s  found th a t the performance of ind iv idua l lo ts of LAL va s  s ig n ifica n tly  
d iffe re n t. This difference vas established by the reagent contro l. Secondly, 
considerable differences vere  often found in  the optical properties of hum an 
plasm a from  d iffe ren t ind ividuals (especially patients undergoing intensive 
tre a tm e n t), or from  the same ind iv idua l vhen samples ve re  taken a t d iffe rent 
tim es. In  cases vhere  patient plasma background contro l differed from  the 
standard curve background control, the optical density value for a patient plasma 
iK ickground contro l va s  subtracted from  the value obtained for the patient's 
plasm a in  the  LAL test.
The fin d in g  th a t the reaction betveen LAL and endotoxin is  in  some v a y  am plified 
in  pingrnn extract, vhen  compared v ith  results obtained in  pyrogen—free v o te r 
(Figs 14 19)^  vas  confirm ed by the results of some vorlcers (104, 205), but
contradicted by others (77,148). Urbaschek and colleagues found th a t differences 
in  am p lifica tion  fo r each sample in  plasma occurred to such an extent, th a t a 
sing le com parison to a common plasma standard curve va s  impossible (104).
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This observation m ay be inherent to th e ir method of assaying endotoxin, v h ic h  
v a s  a k in e tic  tu rb id im e tric  test. In  the present study, v h ic h  used an end-point 
chrom ogenic assay and test controls, as described in  "m ate ria ls, methods and 
pa tien ts", such a v id e  va ria b ility  in  the degree of enhancement of t.at. assay 
resu lts  in  norm al plasma vas never observed.
4 2. Discussion of results 
421, Tvo-stage assay
The se n s itiv ity  of th is  method vas  belov Ipg of endotoxinAnl of pyrogen-free 
v o te r (0 D12 EUAnl) and the standard curve vas linea r v ith in  the range of 0-10 pg 
of endotoxin/m l PFV (0-0115 EU/ml) (Fig 18). For comparison, the m anufacturers 
of QCL-1000 k its  claim ed a sens itiv ity  of 10 pg of endotoxinAnl PFV (0115 EU/ml), 
v ith  the standard curve linea r in  the concentration range 0-100 pgAnl (0-1150 
EU/m l) (m A . Bioproduct's brochure “QCL-KWO"). In  addition to mcreased 
se n s itiv ity  in  th is  tvo-stage assay method, the reagent volumes vere reduced by 
h a lf, thus m aldng the assay more economical. A disadvantage of th is  assay 
m ethod over the m anufacturer s method vas a three-fold increase in  incubation 
tim e . Hovever, th is  vas compensated for by using a m icroU tre plate for 
m ^ is u rin g  absorbance of samples.
4 22, One-stage assay
In  th is  m odifica tion, the m ixture of LAL and chromogenic substrate vas  added to 
a tested sample. This increased the sensitiv ity  of the LAL assay to 02 pg of 
endotoxin An l PFV (0002 EU/ml), in  comparison v ith  a threshold of sens itiv ity  of 1 
pg/m l (ÜÛ12 EU Anl) obtained in  a tvo-stage method. This im provem ent vas 
achieved despite the fact th a t the reacUon vas performed in  condiUons v h ic h
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ve re  no t op tim a l fo r each of the reagents. The optim al conditions are: for the 
ac tiva tion  o f p roclo tting enzyme pH 6 JO-7 5 and re la tive ly  h igh  ion ic streng th , 
and fo r a chromogenic substrate pH > 8Û v ith  lo v  ion ic s tran g th  (see: 
“In troduction , sub-section 123. Limulus amoebocyte lysate assay for endotoxin). 
Hovever, the enhancement of a c tiv ity  of both reagents, vhen  m ixed together, 
c lea rly  m ore than  compensates for the loss of optim al conditions for both of them . 
This m odifica tion also a lloved a reduction of tv o  th ird s  in  the volumes of 
expensive reagents (Table 7). As compared v ith  the tvo-stage assay m ethod, the 
incubation tim e  va s  s lig h tly  longer (Table 7). Hovever, the one-stage procedure 
m in im ized  the rislc of contam ination and reduced the tim e required for 
processing large num bers of samples.
There is  scope lo r fu rth e r m in ia tu riza tion  of the assay, hovever, volumes vou ld  
be too sm a ll fo r the present method, v h ic h  essentially is a test-tube one, and the 
en tire  assay vou ld  have to be performed in  m ic ro titre  plates. This development 
vou ld  also reduce considerably the tim e of processing samples. The use of 
m u lti-chan ne l p ij» tte s  in  the assay vould be a fu rthe r technical im provem ent. 
Hovever, such developments vou ld  necessitate the use of expensive specialized 
equipm ent, such as a la m ina r a ir- flo v  cabinet (to counteract the increased rislc 
of contam ination), a heating bloclc and a cold tra y  for m ic ro titre  p la tes. The 
advantage of the present method is  th a t i t  requires no such equipment and could 
be perform ed, i f  necessary, a t the patient's bedside, or in  camp conditions, v h ic h  
has already d ra v n  the a tten tion  of a VHO specialist. D r. Podoprigora (personal 
com m unication).
The endotoxin levels in  th is  study vere converted from  picograms in to  endotoxin 
tm lls  and expressed in  both. I t  is  thought th a t the conversion from  w eight
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am ounts of endotoxins to endotoxin un its m ay help to overcome the great 
v a ria b ility  of activ ities  of d ifferent endotoxin preparations and batches on a 
v e ig h t basis (607). The reason for th is  v a ria b ility  is  th a t endotoxins from  
d iffe re n t G ram -negative bacteria, and even the same endotoxins, extracted by 
d iffe ren t methods from  the parent bacteria, d iffe r in  th e ir acU vity in  the LAL 
assay (132,137, 228,414,496,636). Furthermore, the a c tiv ity  of endotoxins in  the 
assay depends on th e ir degree of purifica tion . Thus, the potency of 
"environm enta l" or "natura l" endotoxins, although varied, is  very lo v  in  
com parison v ith  purified endotoxins (406,413).
I t  is  also possible.that the a c tiv ity  of "free endotoxin", v h ic h  is released from  cells 
du rin g  no rm a l, hea lthy g rov th ,m ay d iffer in  the LAL test, vhen  compared to the 
a c tiv ity  of endotoxin released by cell lysis, although there is  some evidence to 
con trad ic t th is  (252). Therefore, to a llo v  comparison of results of th is  study v ith  
those obtained by others and to comply v ith  the FDA recommendations and 
appeals by vorlcers in  the fie ld (132,287), Endotoxin Units (EU) have been adopted 
to express endotoxin a c tiv ity  in  the LAL assay. Hovever,due to problems v ith  LAL 
)cits (see "Results", 352. SepUc shoclc tr ia l, and 353. Acute pancreaUtis -  
p re lim in a ry  tr ia l ), in  some cases endotoxin a c tiv ity  in  samples could only be 
asessed by m easuring extincUon of these samples, and vas expressed in  Optical 
Density (0 D J un its , v h ic h  represent re lative levels of endotoxin.
423 . Effect of heat on endotoxin in  plasma and in  pyrogen-free v o te r 
For th is  study, d ilu tion  and heating vere employed as the method of choice for 
rem oval of in h ib ito rs  and non-specific activators present in  plasma. Vhen 
d iffe ren t tim es and temperatures of heaUng vere compared, i t  appeared th a t 
there va s  no difference betveen heating of plasma a t lOO^ C for 10 m inutes and for
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1 m inu te  (Fig 20). Therefore, the la tte r mode of heating plasma samples vas 
chosen fo r the LAL assay for tim e-saving reasons. I t  vas also shovn th a t the 
standard curve, a fte r heating plasma for 10 m inutes a t 56®C, vas completely fla t 
(Fig 20). This observation is supported by the find ings of Cundell and colleagues, 
th a t pasteurization of plasma proteins reduces detectable endotoxin 
concentrations (95). As i t  is  believed th a t heating to 50®C does not destroy 
endotoxin, one possible explanation is  th a t, a t tem peratures up to 60®C, endotoxin 
in h ib ito rs  in  plasm a are not inactivated and they m ay be responsible for the 
disappearance of endotoxin from  tested samples. A decrease in  levels of endotoxin 
heated in  pyrogen-free v o te r vas shovn to be tim e-dependent (Fig 21). This 
fin d in g  is  very .surprising because of the Icnovn resistance of endotoxin to 
physica l factors (593). Aggregation of lipopolysaccharide molecules in  heated PFV 
m ay be a possible explanation. In  v o te r, LPS exists as large aggregates (368) and 
heat m ay encourage fu rth e r aggregation. This endotoxin aggregation may be 
prevented in  p la te le t-rich  plasma, vhere endotoxin is bound to various blood 
components, such as platelets (632), specific antibodies and, possibly, fibronectin 
(44). This m ay be responsible also for am plified reaction betveen LAL and plasma 
endotoxin in  comparison v ith  endotoxin in  PFV, as, even a fte r the heating stage 
of the extraction procedure, plasma endotoxin, being bound to soluble plasma 
components, m ay be prevented from  aggregation and thus m ay exhibit much 
h igher a c tiv ity  in  the reaction v ith  LAL than aggregated endotoxin in  v o te r.
4 2.4. Comparison of three com mercial k its  for the chromogenic LAL assay 
In  th is  study, the method used to test the Coat est Endotoxin Icits and QCL-1000 k its  
va s  our m odification of the m anufacturer's recommended method. This 
m odifica tion optim ized the assay conditions. The one-stage assay procedure for 
h igh  concentrations of endotoxin vas applied to both Jdts to make the
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m odifica tion  comparable v ith  the method recommended for the m allinckrod t 
k its .
Comparison of a ll three k its  shoved poor performance of the m a llinckrod t k it (Fig. 
22). The difference in  performance of d ifferent lots of LAL from  m A. Bioproducts 
(Fig. 23) indicates th a t there is a h igh batch to batch v a ria b ility  of the t  a t. 
reagent. Hovever, the standard curve v h ic h  is f^rfo rm ed v ith  every series of 
samples tested, renders the effects of th is  v a ria b ility  neglig ible. The observed 
differences in  the LAL batches firom m. A.Bioproducts suggest th a t the differences 
in  perform ance noted betveen Idts manufactured by m . A . Bioproducts and Kabi 
D iagnostica m ay not be s ig n ifica n t.
The find ings of th is  study, v h ic h  shoved considerable v a ria b ility  among the 
c u rre n tly  available chromogenic LAL Icits, are supported by the results of Tvohy 
et a l. (602), vh o  demonstrated s im ila r varia tions in  performance of LAL from  
d iffe ren t m anufacturers in  the gel-clot te s t.
425 . C lin ica l applications of the LAL assay 
Gaelic neutroTCnia
Cyclic neutropenia is  a rare haematological disorder, characterized by the 
disappearance of neutrophils from  the blood and bone m a rro v  a t regular 
in te rva ls . In  m ost cases, these neutropenic cycles occur every 21 days, although 
cases of cycles occurring every 15 to 35 days have been reported (399, 654). 
Betveen cycles, the neutrophil count rises, but seldom exceeds 50% of the 
d iffe re n tia l count. In  some patients, a compensatory monocytosis and/or 
eosinophilia perm its the to ta l v h ite  blood cell count to rem ain a t a lo v  norm al 
level du ring  the neutropenic cycles. This compensatory monocytosis during
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periods of nen tro f^n ia  is  Ihongh l lo  te  responsible for the fa d  Ib a l cgclic 
neutropenia, vb e n  com j^ired v itb  congenital neutropenia, leads less breqaentlg 
to  life -th re a te n in g  diseases (213).
Hovever, in  other patients, the v h ite  blood cell count mag fa ll to lo v  levels during 
the neutropenic cgcle and rise  to near norm al levels te tveen  c ^ le s . The 
nentropenic phase of each cgcle is  characteristicallg associated v ith  c lin ica l 
sgm ptom s, sxtch as fever, m alaise, ch ills , anorexia and ulcers of the ora l mucous 
m em brane. Additional sgmptoms in  some patients include: in te rm itte n t 
a rth ra lg ia , abdom inal pa in, sore th ro a t, Igm phadenitis, ischiorectal in fections, 
m enta l depression, con junctiv itis  and cutaneous ulcers.
The c lin ic a l m anifestations usualig appear one to three dags pnor to ang ohongts 
in  the  d iffe re n tia l blood count and mag persist from  three or four dags up to 10 
d a ^ . The pa tien t is  generallg healthg te tveen  the periods of neutropenia (543). 
I t  is  thought th a t endotoxin mag te  responsible for fever and m alaise in  the 
neutropenic phase o f the cgcle. Thus Greenberg et a l. demonstrated th a t the 
presence of sgstem ic endotoxaemia or staphglococcal abscesses vere  associated 
v ith  blood neutroph il nad irs, monocgte elevations, and pealc u rina rg  Colong- 
S tim u la ting  Factor (CS J J levels. In  th e ir studg,theg also observed the absence of 
endotoxaemia during  four neutrophil nadirs. Theg attributed i t  to the patient 
having received o ra l an tib io tics during these periods (184).
Such trea tm en t decreases endotoxaemia in  experimental anim als bg d im in ish in g 
the content of Gram -negative organisms in  the hovel (60). In  a hum an studg, 
selective decontam ination v ith  polgmgxin to remove Enterobactertqcege from  
the digestive tra c t, d id cause a s ign ificant decrease in  the faecal endotoxin
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concentration in  im munocomprom ised patients (524).
In  our studg, v e  failed to demonstrate ang correlation betveen endotoxin levels, 
bodg tem perature and neutroph il counts (Fig 24). This is  probablg a resu lt of 
shortcom ings in  the design of th is  studg. The patient vas m onitored v ith  
in su ffic ien t frequencg, ie .a t  in te rva ls  of a fev  dags.
I t  is  suggested th a t in  future studies, relevant parameters should be measured 
da ilg ,and  even more frequentlg around the tim e of expected neutroph il nad ir, i  e . 
a t fou r-hourlg  in te rva ls .
A rise  in  pa tien t's  tem perature is  an unsatisfactorg indication for more firequent 
m on ito ring  of endotoxin levels. This is because there is a latencg period of a fe v  
hours betveen the appearance of endotoxin in  the bloodstream and the release of 
the endogenous pgrogen (Leulcocgtic Endogenous m ediator, LEIH), v h ic h  mediates 
fever bg d irect action on the therm oregulatorg centres in  the hgpothalam us.
V ith  the "ephem eral" character of endotoxin in  blood, there mag not be ang 
endotoxin detectable in  the sgstemic circulation a t the tim e vhen  the bodg 
tem perature rises .
I f  gu t-derived  endotoxin appears to plag a significant role in  c lin ica l 
m anifestations associated v ith  the neutrophil n ad ir, it  m ag prove beneficial for 
p atien ts  v ith  cgolic neutropenia to undergo treatm ent v ith  an oral endotoxin 
adsorbent p rio r to and during the neutrophil n a d ir.
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Septic shock t r ia l
The resu lts of LAL assays of blood in  a group of 10 c ritic a lly  i l l ,  but not necessarily 
sepUc shock, patients ve re  disappointing. Hovever, the.v wgs a
good corre la tion  betveen s ign ifican t levels of endotoxin, posiUve blood cultures 
and the  c lin ic a l course in  one pa tien t, R.O. (Fig 25). of endotoxaemia a fte r
surgery, such as seen in  th is  pa tient, have also been reported by Grundmann and 
Papavasiliou (191).
Hovever, the  resu lts from  th is  group of patients did suggest th a t more frequent 
m on ito ring  of patients in  septic shook could provide in fo rm ation  on the possible 
re la tionsh ip  o f endotoxin levels and severity of septic shock. This proved to be the 
r ig h t course, as te s t confirm ed bg the results obtained from  patient B l.  (Fig.27). 
I f  th is  {K itien t had been m onitored da ily , her septic episode vou ld  probablg have 
been m issed . Hovever, there is  a s trildng  feature in  th is  case of septic
shcKïk. A G ram -positive organism , Staphulococcus aureus, vas isolated from  six 
out of 10 blood cultures from  th is  patient during the period corresponding v ith  
endotoxaemia. G ram -negative organism s vere never isolated firom th is  patient's 
blood cu ltures. S im ila rly , H arris and colleagues, in  tv o  of th e ir patients v ith  
G ram -positive bacteraem ia, also found sgstemic endotoxaemia (204). This mag be 
explained in  tv o  vags. F irs tly , th is  patient's Gram-positive septicaemia could 
have caused abnorm al perm eability of the gut. Endotoxin detected in  the LAL 
assay vou ld  in  th is  case be of in tes tin a l o rig in . Secondly, th is  patient could have 
had an undetected septic fcwus outskf^ the bloodstream. Endotoxin released bg 
bacteria from  source could have been a reason for the endotoxaemia in  th is  
pa tien t. According to Levin (285, 287), the presence of endotoxin in  blood is not 
usually a d irect consequence of the bacteria vh ich  are in  the c ircu la tion  a t the 
tim e the sample is  obtained, but more commonly is due to bacteria outside the
109
bloodstream , v h ic h  have generated endotoxin v h ic h  subsequentlg gains access 
to the c ircu la tio n .
In  th is  pa tie n t, there vas a close tem poral re la tionsh ip  betveen levels of 
endotoxin,and cardiovascular and respiratory indices (Fig.27). There vas  also an 
inverse corre lation betveen plasma fibronectin and endotoxin levels (Fig.28). 
Vhen the endotoxin vas elim inated from  the blood, recovery of plasma 
fib ronectin  to v ith in  the norm al range vas observed.
Patient A C . had the highest endotoxin levels recorded in  our septic shock patients 
(FigJS)), approxim ately 10 tim es higher than in  other patients vho  presented 
V ith  septic shock. His plasma fibronectin levels^correlated v e il (inversely) v ith  
h igh  endotoxin levels . Hovever, the corresponding
pulm onary shunt and alveolar a rte ria l oxygen difference vere only m oderately 
elevated. Despite the fact th a t the cardiovascular and respiratory indices of th is  
pa tie n t ve re  not h igh , and despite intensive therapy a t ITU, he died nine hours 
a fte r adm ission.
The hypothesis m ay be postulated th a t th is  patient m igh t have died as a resu lt of 
d irect toxic action of endotoxin, v h ile  the condition of patient BL. vas caused bg 
the in d ire c t action of endotoxin. The septic shock in  patient B l.  could have been 
caused bg host m ediators of shock, ie . various enzym atic systems v h ic h  vere 
activated bg endotoxin present in  the c ircu lation (94,336,TO7).
I t  also seems th a t patients a t the highest risk  of developing septic shock mag be 
hypersensitive to endotoxin. Their hypersensitiv ity mag be a result of th e ir 
c lin ica l condition or the trea tm ent v h ic h  theg receive (see "Introduction , section
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1J3. Biological a c liv ilg ). Fever mag be gel another im portan t factor v h ic h  
increases paUents’ sensitiv itg  to endotoxin. I t  has been shovn to decrease the 
clearance of ce rta in  agents C42) and mag also affect the clearance of endotoxin 
(116). Also, the presence of endotoxin in  the gastro in testina l tra c t (as a pa rt of the 
norm a l in te s tin a l flo ra) apparently seems to increase sensitiv itg  to endotoxin in  
the bloodstream . Experimental data shov th a t c ircu la ting  endotoxin mag 
m obilize add itiona l endotoxin of gut o rig in . Thus endotoxaemia could become a 
se lf-susta in ing  process (60,92).
This hype rsens itiv ity  to endotoxin of some individuals in  certa in  conditions could 
be responsible for catheter fever in  cases vhere endotoxin vas found to 
contam inate catheters (170, 272, 446, 591). Hovever, Garibaldi and colleagues 
reported th a t in  patients v ith  indve iim g  u rin a ry  catheters and no severe 
underly ing  disease, positive LAL tests vere not accompanied bg any c lin ica l signs 
of endotoxaemia. Theg demonstrated, hovever, an excellent correlation betveen 
the presence of Gram-negative u rinarg  tra c t in fection in  these patients and 
positive LAL tests (169). S im ila rly , Sim and mcCartneg,and Kiss et al. found th a t 
tra n s ie n t endotoxaemia in  "norm al" ind ividuals, fo llo v in g  u re th ra l 
in s trum en ta tion  (524) and colonoscopy (263), vas not accompanied bg any c lin ica l 
m anifestations of endotoxaemia, including fever.
This m ag be explained bg rapid clearance of bolus-dose endotoxin from  the 
bloodstream  of norm al, healthg individuals. The speed of th is  clearance mag 
prevent endotoxin from  trigge ring  various systems of host m ediators, including 
endogenous pgrogen, v h ic h  is d irectly responsible for febrile reactions. Also, 
probablg re la tive ly  lo v  doses of endotoxin are involved in  cases of 
post-instrum enta tion  endotoxaemia v ith o u t fever, and th is  contributes to the
I l l
lack of p a tien t response to endotoxin present in  th e ir c ircu la tio n .
For undfTflandablt rtafon#, there ie little experimental data on the epeed of 
endotoxin clearance in  hum ans. H ovever, Greism an and colleagues found th a t 
th e  h a lf-tim e  of clearance of sm all quantities of Pseudomonas so. endotoxin in
hum an volunteers v a s  8 2  + 063 m inutes vh en  labelled v ith  ^^CrClg and 8.2 + 1.3 
m inutes v h e n  labelled v ith  Ila 2^^CrO^ (186).
Experiments on anim als provide much more data on the speed a t v h ic h  
endotoxin is  removed from  the c ircu la tion . Herring and colleagues and the Careg 
group found th a t, a fte r intravenous in jection  in to  rabb its of sublethal doses (0 Û06 
-  0100 m g) o f E. co li endotoxin, %% of c ircu la ting rad ioactiv ity  is  r emoved v ith in  
five  m inutes and appears in  the live r v ith in  15 m inutes (51, 216). These 
observations ve re  suppor ted bg Beeson and A tkins, vho  r eported th a t endotoxin 
ra p id ly  disapjæ ars from  the bloodstream, so th a t litt le  pgrogenic a c tiv ity  can be 
detected in  ra b b it serum  8-10 m inutes after intravenous in jec tio n  of endotoxin 
(17,25)# A fte r intravenous in jection  in to  rabbits of large le tha l doses (5Û mg) of 
radiolabelled E. co li endotoxin, only 30-50% of rad ioactiv ity  is removed from  the 
blood during  the f irs t 15 m inutes, 30-50% mag be found there tv o  hours la te r, and 
20% s t ill circu lates a fte r five hours (51 ).
Hepatic uptake of rad io activ ity  in  xrabbits injected v ith  5 0 mg of Ecoh endotoxin 
is  prnpnrr i^fmf^g 'g less ^bnrt v ith  sublethol doses, so th a t only 20% is  found in  the 
liv e r a fte r 15 m inutes (51). A s im ila r difference in  d is tribu tion  of radioacU vity of 
le tha l (0.75 m g) and sublethal (001 mg) doses has been noted in  m ice (51). Livers 
of norm al m irt# tra p  in  one hour more than K)% of LPS injected in travenously (628).
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In  m ongrel dogs, 99 B to 99 9% of endotoxin adm inistered in travenonsig a t doses of 
5,30 and KH) i^gAcg disappeared from  the circu lation v ith in  five m inutes. For 5 
and 50 |lg /kg  there fo lloved a s lover clearance ra te , v ith  a mean ^m f ufe of 21.4 
and 10 3  m inutes re s j^ t iv e lg . Vhen 5CM) jig/kg vas adm inistered, rap id  clearance 
va s  shovn  t i l l  OT m inu tes. Then, from  30 m inutes to three hours, i t  vas  s lo v lg  
cleared, bu t a fte r three hours there vere no rem arkable changes nnd 
approxim atelg 50 to pg /m l of endotoxin vere s till found a fte r 12 hours (361Î . I t  
should be noted here th a t, according to Berczi et a l.. a le tha l dose of LPS for dogs is 
4 D m g/kg o f bodg v e ig h t (31 ).
There is  also a possib ilitg  th a t, in  some individuals, hypersensitiv ity to endotoxin 
is  determ ined genetica lly and is  expressed as an excessive num ber of endotoxin 
receptors. mcCuskeg and colleagues established th a t the live rs  of an 
endotoxin-resistant m urine  s tra in  C3H/HeJ contained 60% fever phagocytizing 
Kupffer ce lls, and th a t these cells contained much less lysosomal enzymes, in  
com parison v ith  endotoxin-sensitive C3HeB/FeJ mice (312). The authors' 
conclusion v a s  th a t th e ir results suggested th a t the in sens itiv ity  of C3H/BeJ 
m ice to endotoxin m ig h t be related in  part to a lysosomal enzyme deficiency and 
a paucity of phagocytic Kupffer cells in  these anim als. Hovever, im paired 
phagocytosis in  endotoxin-resistant mice seems to be a secondary phenomenon, 
ra th e r ^bnn q cause of resistance. Impaired phagocytosis of endotoxin vould 
resu lt in  prolonged c ircu la tion  of endotoxin in  the bloodstream. This, in  norm al 
conditions, could lead to a much higher activation of various endotoxin m ediators, 
as compared to th a t in  endotoxin-sensitive mice.
Hovever, a hypothesis, th a t endotoxin—resistant mice lack endotoxin receptors, 
and th a t deficiency is  genetically determ ined, could sa tisfactorily  explain
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Ih e ir resistance. As a resu lt of the lack of active, specific receptors, endotoxin 
vou ld  no t be able to attach to the cell surface and thus vou ld  not be able to 
m ediate the release of various enzym atic system s. These systems are probably 
responsible fo r secondary biological effects of endotoxin fie . through host 
m ediators as opposed to d irect toxic ity). Hovever, th is  hypothesis cannot be 
supported by any experim ental evidence, because so fa r very lit t le  is  Icnovn about 
receptors fo r endotoxin. The present state of knovledge is revieved by Bradley 
(50).
I t  should also te  taken in to  account th a t our understanding of the biological 
efiects o f endotoxin is  based on the adm in istra tion of endotoxin as a bolus, ra th e r 
than  as a continuous release in  sm all amounts over a period of hours or days, as 
probably occurs during  an infection (%). Unfortunately, the bolus mode of 
a d m in is tra tio n  is  favoured by m any vorkers, and in  nearly a ll an im a l models 
endotoxin is  given in  a single dose. Results thus obtained m ay be of very lit t le  
value fo r in te rp re ta tion  of the c lin ica l s itua tion .
Hovever, i t  seems lik e ly  th a t vhen  a bolus dose of endotoxin is adm inistered to 
hea lthy ind iv idua ls v ith  norm al sensitiv ity  to endotoxin and unim paired 
clearance of endotoxin, endotoxin is cleared so rap id ly  from  the bloodstream th a t 
the vho le  system  of m ediators rem ains unaffected In  contrast, there are very 
sick pa tien ts, compromised by illness and/or treatm ent, vho  m ay be genetically 
hypersensitive to endotoxin or vho  may be rendered hypersensitive, and in  
vhom  there m ay be a continuous flo v  of endotoxin from  the source of in fection 
in to  the bloodstream . In  these jx itien ts  the clearance of endotoxin m ay be 
s ig n ifica n tly  im pa ired . A ll these factors promote the activation of the cascade of 
host m ediators of response to endotoxin, and as a result the patient m ay die from
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secondary effects of endotoxin. This may also explain the phenomenon v h ic h  is 
som etim es observed in  septic shw k %xitients; they m ay die apparently in  septic 
sh^ck, depite the  fact th a t the level of endotoxin a t the tim e of th e ir death m ay be 
quite lo v . Hovever, in  such paüents, a peak of endotoxin m ig h t have occurred 
some tim e  e a rlie r and m ay even have gone undetected. The c lin ica l p icture of 
such a pa tie n t a t death vould be th a t of lo v  endotoxin levels and h igh  
cardiovascular and resp ira tory indices, as observed in  patient AJHcD. (Fig 31). I t  
is  lik e ly  th a t in  th is  pa tien t, endotoxin levels vere  elevated p rio r to h is admission 
to ITU some 48 hours a fte r the onset of shw k. Hovever, h is  endotoxin levels vere 
unrem arkable during  h is  stay in  ITU, despite grossly elevated pulm onary shunt 
and alveolar a rte ria l oxygen difference.
Conclusions a t present suggest th a t there are probably no "c lin ica lly  s ign ifican t" 
levels o f endotoxin in  c ritic a lly  i l l  j^xitients. Their sens itiv ity  to endotoxin may 
depend on c lin ic a l factors and th e ir genetic m ake-up. This vou ld  im p ly  a v ide  
range of se n s itiv ity  to endotoxin.
I t  is  probably the se ns itiv ity  of the jK itient to endotoxin v h ic h  determ ines the 
pa tien t's  response. Septic shock vould then be one of the vays in  v h ic h  the 
in d iv idua l m ay respond to the presence of endotoxin in  h is b loa lstream .
The degree of hypersensitiv ity to endotoxin could determ ine the extent of the 
organism  response to endotoxin by releasing the appropriate axnount of 
m ediators of septic shock. In  th is  va y , septic shock vould depend on endotoxin 
only in d ire c tly , find the severity of septic shock could depend on factors other 
than  endotoxin levels present in  the patient's bloodstream. This hypothesis, i f  
proven, could have profound im plications for the development of nev vays of
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tre a tm e n t of fx itien ts  v ith  G ram -negative septic shock. There could be a 
possib ilitg  of blocking endotoxin receptors in  such patients (v ith  endotoxin 
analogues, fo r exam ple), thus preventing the release of m ediators of the host 
response to  endotoxin.
The v a g  in  v h ic h  endotoxin gets in to  the blcxxl-stream is probablg another 
im p o rta n t facto r v h ic h  mag decide th a t the response of the ind iv idua l to 
endotoxin takes the fo rm  of septic shock. Continuous levels of endotoxin in  blood 
m ag not be h ig h  enough to cause death d irectly as a result of endotoxin tox ic ity , 
but they m ay be su ffic ien t to trigge r irreversib ly a cascade of m ediators of septic 
shock.
From the  above discussion, i t  seems unlike ly th a t assays for endotoxin v i l l  
become a rou tine  c lin ic a l test v h ic h  could, in  an unequivocal m anner, determ ine 
the pa tie n t's  diagnosis and/or prognosis. This is because the presence of 
endotoxin in  the bloodstream seems to be a requisite but insuffic ient condition for 
the pathogenesis of septic shock. Hovever, the question of the value of the LAL 
assay as a c lin ic a l test requires fu rthe r investigation, as recently Schreibman 
and colleagues found the Lim irlns lysate index valuable in  the early prediction of 
fa ta l sepsis (4%).
nevertheless, the LAL assay for endotoxin can be useful in  c lin ica l research on 
endotoxaemia and septic shock. This study may be regarded only as a p ilo t one, 
v h ic h  leaves m any questions unansvered, and indeed seems to pose many nev 
questions. I t  is  proposed th a t in  future studies endotoxin assays should be carried 
out concurren tly v ith  assays for fib ronectin .
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L illie  v o rk  has been done so fa r to shov the re lationship betveen endotoxin and 
fib ronectin  levels in  d ifie ren t groups of patients (551). The present studg seems to 
con firm  th a t there is  good inverse corre lation betveen them . The fibronectin  
assay could be a helpfu l auxihary assay in  studies on endotoxaemia, e s j^ ia lly  
since the  LAL assay is  very prone to accidental contam ination. Concomitant 
fib ronectin  assays could therefore help in  excluding false-positive resu lts .
Furtherm ore, even a sensitive assay for endotoxin, such as th a t described in  
study, has a ce rta in  lim it  of se n s itiv ity . This a llovs endotoxin in  some samples to 
escape undetected.
The am ount of endotoxin contained in  a single Escherichia coli bacterium  is  40 
fem togram s per in ta c t cell (378, 634), v h ic h  is v e il belov the threshold of 
s e n s itiv ity  of any Icnovn assay for endotoxin. Hovever, one viable bacterium  m ay 
ensure a positive blood cu ltu re . This m ay lead to an apparent paradox vhen  blood 
cu ltures are positive due to a Gram-negative organism , and concom itant 
endotoxin a s s a ^  are negative. In  such a case fibronectin levels vould be expected 
to be decreased, v h ic h  i f  confirm ed vould lend greater cred ib ility  to some results 
of LAL assays.
A proportion of septic shock episodes are due to Gram-positive pathogens. 
C lin ica lly , G ram -positive septic shock is indistinguishable from  Gram-negative 
septic shock (198, 279, 512). Gram-positive septicaemia could in  some cases be 
accompanied by endotoxaemia due to endotoxin of in testina l o rig in , nevertheless, 
in  Gram—positive septicaem ia, fibronectin levels vould be expected to be lo v . In  
such cases the fib ronectin  assay could be used as an aid in  in te rp re ting  endotoxin 
resu lts.
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Endotoxaemia v ith o u t concom itant Gram-negative Ixicteraem ia is also probablg 
a common resu lt of appropriate an tib io tic treatm ent of Gram-negative sepsis. It 
has been dem onstrated th a t antib io tics can induce the release of endotoxin in  
v itro  (10) and in  experim ental models in  vivo (241,510). Although unproven, the 
propensity of an an tib io tic  to liberate s ign ificant amounts of endotoxin from  
G ram -negative bacteria in to  the bloodstream is potentia lly of p ivota l c lin ica l 
relevance. The possib ility  th a t the use of antib io tics for Gram-negative 
bacteraem ia can actua lly cause endotoxaemia and greatly increased m o rta lity  in  
thus-trea ted  patients has been a serious consideration for m any years nov (58, 
59,155,402,443,498,544,630). Tvo more recent studies suggested th a t bactericidal 
an tib io tics  ve re  responsible for the release of large amounts of endotoxin, 
vhereas bacteriostatic antib io tics did not appear to liberate s ign ifican t 
quantities of enditoxin (179, 509). Furthermore, Shenep and colleagues 
dem onstrated s ig n ifica n t differences in  the propensity of d iss im ila r classes of 
bacteric ida l an tib io tics to liberate endotoxin, independently of the rate of 
bacteria l Ic illin g  (509). m onitoring fibronectin levels could also be useful in  cases 
of endotoxaemia v h ic h  occur as a result of antib io tic treatm ent and vh ich  may 
lead to septic shock, despite negative results of m icrobiological investigations.
The fin a l argum ent for m onitoring fibronectin levels concom itantly v ith  
endotoxin is  th a t the detectable endotoxaemia seems to be present only during 
the re la tive ly  short, in iU a l stages of development of sepUc shock (Fig 20). As a 
resu lt, i t  often m ay be missed, v h ile  decreased levels of fibronectin may persist 
fo r a longer period. This is v h a t m ight actually have happened to patient A . me D. 
(Fig 31). He had undergone intensive antib io tic therapy for 48 hours p rio r to his 
adm ission to ITU. This therapy bg itse lf could have been responsible for 
endotoxaemia, leading to endotoxic s h o c k ,although his endotoxin levels vere not
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rem arkable a l the  lim e  of admission to ITU. On the other hand, i t  cannot be 
excluded th a t an tib io tic  treatm ent itse lf did not have adverse effects on th is  
p a tie n t, bu t endotoxin v h ic h  vas present in  the blood during the period of 
bacteraem ia caused irreversib le  damage bg trigge ring  systems of m ediators.
Patients F H .,  J .V . and J m . had moderate septic shock. In  PH., septic shock vas 
of G ram -positive o rig in , v h ic h  could explain h is unrem arkable endotoxin levels 
and m oderately depressed fibronectin levels. In  any case,his pulm onary shunt 
and a lve o la r-a rte ria l oxygen differences vere lo v  (Fig33). Hovever, patients J.V . 
and J m ., although th e ir septic status vas s im ila r to th a t of PH.,had moderately 
elevated cardiovascular and respiratory indices (Figs. 35 and 36). Their endotoxin 
levels a t the  te g in n in g  vere  h igher than those of P.H.
Acute pancrea titis  -  p re lim inaru  tr ia l
P atient JD . (Fig.41) seemed to have endotoxaemia related to h is severe 
p a n c re a titis . Hovever, m onitoring of his endotoxin levels started only 60 hours 
from  the  onset of c lin ica l symptoms and furtherm ore the patient had been 
commenced on antib io tics tv o  days p rio r to the s ta rt of endotoxin sam pling 
These factors make any defin ite conclusions very d iffic u lt. Hovever, m ild  pyrexia 
on day four m ay be related to transien t increase of endotoxin levels in  th is  
pa tien t (Fig .41). Also, testing of h is peritoneal flu id  for endotoxin in  para lle l v ith  
h is  blood va s  not done. This could have provided additional valuable in form ation 
on the role of endotoxin in  pathogenesis of acute pancreatitis. Technically, 
obta in ing peritoneal flu id  from  patients v ith  severe acute pancreatitis does not 
present any d iffic u lty  in  cases vhere these patients are commenced on peritoneal 
lavage on m edical grounds, as many such patients are .
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In  another pa tien t v ith  severe acute pancreatitis, no s ign ifican t levels of 
endotoxin ve re  found, but th is  could be a ttributed to the delayed commencement 
of m on ito rin g  h is  blood for endotoxin. This delay vas 96 hours firom the onset.
Patients C B . and n C . had endotoxaemia unrelated to fx increa tltis  (Figs. 42 nnrt 4 3 j . 
Peaks in  th e ir endotoxin levels could be attributed to surgical m anipulations -  
in tub a tion  and extubation -  v h ic h  vere carried out during the course of th e ir 
tre a tm e n t. I t  is  in te resting  to notice th a t the rise in  endotoxin levels in  these 
patien ts v a s  not accompanied by fever. Although, in  patient n.C., a rise in  
tem perature to  3 8 ^  vas  observed, i t  preceded the extubation of th is  patient and 
concom itant rise  in  endotoxin level in  one instance, and in  another instance, no 
p a ra lle l increase in  endotoxin levels vas observed.
In  pa tie n t m m ., vh o  had m ild  pancreatitis, no rem arkable levels of endotoxin 
ve re  observed. Hovever, endotoxin levels vere s lig h tly  elevated on day tvo ,  
v h ic h  could probably be attributed to the in d ve ilin g  u rina ry  catheter (Fig .44).
On the basis of the present p re lim inary tr ia l, i t  seems th a t endotoxin m ay play 
some role in  acute pancreatitis, but i t  is d ifficu lt to assess the extent of its  role in  
the pathogenesis of th is  condition, and also its  potentia l value in  diagnosis and 
prognosis of acute pancreatitis. In  conclusion, for future studies frequent 
monitoring of endotoxin levels firom the very onset of acute jxm creatitis  is  
proposed, combined v ith  measuring of endotoxin levels in  peritoneal flu id , 
vhe reve r feasib le.
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4 2 JB. non-clin icol applications of the LAL assay 
Extra-com oreal filte r to remove endotoxin from hrrmnn wnmH 
The obtained results clearly demonstrated that the I-DEP filte r is not capable of 
extracting endotoxin from  human plasma in  amounts vh ich  could be useful 
clin ically . These results are contradictory to those obtained by Qerba and 
colleagues, v h ich  shoved that the I-DEP fille r vould extract endotoxin from  
hum an plasm a (171). Hovever, the results obtained in the present study suggest 
th a t spontaneous extracorporeal endotoxin decay may present as efficient a 
method of endotoxin rem oval from human blood as any knovn extraction system .
Thus, fu rther vo rk  vas  planned, vh ich  could also viden our knovledge about the 
Icinetics of endotoxin decay in  norm al human plasma and in septic plasm a. It  
vas  proposed to test the rate of decay of exogenous endotoxin in  plasma from 20 
norm al volunteers a t CPC and 37®C. The results thus obtained could be compared 
v ith  the Icinetics of decay of native endotoxin in  plasma from Gram-negative 
septic patients, and v ith  the kinetics of endotoxin decay in plasma from  
Gram -negative septic patients after the addition of exogenous endotoxin. It  vas  
also planned to test the rate of decay of exogenous endotoxin in plasma of patients 
v ith  Gram -positive sepsis in  order to establish vhether the kinetics of endotoxin 
decay in  Gram -negative septic patients vas peculiar to this condition or vhether 
it  vas  s im ila r in  other comparable conditions.
It  could be expected th a t the rate of endotoxin decay in septic patients is severely 
im paired. If  so, th is  could be one of the factors responsible for the development of 
septic shock. A further project on the kinetics of endotoxin decay in  plasma from  
the same patient a t different stages of sepsis or septic shock (in a group of septic
patients) vas  also planned.
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A lternative means of removal of endotoxin from the blood of severely ill patients 
v ith  endotoxaemia also seem to v a rra n t urgent investigaUon. It  is certainly  
{K)ssible to remove endotoxin from circulating bltx)d by perfusion through 
charcoal or resins (416), or by passage over membranes, to vh ich  anti-endotoxin 
antibody has been attached (156). Hovever, the clinical usefulness of these 
models requires further investigation. Also, Detoxi-Gel (endotoxin removing gel) 
m anufactured by the Pierce Chemical Company (Roclcford, Illinois 61105, USA) m ay 
prove to be a viable means of endotoxin removal from human plasm a. Its formula 
(vh ich  cannot be revealed due to a binding Secrecy Agreement) suggests th a t 
tetoxi-G el can be efficient and, v h a t is more, applicable in  the clinical situation 
for extracorporeal removal of endotoxin from patients' plasm a.
Endotoxin can also be removed by u ltrafiltration (599). Hovever, vh ile  
u ltra filtra tio n  techniques vorlc v e il v ith  some solutions vh ich  contain only 
sm all molecules, they are not suitable for plasm a. A further means of removing 
contam inating endotoxin from biological preparations is by absorption v ith  the 
Limulus amoebroyte lysate (40, 448). Hovever, this method, if  applied on a large 
scale, vould be unacceptably expensive and is clearly unsuitable c lin ically .
It  has been suggested by different authors (see above) th a t, in  m any cases, 
endotoxin in  clinical endotoxaemia could be of intestinal origin. Therefore, 
V ellm an gnfi colleagues employed a modified method of vhole gut irrigation as 
antiendotoxaemia therapy to treat patients, suffering from in flam m atory hovel 
disease v ith  m ar Iced endotoxaemia, and vho vere unresponsive to conservative 
treatm ent (640). Folloving the lavage, the condition of a ll the patients improved. 
This vas  accompanied by a rapid decrease in  endotoxin levels. At the same tim e, 
serum iron increased and in  a ll patients vho had been persistently pyrexial prior
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to Irrig a tio n , the bodg temperature returned to norm al bg the dag a lter lavage 
and did not increase therafter. It  should te  noted here th a t decreased levels of 
serum  iron and increased bodg temperature seen in  these patients could be 
attributed  to endotoxaemia.
Another approach to endotoxaemia of intestinal origin vas  employed by the 
Urbaschek group (609) and bg Shimanko and colleagues (511). In  the ir laboratory 
model J Urbaschek et a l. found that Bentonite, Kaopectate and Kaolin administered 
per os v e re  able to prevent endotoxaemia completely. S im ilarly, Shimanko et a l. 
found th a t, after oral adm inistration of Enter odes and Enterosorb, an 
im provem ent in  the clinical condition of patients v ith  severe endotoxicosis vas  
observed.
The m echanism  of action of the above preparations lies in  their ab ility to bind 
toxins in  the gut. They may be useful on a v id er scale in  the prevention and 
treatm ent of clinical endotoxaemia.
Baffle Plate m a te ria l and dust sample.
In  v ie v  of the fact th a t both baffle plate m ateria l and dust sample vere found to 
contain re la tive ly  h igh amounts of endotoxin, and th a t respiratory 
hype rse ns itiv ity  reactions to airborne endotoxin are knovn to occur (see 
"In troduction", subsection 123. Limulus amoebocyte lysate assay for endotoxin. 
Applications of the LAL assay. Ilon-clin ica l applications), endotoxin m ay be at 
least one of the factors responsible for the symptoms reported by the 
sem iconductor factory vorkers and the archives lib ra ria n  (see "m aterials, 
methods and patients").
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